<?xml version="1.0" encoding="UTF-8"?>
 <forms>
  <collectionName>XML-2019339</collectionName>
  <collectionDescription>Load XML</collectionDescription> 
 <form>
  <context>CTEP</context>
  <createdBy>ALAIS</createdBy>
  <dateCreated>2006-06-22T10:20:35</dateCreated>
  <dateModified>2010-11-22T15:50:13</dateModified>
  <modifiedBy>ALAIS</modifiedBy>
  <longName>Primary Cervical Cancer - On-Study Form</longName>
  <preferredDefinition>Primary Cervical Cancer - On-Study Form</preferredDefinition>
  <cadsrRAI>2.16.840.1.113883.3.26.2</cadsrRAI>
  <publicID>2019339</publicID>
  <version>3</version>
  <workflowStatusName>RELEASED</workflowStatusName>
  <categoryName>On-Study</categoryName>
  <type>TEMPLATE</type>
  <headerInstruction/>
     <module>
    <displayOrder>0</displayOrder>
    <maximumModuleRepeat>0</maximumModuleRepeat>
    <longName>CRF Header</longName>
    <instruction>
     <text>(Information contained in this section is optional and may be included at the discretion of the group; for example: preprinted labels or electronically populated fields may be used)</text>
    </instruction>
    <preferredDefinition>CRF Header</preferredDefinition>
    <publicID>2488510</publicID>
    <version>1</version>
    <usageCategory>
     <usageType>None</usageType>
     <rule>(Information contained in this section is optional and may be included at the discretion of the group; for example: preprinted labels or electronically populated fields may be used)</rule>
    </usageCategory>
         <question>
      <publicID>2488512</publicID>
      <version>1</version>
      <isDerived>false</isDerived>
      <displayOrder>2</displayOrder>
      <dateCreated>2006-06-22T10:22:47</dateCreated>
      <dateModified>2006-06-22T10:22:47</dateModified>
      <questionText>Coordinating Group Protocol No.</questionText>
            <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Protocol Coordinating Identifier Number</longName>
       <shortName>PROT_COORD_ID_NUM</shortName>
       <publicID>59</publicID>
       <version>4</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the numeric or alphanumeric identification assigned to the study by the National Cancer Institute.</preferredDefinition>
              <valueDomain>
        <longName>Protocol Identifier Number</longName>
        <shortName>PROT_ID_NUM</shortName>
        <publicID>2018389</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>35</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Coordinating Group Protocol Number</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Source</name>
         <type>DATA_ELEMENT_SOURCE</type>
         <context>CTEP</context>
         <doctext>CDE and values comply with Clinical Data Update System v. 3.0 May 2002</doctext>
         <languageName>ENGLISH</languageName>
         <URL>www.cancer.gov</URL>
                 </referenceDocument>
        <referenceDocument>
         <name>Coordinating Group Protocol N</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Coordinating Group Protocol No.</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text 1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>If yes, provide CTEP # or NCT #</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=59&amp;version=4</cdeBrowserLink>
      </dataElement>
           </question>
     <question>
      <publicID>2488513</publicID>
      <version>1</version>
      <isDerived>false</isDerived>
      <displayOrder>3</displayOrder>
      <dateCreated>2006-06-22T10:22:47</dateCreated>
      <dateModified>2006-06-22T10:22:47</dateModified>
      <questionText>Coordinating Group Code</questionText>
            <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Coordinating Group Identifier Code</longName>
       <shortName>COORD_GP_ID_CD</shortName>
       <publicID>2797</publicID>
       <version>4</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the unique alphanumeric or numeric code assigned by the NCI to identify the Cooperative Group coordinating the clinical study.</preferredDefinition>
              <valueDomain>
        <longName>Group Identifier Code</longName>
        <shortName>GP_ID_CD</shortName>
        <publicID>2018391</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>40</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>Source</name>
         <type>DATA_ELEMENT_SOURCE</type>
         <context>CTEP</context>
         <doctext>Data element and all values comply with Clinical Data Update System (CDUS) v3.0 Release 2</doctext>
         <languageName>ENGLISH</languageName>
         <URL>http://ctep.cancer.gov/reporting/cdus.html</URL>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Coordinating Group Code</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Coord Group Code</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Coord Group Code</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=2797&amp;version=4</cdeBrowserLink>
      </dataElement>
           </question>
     <question>
      <publicID>2488514</publicID>
      <version>1</version>
      <isDerived>false</isDerived>
      <displayOrder>4</displayOrder>
      <dateCreated>2006-06-22T10:22:47</dateCreated>
      <dateModified>2006-06-22T10:22:47</dateModified>
      <questionText>Protocol Title</questionText>
            <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Protocol Title Name</longName>
       <shortName>PROT_TITLE_NAME</shortName>
       <publicID>201</publicID>
       <version>4</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the complete title of the clinical protocol.</preferredDefinition>
              <valueDomain>
        <longName>Protocol Title Name</longName>
        <shortName>PROT_TITLE_NAME</shortName>
        <publicID>2018383</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>200</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Title</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Protocol Title</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Protocol Title</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Source</name>
         <type>DATA_ELEMENT_SOURCE</type>
         <context>CTEP</context>
         <doctext>Data element and all values comply with Clinical Data Update System (CDUS) v3.0 Release 2</doctext>
         <languageName>ENGLISH</languageName>
         <URL>http://ctep.cancer.gov/reporting/cdus.html</URL>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=201&amp;version=4</cdeBrowserLink>
      </dataElement>
           </question>
     <question>
      <publicID>2488515</publicID>
      <version>1</version>
      <isDerived>false</isDerived>
      <displayOrder>5</displayOrder>
      <dateCreated>2006-06-22T10:22:47</dateCreated>
      <dateModified>2006-06-22T10:22:47</dateModified>
      <questionText>Patient Study ID</questionText>
            <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Patient Coordinating Identifier Number</longName>
       <shortName>PT_COORD_ID_NUM</shortName>
       <publicID>782</publicID>
       <version>4</version>
       <context>CTEP</context>
       <workflowStatusName>RETIRED ARCHIVED</workflowStatusName>
       <preferredDefinition>the unique identifier assigned to a patient by the coordinating group for a protocol.</preferredDefinition>
              <valueDomain>
        <longName>Patient Identifier Number</longName>
        <shortName>PT_ID_NUM</shortName>
        <publicID>2018384</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>20</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Patient Study ID</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Coordinating Group Patient ID</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Source</name>
         <type>DATA_ELEMENT_SOURCE</type>
         <context>CTEP</context>
         <doctext>Data element and all values comply with Clinical Data Update System (CDUS) v3.0 Release 2</doctext>
         <languageName>ENGLISH</languageName>
         <URL>http://ctep.cancer.gov/reporting/cdus.html</URL>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=782&amp;version=4</cdeBrowserLink>
      </dataElement>
           </question>
     <question>
      <publicID>2488516</publicID>
      <version>1</version>
      <isDerived>false</isDerived>
      <displayOrder>6</displayOrder>
      <dateCreated>2006-06-22T10:22:47</dateCreated>
      <dateModified>2006-06-22T10:22:47</dateModified>
      <questionText>Institution/Affiliate</questionText>
            <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Combined Institution Name</longName>
       <shortName>COMB_INST_NAME</shortName>
       <publicID>2001040</publicID>
       <version>4</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the name of the clinical center or other facility within the central Cooperative Group institution where work is done on a clinical study; question asks for Institution and Affiliate Name.</preferredDefinition>
              <valueDomain>
        <longName>Institution Name</longName>
        <shortName>INST_NAME</shortName>
        <publicID>2018256</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>100</maximumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Institution/Affiliate</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Inst/Affiliate</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Inst/Affiliate</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Source</name>
         <type>DATA_ELEMENT_SOURCE</type>
         <context>CTEP</context>
         <doctext>CDE and values comply with Clinical Data Update System v. 3.0 May 2002</doctext>
         <languageName>ENGLISH</languageName>
         <URL>www.cancer.gov</URL>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=2001040&amp;version=4</cdeBrowserLink>
      </dataElement>
           </question>
     <question>
      <publicID>2488517</publicID>
      <version>1</version>
      <isDerived>false</isDerived>
      <displayOrder>7</displayOrder>
      <dateCreated>2006-06-22T10:22:47</dateCreated>
      <dateModified>2006-06-22T10:22:48</dateModified>
      <questionText>Other Patient ID</questionText>
            <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Patient Participating Identifier Number</longName>
       <shortName>PT_PARTIC_ID_NUM</shortName>
       <publicID>2269</publicID>
       <version>4</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>for intergroup protocols, the unique patient identifier assigned by the Cooperative Group who registers the patient on the study.</preferredDefinition>
              <valueDomain>
        <longName>Patient Identifier Number</longName>
        <shortName>PT_ID_NUM</shortName>
        <publicID>2018384</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>20</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Participating Group Patient ID</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Other Patient ID</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Other Patient ID</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Source</name>
         <type>DATA_ELEMENT_SOURCE</type>
         <context>CTEP</context>
         <doctext>Data element and all values comply with Clinical Data Update System (CDUS) v3.0 Release 2</doctext>
         <languageName>ENGLISH</languageName>
         <URL>http://ctep.cancer.gov/reporting/cdus.html</URL>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=2269&amp;version=4</cdeBrowserLink>
      </dataElement>
           </question>
     <question>
      <publicID>2488518</publicID>
      <version>1</version>
      <isDerived>false</isDerived>
      <displayOrder>8</displayOrder>
      <dateCreated>2006-06-22T10:22:48</dateCreated>
      <dateModified>2006-06-22T10:22:48</dateModified>
      <questionText>Participating Group Code</questionText>
            <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Participating Group Identifier Code</longName>
       <shortName>PARTIC_GP_ID_CD</shortName>
       <publicID>828</publicID>
       <version>3</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>for an intergroup protocol, the coded identifier for a Cooperative Group assigned by NCI to the group participating in a clinical study.</preferredDefinition>
              <valueDomain>
        <longName>Group Identifier Code</longName>
        <shortName>GP_ID_CD</shortName>
        <publicID>2018391</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>40</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Participating Group Code</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Source</name>
         <type>DATA_ELEMENT_SOURCE</type>
         <context>CTEP</context>
         <doctext>CDE and values comply with Clinical Data Update System v. 3.0 May 2002</doctext>
         <languageName>ENGLISH</languageName>
         <URL>www.cancer.gov</URL>
                 </referenceDocument>
        <referenceDocument>
         <name>Partic Group Code</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Partic Group Code</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=828&amp;version=3</cdeBrowserLink>
      </dataElement>
           </question>
     <question>
      <publicID>2488519</publicID>
      <version>1</version>
      <isDerived>false</isDerived>
      <displayOrder>9</displayOrder>
      <dateCreated>2006-06-22T10:22:48</dateCreated>
      <dateModified>2006-06-22T10:22:48</dateModified>
      <questionText>Patient Name</questionText>
      <instruction>
       <text>(initials acceptable)</text>
      </instruction>
      <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Patient Name</longName>
       <shortName>PT_NAME</shortName>
       <publicID>2001011</publicID>
       <version>5</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the current legal name of the person registered on the clinical trial.</preferredDefinition>
              <valueDomain>
        <longName>Individuals Name</longName>
        <shortName>INDS_NAME</shortName>
        <publicID>2018284</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>100</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Patient Name</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Patient&apos;s Name</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Patient&apos;s Name</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Source</name>
         <type>DATA_ELEMENT_SOURCE</type>
         <context>CTEP</context>
         <doctext>CDE and values comply with Clinical Data Update System v. 3.0 May 2002</doctext>
         <languageName>ENGLISH</languageName>
         <URL>www.cancer.gov</URL>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Name</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>2015 Edition Common Clinical Data Set</name>
         <type>REFERENCE</type>
         <context>ONC SDC Project</context>
         <doctext>CFR_Part_45_170.315</doctext>
         <languageName>ENGLISH</languageName>
         <URL>http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;amp;SID=100cd9d5ee5778b04fdc629f70dc02a1&amp;amp;mc=true&amp;amp;r=SECTION&amp;amp;n=se45.1.170_1315</URL>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=2001011&amp;version=5</cdeBrowserLink>
      </dataElement>
           </question>
       </module>
   <module>
    <displayOrder>1</displayOrder>
    <maximumModuleRepeat>0</maximumModuleRepeat>
    <longName>Cervical: Form Administration</longName>
        <preferredDefinition>Sarcoma: Follow-up Reporting Period</preferredDefinition>
    <publicID>2488521</publicID>
    <version>1</version>
    <usageCategory>
     <usageType>None</usageType>
    </usageCategory>
         <question>
      <publicID>2488522</publicID>
      <version>1</version>
      <isDerived>false</isDerived>
      <displayOrder>0</displayOrder>
      <dateCreated>2006-06-22T10:22:48</dateCreated>
      <dateModified>2006-06-22T10:22:48</dateModified>
      <questionText>Person Completing Form</questionText>
            <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Responsible Person Name</longName>
       <shortName>RSPBLPERSON_NAME</shortName>
       <publicID>2006163</publicID>
       <version>1</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the legal name of the person who documented information on the case report form or other document.</preferredDefinition>
              <valueDomain>
        <longName>Individuals Name</longName>
        <shortName>INDS_NAME</shortName>
        <publicID>2018284</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>100</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>Person Completing Form</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Person Completing Form</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Completed by</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Completed by</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>DCP Document Text</name>
         <type>Alternate Question Text</type>
         <context>DCP</context>
         <doctext>Name of person completing form</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text2</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Initials of person who completed the form</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text3</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Initials of person completing the form</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Standard Question Text</name>
         <type>Alternate Question Text</type>
         <context>NCIP</context>
         <doctext>Responsible Person Name</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text4</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Person completing MBS</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Name</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text5</name>
         <type>Alternate Question Text</type>
         <context>NRG</context>
         <doctext>Radiologist/Nuclear Medicine M.D./Radiology Technician completing form</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>BPV - Data entry in the local pathology review form was performed by</name>
         <type>Alternate Question Text</type>
         <context>BBRB</context>
         <doctext>Data entry in the local pathology review form was performed by</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>GTEx - Data Entered By (first name, last name)</name>
         <type>Alternate Question Text</type>
         <context>BBRB</context>
         <doctext>Data Entered By (first name, last name)</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>BPV - Form Completed By</name>
         <type>Alternate Question Text</type>
         <context>BBRB</context>
         <doctext>Form Completed By</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>DCP Text 1</name>
         <type>Alternate Question Text</type>
         <context>DCP</context>
         <doctext>Name of Person Submitting the Data</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Staff Contact Name</name>
         <type>Alternate Question Text</type>
         <context>SWOG</context>
         <doctext>Staff Contact Name</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=2006163&amp;version=1</cdeBrowserLink>
      </dataElement>
           </question>
     <question>
      <publicID>2488523</publicID>
      <version>1</version>
      <isDerived>false</isDerived>
      <displayOrder>1</displayOrder>
      <dateCreated>2006-06-22T10:22:48</dateCreated>
      <dateModified>2006-06-22T10:22:48</dateModified>
      <questionText>Are data amended</questionText>
      <instruction>
       <text>(If amended, please circle the changed data in red when using paper form)</text>
      </instruction>
      <isEditable>Yes</isEditable>
      <isMandatory>No</isMandatory>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Data Amended Ind-3</longName>
       <shortName>DATA_AMD_IND-3</shortName>
       <publicID>1226</publicID>
       <version>6</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>a yes/no indicator that asks whether information on the form was changed after initial submission of the form.</preferredDefinition>
              <valueDomain>
        <longName>Yes No Unknown Indicator</longName>
        <shortName>YES_NO_UNKNOWN_IND</shortName>
        <publicID>3506034</publicID>
        <version>1</version>
        <type>Enumerated</type>
        <context>NCI Standards</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>7</maximumLengthNumber>
        <minimumLengthNumber>2</minimumLengthNumber>
                        <permissibleValue>
          <value>No</value>
          <valueMeaning>
           <publicID>3197154</publicID>
           <version>1</version>
           <longName>No</longName>
                       <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>LA32-8</name>
             <type>LOINC_CODE</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>No</name>
             <type>LOINC_NAME</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2017-03-30T20:04:49</dateCreated>
             <languageName>Spanish</languageName>
             <name>No</name>
             <type>VM Alt Name</type>
             <context>NCI Standards</context>
                         </designation>
            <designation>
             <createdBy>TSESU</createdBy>
             <dateCreated>2017-10-04T12:02:06</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>2</name>
             <type>VM Alt Name</type>
             <context>ABTC</context>
                         </designation>
            <designation>
             <createdBy>MAESKEB</createdBy>
             <dateCreated>2017-08-25T10:11:45</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>N</name>
             <type>VM Alt Name</type>
             <context>Theradex</context>
                         </designation>
                                 <preferredDefinition>The non-affirmative response to a question.</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-03-16T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Yes</value>
          <valueMeaning>
           <publicID>3197153</publicID>
           <version>1</version>
           <longName>Yes</longName>
                       <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>LA33-6</name>
             <type>LOINC_CODE</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Yes</name>
             <type>LOINC_NAME</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2017-03-30T20:04:49</dateCreated>
             <languageName>Spanish</languageName>
             <name>Sí</name>
             <type>VM Alt Name</type>
             <context>NCI Standards</context>
                         </designation>
            <designation>
             <createdBy>MAESKEB</createdBy>
             <dateCreated>2017-08-25T10:11:45</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Y</name>
             <type>VM Alt Name</type>
             <context>Theradex</context>
                         </designation>
            <designation>
             <createdBy>TSESU</createdBy>
             <dateCreated>2017-10-04T11:56:09</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>1</name>
             <type>VM Alt Name</type>
             <context>ABTC</context>
                         </designation>
                                 <preferredDefinition>The affirmative response to a question.</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-06-23T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Unknown</value>
          <valueMeaning>
           <publicID>3241403</publicID>
           <version>1</version>
           <longName>Unknown</longName>
                       <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:30</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>LA4489-6</name>
             <type>LOINC_CODE</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Unknown</name>
             <type>LOINC_NAME</type>
             <context>ONC SDC Project</context>
                         </designation>
                                 <preferredDefinition>Not known, not observed, not recorded, or refused.</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-09-22T00:00:00</beginDate>
         </permissibleValue>
                       </valueDomain>
                      <referenceDocument>
         <name>COMMENT_GYN_159</name>
         <type>COMMENT</type>
         <context>CTEP</context>
         <doctext>Add instruction: If amended, please circle the changed data in red when using paper form</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COMMENT_LEUKEMIA_162</name>
         <type>COMMENT</type>
         <context>CTEP</context>
         <doctext>Add instruction: If data are amended, please circle in red when using paper form</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Amended Data</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Are data amended</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Are data amended</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=1226&amp;version=6</cdeBrowserLink>
      </dataElement>
             <validValue>
        <displayOrder>0</displayOrder>
        <value>yes</value>
        <meaningText>YES</meaningText>
        <description>YES</description>
                <valueMeaning>
         <publicID>2560453</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>1</displayOrder>
        <value>no</value>
        <meaningText>NO</meaningText>
        <description>NO</description>
                <valueMeaning>
         <publicID>2559515</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
           </question>
     <question>
      <publicID>2488527</publicID>
      <version>1</version>
      <isDerived>false</isDerived>
      <displayOrder>2</displayOrder>
      <dateCreated>2006-06-22T10:22:48</dateCreated>
      <dateModified>2006-06-22T10:22:48</dateModified>
      <questionText>Reporting Period Start Date</questionText>
      <instruction>
       <text>MM DD YYYY</text>
      </instruction>
      <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Treatment Reporting Period Begin Date</longName>
       <shortName>TX_REP_PD_BEGDT</shortName>
       <publicID>2993</publicID>
       <version>4</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the start date of the reporting interval.</preferredDefinition>
              <valueDomain>
        <longName>Begin Date</longName>
        <shortName>BEG_DT</shortName>
        <publicID>2188673</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>NCI Standards</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>DATE</datatypeName>
        <formatName>mm/dd/yyyy</formatName>
        <maximumLengthNumber>8</maximumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Interval Report From Date</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Reporting Period Start Date</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Reporting Period Start Date</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Report Period Start Date</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG_CRF_TEXT_1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Follow Up Start Date</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF Text 2</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Study Period Start date:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF Text 3</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Reporting Period Start Date:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF Text 4</name>
         <type>Alternate Question Text</type>
         <context>COG</context>
         <doctext>Reporting period start date:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=2993&amp;version=4</cdeBrowserLink>
      </dataElement>
           </question>
     <question>
      <publicID>2488529</publicID>
      <version>1</version>
      <isDerived>false</isDerived>
      <displayOrder>3</displayOrder>
      <dateCreated>2006-06-22T10:22:48</dateCreated>
      <dateModified>2006-06-22T10:22:48</dateModified>
      <questionText>Reporting Period End Date</questionText>
      <instruction>
       <text>MM DD YYYY</text>
      </instruction>
      <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Treatment Reporting Period End Date</longName>
       <shortName>TX_REP_PD_END_DT</shortName>
       <publicID>2992</publicID>
       <version>4</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the end date of the reporting interval.</preferredDefinition>
              <valueDomain>
        <longName>End Date</longName>
        <shortName>END_DT</shortName>
        <publicID>2188674</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>NCI Standards</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>DATE</datatypeName>
        <formatName>mm/dd/yy</formatName>
        <maximumLengthNumber>8</maximumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Interval Report To Date</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Reporting Period End Date</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Reporting Period End Date</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Report Period End Date</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG_CRF_TEXT_1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Follow Up End Date</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text2</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Last day of this reporting period</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF Text 2</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Study Period End date:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF Text 3</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Reporting Period End Date:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF Text 4</name>
         <type>Alternate Question Text</type>
         <context>COG</context>
         <doctext>Reporting period end date:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>DCP Text 1</name>
         <type>Alternate Question Text</type>
         <context>DCP</context>
         <doctext>Report Cut-off Date</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=2992&amp;version=4</cdeBrowserLink>
      </dataElement>
           </question>
       </module>
   <module>
    <displayOrder>2</displayOrder>
    <maximumModuleRepeat>0</maximumModuleRepeat>
    <longName>Cervical:  Disease Description</longName>
    <instruction>
     <text>(Note:  Some questions in this section may need to be modified to identify time of capture per protocol requirement - modify italic phrases &quot;at Diagnosis&quot; or &quot;at Study Entry.&quot;)</text>
    </instruction>
    <preferredDefinition>CERVICAL: DISEASE DESCRIPTION</preferredDefinition>
    <publicID>2488349</publicID>
    <version>3</version>
    <usageCategory>
     <usageType>None</usageType>
     <rule>(Note:  Some questions in this section may need to be modified to identify time of capture per protocol requirement - modify italic phrases &quot;at Diagnosis&quot; or &quot;at Study Entry.&quot;)</rule>
    </usageCategory>
         <question>
      <publicID>2488545</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>0</displayOrder>
      <dateCreated>2006-06-22T13:05:21</dateCreated>
      <dateModified>2006-06-22T13:45:39</dateModified>
      <questionText>Date of Definitive Histologic Diagnosis of Primary Tumor</questionText>
            <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Primary Tumor Diagnosis Date</longName>
       <shortName>PRM_TUMOR_DX_DT</shortName>
       <publicID>61393</publicID>
       <version>3</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the date on which a definitive histologic diagnosis of a primary tumor is made.</preferredDefinition>
               <designation>
         <createdBy>WOODC</createdBy>
         <dateCreated>2015-11-30T13:23:47</dateCreated>
         <languageName>ENGLISH</languageName>
         <name>Biological parent date of birth</name>
         <type>VM Alt Name</type>
         <context>COG</context>
                 </designation>
              <valueDomain>
        <longName>Date</longName>
        <shortName>DT</shortName>
        <publicID>2018550</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>NCI Standards</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>DATE</datatypeName>
        <formatName>MM/DD/YYYY</formatName>
        <maximumLengthNumber>8</maximumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>Date of Definitive Histologic</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Date of Definitive Histologic Diagnosis of Primary Tumor</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Primary Tumor Diagnosis Date </doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text3</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Date primary confirmed</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text4</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Date primary confirmed histologically?</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text5</name>
         <type>Alternate Question Text</type>
         <context>Alliance</context>
         <doctext>When were you diagnosed with this illness?</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=61393&amp;version=3</cdeBrowserLink>
      </dataElement>
           </question>
     <question>
      <publicID>2488546</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>1</displayOrder>
      <dateCreated>2006-06-22T13:05:21</dateCreated>
      <dateModified>2006-06-22T13:45:39</dateModified>
      <questionText>Stage</questionText>
      <instruction>
       <text>at Diagnosis
(FIGO/Clinical)</text>
      </instruction>
      <isEditable>Yes</isEditable>
      <isMandatory>No</isMandatory>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Gynecologic Tumor Grouping Stage</longName>
       <shortName>GYN_TUMOR_GP_ST</shortName>
       <publicID>62343</publicID>
       <version>4</version>
       <context>CTEP</context>
       <workflowStatusName>RETIRED ARCHIVED</workflowStatusName>
       <preferredDefinition>assignment of TNM categories into groups used to select and evaluate therapy, estimate prognosis and calculate end results.</preferredDefinition>
              <valueDomain>
        <longName>Gynecologic Tumor Grouping Stage</longName>
        <shortName>GYN_TUMOR_GP_ST</shortName>
        <publicID>2015357</publicID>
        <version>3</version>
        <type>Enumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RETIRED ARCHIVED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>10</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                        <permissibleValue>
          <value>0</value>
          <valueMeaning>
           <publicID>2558062</publicID>
           <version>1</version>
           <longName>0</longName>
                                 <preferredDefinition>No value exists.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:41</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>I</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IA</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IA1</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IA2</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IB</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IB1</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IB2</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IC</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>II</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IIA</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IIB</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IIC</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>III</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IIIA</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IIIB</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IIIC</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IV</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IVA</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IVB</value>
          <valueMeaning>
           <publicID>2559953</publicID>
           <version>1</version>
           <longName>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</longName>
                                 <preferredDefinition>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>X</value>
          <valueMeaning>
           <publicID>2560104</publicID>
           <version>1</version>
           <longName>STAGE GROUPING CANNOT BE ASSESSED</longName>
                                 <preferredDefinition>STAGE GROUPING CANNOT BE ASSESSED</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:51</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Not available</value>
          <valueMeaning>
           <publicID>2562605</publicID>
           <version>1</version>
           <longName>Not Available</longName>
                                  <definition>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2012-10-31T16:01:23</dateCreated>
             <text>Not Available</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>Information regarding the subject is unknown or inaccessible at this time.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-12-16T12:55:57</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Persistent</value>
          <valueMeaning>
           <publicID>2567846</publicID>
           <version>1</version>
           <longName>Persistent</longName>
                                 <preferredDefinition>Persistent</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-12T09:23:51</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Recurrent</value>
          <valueMeaning>
           <publicID>2567847</publicID>
           <version>1</version>
           <longName>Recurrent</longName>
                                 <preferredDefinition>Recurrent</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-12T09:23:51</beginDate>
         </permissibleValue>
                       </valueDomain>
                      <referenceDocument>
         <name>COMMENT_366</name>
         <type>COMMENT</type>
         <context>CTEP</context>
         <doctext>Instruction on template form:  (FIGO)</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Stage Grouping</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Stage</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Stage</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=62343&amp;version=4</cdeBrowserLink>
      </dataElement>
             <validValue>
        <displayOrder>0</displayOrder>
        <value>IA1</value>
        <meaningText>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</meaningText>
        <description>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</description>
                <valueMeaning>
         <publicID>2559953</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>1</displayOrder>
        <value>IA2</value>
        <meaningText>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</meaningText>
        <description>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</description>
                <valueMeaning>
         <publicID>2559953</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>2</displayOrder>
        <value>IB1</value>
        <meaningText>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</meaningText>
        <description>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</description>
                <valueMeaning>
         <publicID>2559953</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>3</displayOrder>
        <value>IB2</value>
        <meaningText>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</meaningText>
        <description>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</description>
                <valueMeaning>
         <publicID>2559953</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>4</displayOrder>
        <value>IIA</value>
        <meaningText>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</meaningText>
        <description>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</description>
                <valueMeaning>
         <publicID>2559953</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>5</displayOrder>
        <value>IIB</value>
        <meaningText>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</meaningText>
        <description>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</description>
                <valueMeaning>
         <publicID>2559953</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>6</displayOrder>
        <value>IIIA</value>
        <meaningText>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</meaningText>
        <description>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</description>
                <valueMeaning>
         <publicID>2559953</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>7</displayOrder>
        <value>IIIB</value>
        <meaningText>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</meaningText>
        <description>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</description>
                <valueMeaning>
         <publicID>2559953</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>8</displayOrder>
        <value>IVA</value>
        <meaningText>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</meaningText>
        <description>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</description>
                <valueMeaning>
         <publicID>2559953</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>9</displayOrder>
        <value>IVB</value>
        <meaningText>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</meaningText>
        <description>REFER TO FIGO STAGING FOR SPECIFIC GYNECOLOGIC CANCER</description>
                <valueMeaning>
         <publicID>2559953</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
           </question>
     <question>
      <publicID>2488571</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>2</displayOrder>
      <dateCreated>2006-06-22T13:36:01</dateCreated>
      <dateModified>2006-06-22T13:45:40</dateModified>
      <questionText>Does the patient have parametrial involvement with this disease</questionText>
            <isEditable>Yes</isEditable>
      <isMandatory>No</isMandatory>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Gynecologic Malignant Neoplasm Parametrium Involvement Indicator</longName>
       <shortName>GYN_MALN_PAR_INV_IND</shortName>
       <publicID>61361</publicID>
       <version>3</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>a yes/no indicator to asks if parametrial tissue shows presence of malignant atypical neoplastic cells (including laterality) from tumor in the female reproductive organs.</preferredDefinition>
              <valueDomain>
        <longName>Gynecologic Malignant Neoplasm Parametrium Involvement Indicator</longName>
        <shortName>GYN_MALN_PAR_INV_IND</shortName>
        <publicID>2015332</publicID>
        <version>3</version>
        <type>Enumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>15</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                        <permissibleValue>
          <value>None</value>
          <valueMeaning>
           <publicID>2559515</publicID>
           <version>1</version>
           <longName>No</longName>
                       <designation>
             <createdBy>HARTLEYG</createdBy>
             <dateCreated>2012-03-05T17:58:01</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>No</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                           <classification>
               <name>Children&apos;s Oncology Group (COG)</name>
               <publicID>2961451</publicID>
               <version>1</version>
               <preferredDefinition>Children&apos;s Oncology </preferredDefinition>
               <classificationSchemeItem>
                <name>Statistics and Data Center</name>
                <publicID>2961452</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
                <preferredDefinition>Children&apos;s Oncology Group SDC</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>REEVESD</createdBy>
             <dateCreated>2012-04-26T14:16:12</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Not a Serious Adverse Event</name>
             <type>C3D Name</type>
             <context>CCR</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>LA32-8</name>
             <type>LOINC_CODE</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>No</name>
             <type>LOINC_NAME</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>HARTLEYG</createdBy>
             <dateCreated>2016-01-05T17:25:28</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Exception</name>
             <type>VM Alt Name</type>
             <context>Theradex</context>
                         </designation>
            <designation>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2017-04-13T08:07:52</dateCreated>
             <languageName>Spanish</languageName>
             <name>No</name>
             <type>VM Alt Name</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>GARRIDOJ</createdBy>
             <dateCreated>2017-08-16T09:59:34</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>1 - No</name>
             <type>VM Alt Name</type>
             <context>ECOG-ACRIN</context>
                         </designation>
                                  <definition>
             <createdBy>REEVESD</createdBy>
             <dateCreated>2009-06-08T04:17:58</dateCreated>
             <dateModified>2012-04-25T15:48:58</dateModified>
             <modifiedBy>REEVESD</modifiedBy>
             <languageName>ENGLISH</languageName>
             <text>No occurrence of a Serious Adverse Event (SAE)</text>
             <type>Manually-curated</type>
                           <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>The non-affirmative response to a question.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Yes bilateral</value>
          <valueMeaning>
           <publicID>2560454</publicID>
           <version>1</version>
           <longName>YES, BILATERAL</longName>
                                 <preferredDefinition>YES, BILATERAL</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Yes unilateral</value>
          <valueMeaning>
           <publicID>2560473</publicID>
           <version>1</version>
           <longName>YES, UNILATERAL</longName>
                                 <preferredDefinition>YES, UNILATERAL</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
                       </valueDomain>
                      <referenceDocument>
         <name>Does the patient have paramet</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Does the patient have parametrial involvement with this disease</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Parametrial Involvement</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=61361&amp;version=3</cdeBrowserLink>
      </dataElement>
             <validValue>
        <displayOrder>0</displayOrder>
        <value>Yes unilateral</value>
        <meaningText>YES, UNILATERAL</meaningText>
        <description>YES, UNILATERAL</description>
                <valueMeaning>
         <publicID>2560473</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>1</displayOrder>
        <value>Yes bilateral</value>
        <meaningText>YES, BILATERAL</meaningText>
        <description>YES, BILATERAL</description>
                <valueMeaning>
         <publicID>2560454</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>2</displayOrder>
        <value>None</value>
        <meaningText>NO</meaningText>
        <description>NO</description>
                <valueMeaning>
         <publicID>2559515</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
           </question>
     <question>
      <publicID>2488575</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>3</displayOrder>
      <dateCreated>2006-06-22T13:36:01</dateCreated>
      <dateModified>2006-06-22T13:45:40</dateModified>
      <questionText>Histologic Grade</questionText>
      <instruction>
       <text>(check highest grade)</text>
      </instruction>
      <isEditable>Yes</isEditable>
      <isMandatory>No</isMandatory>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Gynecologic Tumor Histologic Grade</longName>
       <shortName>GYN_TUMOR_HIST_GD</shortName>
       <publicID>61301</publicID>
       <version>4</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>a microscopic pattern indicating the degree of similarity between the tumor and the tissue of origin, following WHO critieria.</preferredDefinition>
              <valueDomain>
        <longName>Gynecologic Tumor Histologic Grade</longName>
        <shortName>GYN_TUMOR_HIST_GD</shortName>
        <publicID>2015324</publicID>
        <version>3</version>
        <type>Enumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>15</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                        <permissibleValue>
          <value>Not Graded</value>
          <valueMeaning>
           <publicID>3121587</publicID>
           <version>1</version>
           <longName>Not Graded</longName>
                                 <preferredDefinition>Not Graded</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-07-14T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>1</value>
          <valueMeaning>
           <publicID>2558827</publicID>
           <version>1</version>
           <longName>GRADE 1-WELL DIFFERENTIATED</longName>
                                 <preferredDefinition>GRADE 1-WELL DIFFERENTIATED</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:41</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>2</value>
          <valueMeaning>
           <publicID>2558828</publicID>
           <version>1</version>
           <longName>GRADE 2-MODERATELY DIFFERENTIATED</longName>
                                 <preferredDefinition>GRADE 2-MODERATELY DIFFERENTIATED</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:41</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>3</value>
          <valueMeaning>
           <publicID>2558829</publicID>
           <version>1</version>
           <longName>GRADE 3-POORLY DIFFERENTIATED</longName>
                                 <preferredDefinition>GRADE 3-POORLY DIFFERENTIATED</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:41</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Indeterminate</value>
          <valueMeaning>
           <publicID>2558962</publicID>
           <version>1</version>
           <longName>Indeterminate</longName>
                       <designation>
             <createdBy>GARRIDOJ</createdBy>
             <dateCreated>2017-08-16T09:12:29</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>3 - Indeterminate</name>
             <type>VM Alt Name</type>
             <context>ECOG-ACRIN</context>
                         </designation>
                                 <preferredDefinition>Cannot distinguish between two or more possible values in the current context.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Unknown</value>
          <valueMeaning>
           <publicID>2558830</publicID>
           <version>1</version>
           <longName>GRADE UNKNOWN</longName>
                                 <preferredDefinition>GRADE UNKNOWN</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:50</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Not applicable</value>
          <valueMeaning>
           <publicID>2581003</publicID>
           <version>1</version>
           <longName>Not applicable</longName>
                       <designation>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2007-08-02T15:44:56</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Not applicable sequence feature</name>
             <type>UML Value Name</type>
             <context>NCIP</context>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caArray_1.1</name>
               <publicID>2534950</publicID>
               <version>1.1</version>
               <preferredDefinition>This model makes up a the portion of caArray that reflects MGED&apos;s MAGE model.</preferredDefinition>
               <classificationSchemeItem>
                <name>gov.nih.nci.mageom.domain.Measurement</name>
                <publicID>2812473</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>gov.nih.nci.mageom.domain.Measurement</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>edu.wustl.catissuecore.domain.ValueDomain</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-06-07T15:54:35</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>NA</name>
             <type>NAACCR Alt Name</type>
             <context>PS-CC</context>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>edu.wustl.catissuecore.domain.ValueDomain</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2014-12-18T01:56:53</dateCreated>
             <dateModified>2014-12-18T01:59:53</dateModified>
             <modifiedBy>DWARZEL</modifiedBy>
             <languageName>ENGLISH</languageName>
             <name>Doesn&apos;t Apply</name>
             <type>VM Alt Name</type>
             <context>NCIP</context>
                           <classification>
               <name>FDA MedWatch Form 3500</name>
               <publicID>4382692</publicID>
               <version>1</version>
               <preferredDefinition>CDEs in MedWatch Form FDA 3500</preferredDefinition>
               <classificationSchemeItem>
                <name>Suspect Product(s)</name>
                <publicID>4394093</publicID>
                <version>1</version>
                <type>Case Report Form</type>
                <preferredDefinition>Suspect Product(s) Case Report Form CDEs</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
                                  <definition>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2007-08-02T15:44:56</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>How a sequence feature was determined is not applicable.</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caArray_1.1</name>
               <publicID>2534950</publicID>
               <version>1.1</version>
               <preferredDefinition>This model makes up a the portion of caArray that reflects MGED&apos;s MAGE model.</preferredDefinition>
               <classificationSchemeItem>
                <name>gov.nih.nci.mageom.domain.BioSequence</name>
                <publicID>2812479</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
            <definition>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-04-30T12:22:44</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Not applicable 9e.g., census tracting not attempted); Census Tract Certainty information for 1970/80/90 not coded.</text>
             <type>NAACCR</type>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>Demographic11.1</name>
                <publicID>3242099</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>PS-CC</context>
            </definition>
            <definition>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-04-30T12:32:10</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Not applicable (e.g., census tracting not attempted); Census Tract Certainty information for 2000 not coded.</text>
             <type>NAACCR</type>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>Demographic11.1</name>
                <publicID>3242099</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>PS-CC</context>
            </definition>
                      <preferredDefinition>Determination of a value is not relevant in the current context.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-08-17T12:51:19</beginDate>
         </permissibleValue>
                       </valueDomain>
                      <referenceDocument>
         <name>COMMENT_334</name>
         <type>COMMENT</type>
         <context>CTEP</context>
         <doctext>check highest grade</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Histologic Grade</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Histologic Grade (Differentia</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Histologic Grade (Differentiation)</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text2</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>What was the grade of the primary tumor</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text4</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>What is the grade of the primary tumor</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF_Text_5</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Histology grade of primary tumor</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF_Text_6</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Histologic grade of primary tumor</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=61301&amp;version=4</cdeBrowserLink>
      </dataElement>
             <validValue>
        <displayOrder>0</displayOrder>
        <value>1</value>
        <meaningText>GRADE 1-WELL DIFFERENTIATED</meaningText>
        <description>GRADE 1-WELL DIFFERENTIATED</description>
                <valueMeaning>
         <publicID>2558827</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>1</displayOrder>
        <value>2</value>
        <meaningText>GRADE 2-MODERATELY DIFFERENTIATED</meaningText>
        <description>GRADE 2-MODERATELY DIFFERENTIATED</description>
                <valueMeaning>
         <publicID>2558828</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>2</displayOrder>
        <value>3</value>
        <meaningText>GRADE 3-POORLY DIFFERENTIATED</meaningText>
        <description>GRADE 3-POORLY DIFFERENTIATED</description>
                <valueMeaning>
         <publicID>2558829</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
           </question>
     <question>
      <publicID>2488582</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>4</displayOrder>
      <dateCreated>2006-06-22T13:36:01</dateCreated>
      <dateModified>2006-06-22T13:45:40</dateModified>
      <questionText>Histologic Type</questionText>
      <instruction>
       <text>(check all that apply)</text>
      </instruction>
      <isEditable>Yes</isEditable>
      <isMandatory>No</isMandatory>
      <multiValue>Yes</multiValue>
      <dataElement>
       <longName>Gynecologic Tumor Histologic Category</longName>
       <shortName>GYN_TUMOR_HIST_CAT</shortName>
       <publicID>62334</publicID>
       <version>4</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the structural pattern of cancer cells used to define a diagnosis.</preferredDefinition>
              <valueDomain>
        <longName>Gynecologic Tumor Histologic Category</longName>
        <shortName>GYN_TUMOR_HIST_CAT</shortName>
        <publicID>2015349</publicID>
        <version>3</version>
        <type>Enumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>50</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                        <permissibleValue>
          <value>Sclerosing Stromal Tumor</value>
          <valueMeaning>
           <publicID>3252148</publicID>
           <version>1</version>
           <longName>Ovarian Sclerosing Stromal Tumor</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-08-25T17:26:51</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Sclerosing Stromal Tumor</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>A benign ovarian stromal tumor characterized by the presence of cellular areas which contain fibroblasts and round cells. The cellular areas are separated by sclerotic or edematous hypocellular tissue. Symptoms include abdominal discomfort and menstrual abnormalities.</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-08-25T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Small cell carcinoma</value>
          <valueMeaning>
           <publicID>2567204</publicID>
           <version>1</version>
           <longName>Small cell carcinoma</longName>
                                 <preferredDefinition>A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble &quot;oat cells&quot; under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.</preferredDefinition>
          </valueMeaning>
          <beginDate>2006-11-07T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Embryonal carcinoma</value>
          <valueMeaning>
           <publicID>2567194</publicID>
           <version>1</version>
           <longName>Embryonal carcinoma</longName>
                                 <preferredDefinition>A non-seminomatous malignant germ cell tumor characterized by the presence of large germ cells with abundant cytoplasm resembling epithelial cells, geographic necrosis, high mitotic activity, and pseudoglandular and pseudopapillary structures formation. It can arise from the testis, ovary, and extragonadal sites (central nervous system and mediastinum).</preferredDefinition>
          </valueMeaning>
          <beginDate>2006-11-08T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Choriocarcinoma</value>
          <valueMeaning>
           <publicID>2574079</publicID>
           <version>1</version>
           <longName>Choriocarcinoma</longName>
                                 <preferredDefinition>An aggressive malignant tumor arising from trophoblastic cells.  The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells.  Approximately half of the cases develop from a complete hydatidiform mole.  A minority of cases arise in the testis or the ovaries.  There is often marked elevation of human chorionic gonadotropin (hCG) in the blood.  Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected. --2004</preferredDefinition>
          </valueMeaning>
          <beginDate>2006-11-08T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Teratoma, mature</value>
          <valueMeaning>
           <publicID>2567196</publicID>
           <version>1</version>
           <longName>Teratoma, mature</longName>
                                 <preferredDefinition>Teratoma, mature</preferredDefinition>
          </valueMeaning>
          <beginDate>2006-11-08T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Endometrial carcinoma</value>
          <valueMeaning>
           <publicID>2761246</publicID>
           <version>1</version>
           <longName>Endometrial carcinoma</longName>
                                 <preferredDefinition>Endometrial carcinoma</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Uterine carcinosarcoma</value>
          <valueMeaning>
           <publicID>2761247</publicID>
           <version>1</version>
           <longName>Uterine carcinosarcoma</longName>
                                 <preferredDefinition>Uterine carcinosarcoma</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Adenocarcinoma</value>
          <valueMeaning>
           <publicID>2831117</publicID>
           <version>1</version>
           <longName>Adenocarcinoma</longName>
                                 <preferredDefinition>carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.</preferredDefinition>
          </valueMeaning>
          <beginDate>2009-02-02T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Metaplasia</value>
          <valueMeaning>
           <publicID>2838903</publicID>
           <version>1</version>
           <longName>Metaplasia</longName>
                                 <preferredDefinition>Transformation of a mature, normal cell or groups of mature cells to other forms of mature cells.  The capacity for malignant transformation of metaplastic cells is a subject of controversy.</preferredDefinition>
          </valueMeaning>
          <beginDate>2009-02-11T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Unclassified carcinoma</value>
          <valueMeaning>
           <publicID>3120329</publicID>
           <version>1</version>
           <longName>Unclassified Carcinoma</longName>
                                 <preferredDefinition>Not arranged or included in any specific grouping.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-07-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Other carcinoma</value>
          <valueMeaning>
           <publicID>3120330</publicID>
           <version>1</version>
           <longName>Other Carcinoma</longName>
                                 <preferredDefinition>Different than the one(s) previously specified or mentioned.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-07-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Malignant Brenner&apos;s tumor</value>
          <valueMeaning>
           <publicID>3120341</publicID>
           <version>1</version>
           <longName>Malignant Ovarian Brenner Tumor</longName>
                                 <preferredDefinition>A Brenner tumor of the ovary characterized by a cytologically malignant cell population and stromal invasion.</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-07-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Adenocarcinoma, NOS</value>
          <valueMeaning>
           <publicID>2861284</publicID>
           <version>1</version>
           <longName>Not Otherwise Specified Adenocarcinoma</longName>
                                 <preferredDefinition>Not characterized in any other way.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-07-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Transitional Cell Carcinoma</value>
          <valueMeaning>
           <publicID>2560303</publicID>
           <version>1</version>
           <longName>Transitional Cell Carcinoma</longName>
                                 <preferredDefinition>A malignant neoplasm arising from the transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. It may or may not have a papillary configuration. It is graded 1 to 3 or 4 according to the degree of cellular differentiation and architectural patterns. Grade 1 transitional cell carcinoma is histologically benign but it may recur. Transitional cell carcinomas may also affect the upper respiratory tract and the ovaries.</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-07-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Adenocarcinoma with Squamous Differentiation</value>
          <valueMeaning>
           <publicID>2558178</publicID>
           <version>1</version>
           <longName>ADENOCARCINOMA WITH SQUAMOUS DIFFERENTIATION</longName>
                                 <preferredDefinition>ADENOCARCINOMA WITH SQUAMOUS DIFFERENTIATION</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Adenocarcinoma, unspecified</value>
          <valueMeaning>
           <publicID>2567183</publicID>
           <version>1</version>
           <longName>Adenocarcinoma, unspecified</longName>
                                 <preferredDefinition>Adenocarcinoma, unspecified</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Adenofibroma</value>
          <valueMeaning>
           <publicID>2558182</publicID>
           <version>1</version>
           <longName>ADENOFIBROMA</longName>
                                 <preferredDefinition>ADENOFIBROMA</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Adenosarcoma</value>
          <valueMeaning>
           <publicID>2567182</publicID>
           <version>1</version>
           <longName>Adenosarcoma</longName>
                                 <preferredDefinition>Adenosarcoma</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Brenner tumor (benign)</value>
          <valueMeaning>
           <publicID>2558335</publicID>
           <version>1</version>
           <longName>BRENNER TUMOR (BENIGN)</longName>
                                 <preferredDefinition>BRENNER TUMOR (BENIGN)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Brenner tumor (malignant)</value>
          <valueMeaning>
           <publicID>2567185</publicID>
           <version>1</version>
           <longName>Brenner tumor (malignant)</longName>
                                 <preferredDefinition>Brenner tumor (malignant)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Brenner tumor of LMP</value>
          <valueMeaning>
           <publicID>2558337</publicID>
           <version>1</version>
           <longName>BRENNER TUMOR OF LOW MALIGNANT POTENTIAL</longName>
                                 <preferredDefinition>BRENNER TUMOR OF LOW MALIGNANT POTENTIAL</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Cancer with dermoid cyst</value>
          <valueMeaning>
           <publicID>2558349</publicID>
           <version>1</version>
           <longName>CANCER WITH DERMOID CYST, SPECIFY TYPES</longName>
                                 <preferredDefinition>CANCER WITH DERMOID CYST, SPECIFY TYPES</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Clear cell carcinoma</value>
          <valueMeaning>
           <publicID>2558510</publicID>
           <version>1</version>
           <longName>CLEAR CELL CARCINOMA</longName>
                                 <preferredDefinition>CLEAR CELL CARCINOMA</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Clear cell cystadenofibroma (benign)</value>
          <valueMeaning>
           <publicID>2558511</publicID>
           <version>1</version>
           <longName>CLEAR CELL CYSTADENOFIBROMA (BENIGN)</longName>
                                 <preferredDefinition>CLEAR CELL CYSTADENOFIBROMA (BENIGN)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Clear cell cystadenoma (benign)</value>
          <valueMeaning>
           <publicID>2558512</publicID>
           <version>1</version>
           <longName>CLEAR CELL CYSTADENOMA (BENIGN)</longName>
                                 <preferredDefinition>CLEAR CELL CYSTADENOMA (BENIGN)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Clear cell tumor of LMP</value>
          <valueMeaning>
           <publicID>2558513</publicID>
           <version>1</version>
           <longName>CLEAR CELL TUMOR OF LOW MALIGNANT POTENTIAL</longName>
                                 <preferredDefinition>CLEAR CELL TUMOR OF LOW MALIGNANT POTENTIAL</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Dysgerminoma</value>
          <valueMeaning>
           <publicID>2574078</publicID>
           <version>1</version>
           <longName>Dysgerminoma</longName>
                                 <preferredDefinition>Dysgerminoma</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Endodermal sinus tumor</value>
          <valueMeaning>
           <publicID>2558716</publicID>
           <version>1</version>
           <longName>ENDODERMAL SINUS TUMOR (YOLK SAC TUMOR)</longName>
                                 <preferredDefinition>ENDODERMAL SINUS TUMOR (YOLK SAC TUMOR)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Endometrial stromal sarcoma</value>
          <valueMeaning>
           <publicID>2567186</publicID>
           <version>1</version>
           <longName>Endometrial Stromal Sarcoma</longName>
                                 <preferredDefinition>A malignant, infiltrating mesenchymal tumor arising from the uterine corpus, cervix, vagina, and the ovary. Based on its morphologic characteristics, it is classified as either a low grade or an undifferentiated (high grade) stromal sarcoma. The low grade endometrial stromal sarcoma is characterized by the presence of oval to spindle-shape cells that resemble the cells of the endometrial stroma, without evidence of significant atypia and pleomorphism. Numerous small vessels are also present. The undifferentiated stromal sarcoma is characterized by an aggressive clinical course, the presence of significant cellular atypia, pleomorphism, and high mitotic activity.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Endometrioid adenocarcinoma</value>
          <valueMeaning>
           <publicID>2567180</publicID>
           <version>1</version>
           <longName>Endometrioid adenocarcinoma</longName>
                                 <preferredDefinition>Endometrioid adenocarcinoma</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Endometrioid cystadenofibroma (benign)</value>
          <valueMeaning>
           <publicID>2558719</publicID>
           <version>1</version>
           <longName>ENDOMETRIOID CYSTADENOFIBROMA (BENIGN)</longName>
                                 <preferredDefinition>ENDOMETRIOID CYSTADENOFIBROMA (BENIGN)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Endometrioid cystadenoma (benign)</value>
          <valueMeaning>
           <publicID>2558720</publicID>
           <version>1</version>
           <longName>ENDOMETRIOID CYSTADENOMA (BENIGN)</longName>
                                 <preferredDefinition>ENDOMETRIOID CYSTADENOMA (BENIGN)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Endometrioid tumor of LMP</value>
          <valueMeaning>
           <publicID>2558721</publicID>
           <version>1</version>
           <longName>ENDOMETRIOID TUMOR OF LOW MALIGNANT POTENTIAL</longName>
                                 <preferredDefinition>ENDOMETRIOID TUMOR OF LOW MALIGNANT POTENTIAL</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Fibroma</value>
          <valueMeaning>
           <publicID>2558772</publicID>
           <version>1</version>
           <longName>FIBROMA</longName>
                                 <preferredDefinition>FIBROMA</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Germ cell tumor, mixed</value>
          <valueMeaning>
           <publicID>2558822</publicID>
           <version>1</version>
           <longName>GERM CELL TUMOR, MIXED</longName>
                                 <preferredDefinition>GERM CELL TUMOR, MIXED</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Gestational trophoblastic disease</value>
          <valueMeaning>
           <publicID>2558824</publicID>
           <version>1</version>
           <longName>GESTATIONAL TROPHOBLASTIC DISEASE</longName>
                                 <preferredDefinition>GESTATIONAL TROPHOBLASTIC DISEASE</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Granulosa cell tumor</value>
          <valueMeaning>
           <publicID>2567190</publicID>
           <version>1</version>
           <longName>Granulosa Cell Tumor</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-08-25T14:06:06</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Juvenile Granulosa Cell Tumor</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                           <classification>
               <name>ModelTest</name>
               <publicID>5527905</publicID>
               <version>1</version>
               <preferredDefinition>Test to see if CDE Details open post loading.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>EDRN_CDE_Project</name>
               <publicID>5542681</publicID>
               <version>1</version>
               <preferredDefinition>Collection of CDEs related to biospecimens.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
                                 <preferredDefinition>A slow-growing, malignant tumor, characterize by the presence of granulosa-like cells and Call-Exner bodies, that is almost always found in the ovary. In rare cases, it has also been found in the testicle.  There are two types of granulosa cell tumor that can be distinguished under the microscope: the adult and the juvenile.  The testicular juvenile granulosa cell tumors are perhaps the most common congenital testicular neoplasms.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Gynandroblastoma</value>
          <valueMeaning>
           <publicID>2567191</publicID>
           <version>1</version>
           <longName>Gynandroblastoma</longName>
                                 <preferredDefinition>Gynandroblastoma</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Mixed epithelial carcinoma</value>
          <valueMeaning>
           <publicID>2567188</publicID>
           <version>1</version>
           <longName>Mixed epithelial carcinoma, specify components</longName>
                                 <preferredDefinition>Mixed epithelial carcinoma, specify components</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:45</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Mixed malignant germ cell tumor</value>
          <valueMeaning>
           <publicID>2567197</publicID>
           <version>1</version>
           <longName>Mixed malignant germ cell tumor, specify components</longName>
                                 <preferredDefinition>Mixed malignant germ cell tumor, specify components</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:45</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Mucinous adenocarcinoma</value>
          <valueMeaning>
           <publicID>2567179</publicID>
           <version>1</version>
           <longName>Mucinous adenocarcinoma</longName>
                                 <preferredDefinition>An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:45</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Mucinous cystadenofibroma (benign)</value>
          <valueMeaning>
           <publicID>2559284</publicID>
           <version>1</version>
           <longName>MUCINOUS CYSTADENOFIBROMA (BENIGN)</longName>
                                 <preferredDefinition>MUCINOUS CYSTADENOFIBROMA (BENIGN)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:45</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Mucinous cystadenoma (benign)</value>
          <valueMeaning>
           <publicID>2559285</publicID>
           <version>1</version>
           <longName>MUCINOUS CYSTADENOMA (BENIGN)</longName>
                                 <preferredDefinition>MUCINOUS CYSTADENOMA (BENIGN)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:45</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Mucinous tumor of LMP</value>
          <valueMeaning>
           <publicID>2559287</publicID>
           <version>1</version>
           <longName>MUCINOUS TUMOR OF LOW MALIGNANT POTENTIAL</longName>
                                 <preferredDefinition>MUCINOUS TUMOR OF LOW MALIGNANT POTENTIAL</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:45</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Ovarian endometriosis</value>
          <valueMeaning>
           <publicID>2559680</publicID>
           <version>1</version>
           <longName>OVARIAN ENDOMETRIOSIS</longName>
                                 <preferredDefinition>OVARIAN ENDOMETRIOSIS</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:47</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Physiologic cyst (corpus luteum)</value>
          <valueMeaning>
           <publicID>2559806</publicID>
           <version>1</version>
           <longName>PHYSIOLOGIC CYST (CORPUS LUTEUM)</longName>
                                 <preferredDefinition>PHYSIOLOGIC CYST (CORPUS LUTEUM)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:47</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Physiologic cyst (follicle)</value>
          <valueMeaning>
           <publicID>2559807</publicID>
           <version>1</version>
           <longName>PHYSIOLOGIC CYST (FOLLICLE)</longName>
                                 <preferredDefinition>PHYSIOLOGIC CYST (FOLLICLE)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:47</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Polyembryoma</value>
          <valueMeaning>
           <publicID>2559823</publicID>
           <version>1</version>
           <longName>POLYEMBRYOMA</longName>
                                 <preferredDefinition>POLYEMBRYOMA</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:47</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Serous adenocarcinoma</value>
          <valueMeaning>
           <publicID>2567199</publicID>
           <version>1</version>
           <longName>Serous adenocarcinoma</longName>
                                 <preferredDefinition>Serous adenocarcinoma</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Serous cystadenofibroma (benign)</value>
          <valueMeaning>
           <publicID>2560030</publicID>
           <version>1</version>
           <longName>SEROUS CYSTADENOFIBROMA (BENIGN)</longName>
                                 <preferredDefinition>SEROUS CYSTADENOFIBROMA (BENIGN)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Serous cystadenoma (benign)</value>
          <valueMeaning>
           <publicID>2560031</publicID>
           <version>1</version>
           <longName>SEROUS CYSTADENOMA (BENIGN)</longName>
                                 <preferredDefinition>SEROUS CYSTADENOMA (BENIGN)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Serous tumor of LMP</value>
          <valueMeaning>
           <publicID>2560032</publicID>
           <version>1</version>
           <longName>SEROUS TUMOR OF LOW MALIGNANT POTENTIAL</longName>
                                 <preferredDefinition>SEROUS TUMOR OF LOW MALIGNANT POTENTIAL</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Sertoli-Leydig cell (Androblastoma)</value>
          <valueMeaning>
           <publicID>2560033</publicID>
           <version>1</version>
           <longName>SERTOLI-LEYDIG CELL (ANDROBLASTOMA)</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-08-25T17:26:52</dateCreated>
             <dateModified>2015-08-27T12:48:13</dateModified>
             <modifiedBy>WONGW</modifiedBy>
             <languageName>ENGLISH</languageName>
             <name>Sertoli-Leydig cell tumor</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>SERTOLI-LEYDIG CELL (ANDROBLASTOMA)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Sex-cord/stromal, unclassified</value>
          <valueMeaning>
           <publicID>2567192</publicID>
           <version>1</version>
           <longName>Sex-cord/stromal, unclassified</longName>
                                 <preferredDefinition>Sex-cord/stromal, unclassified</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:49</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Simple cyst</value>
          <valueMeaning>
           <publicID>2560052</publicID>
           <version>1</version>
           <longName>SIMPLE CYST</longName>
                                 <preferredDefinition>SIMPLE CYST</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:49</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Squamous cell carcinoma</value>
          <valueMeaning>
           <publicID>2574081</publicID>
           <version>1</version>
           <longName>Squamous cell carcinoma</longName>
                       <designation>
             <createdBy>ROUILLAS</createdBy>
             <dateCreated>2014-07-30T13:14:39</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Squamous</name>
             <type>VM Alt Name</type>
             <context>ECOG-ACRIN</context>
                         </designation>
                                 <preferredDefinition>A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:49</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Steroid/Lipid cell tumor</value>
          <valueMeaning>
           <publicID>2560106</publicID>
           <version>1</version>
           <longName>STEROID/LIPID CELL TUMOR</longName>
                                 <preferredDefinition>STEROID/LIPID CELL TUMOR</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:49</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Teratoma, immature</value>
          <valueMeaning>
           <publicID>2560188</publicID>
           <version>1</version>
           <longName>TERATOMA, IMMATURE, SPECIFY COMPONENTS</longName>
                                 <preferredDefinition>TERATOMA, IMMATURE, SPECIFY COMPONENTS</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:50</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Transitional cell carcinoma (including Brenner)</value>
          <valueMeaning>
           <publicID>2560304</publicID>
           <version>1</version>
           <longName>TRANSITIONAL CELL CARCINOMA, INCLUDING BRENNER TUMOR</longName>
                                 <preferredDefinition>TRANSITIONAL CELL CARCINOMA, INCLUDING BRENNER TUMOR</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:50</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Undifferentiated carcinoma</value>
          <valueMeaning>
           <publicID>2567189</publicID>
           <version>1</version>
           <longName>Undifferentiated carcinoma</longName>
                                 <preferredDefinition>Undifferentiated carcinoma</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:50</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Adenoid Cystic Carcinoma</value>
          <valueMeaning>
           <publicID>2567905</publicID>
           <version>1</version>
           <longName>Adenoid cystic carcinoma</longName>
                                 <preferredDefinition>A malignant tumor arising from the epithelial cells. Microscopically, the neoplastic epithelial cells form cylindrical spatial configurations (cribriform or classic type of adenoid cystic carcinoma), cordlike structures (tubular type of adenoid cystic carcinoma), or solid structures (basaloid variant of adenoid cystic carcinoma). Adenoid cystic carcinomas mostly occur in the salivary glands. Other primary sites of involvement include the lacrimal gland, the larynx, and the lungs. Adenoid cystic carcinomas spread along nerve sheaths, resulting in severe pain, and they tend to recur. Lymph node metastases are unusual; hematogenous tumor spread is characteristic.</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-03-25T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Hydatidiform Mole</value>
          <valueMeaning>
           <publicID>3211157</publicID>
           <version>1</version>
           <longName>Hydatidiform Mole</longName>
                       <designation>
             <createdBy>UMLLOADER_CBM</createdBy>
             <dateCreated>2011-03-25T13:42:26</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Hydatidiform Mole</name>
             <type>UML Value Name</type>
             <context>NCIP</context>
                           <classification>
               <name>Common Biorepository Model</name>
               <publicID>3204728</publicID>
               <version>1</version>
               <preferredDefinition>A common model to contain summary-level details of biorepository / biobank holdings which can be advertised through the OBBR Specimen Resource Locator</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
                                  <definition>
             <createdBy>UMLLOADER_CBM</createdBy>
             <dateCreated>2011-03-25T13:42:26</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>A gestational disorder characterized by an abnormal placenta with marked enlargement of the chorionic villi and hyperplasia of the villous trophoblastic cells.  According to the amount of villous involvement, a hydatidiform mole is defined as complete or partial.  Most molar pregnancies are complete and are characterized by generalized hydropic villous changes.  Partial moles are characterized by a mixture of large hydropic villi and normal placenta tissue.  Complete moles are usually diploid and typically present between the eleventh and twenty-fifth week of pregnancy, whereas partial moles are usually triploid and usually present around the nineteenth week of pregnancy.  The incidence of choriocarcinoma is higher in patients with complete hydatidiform mole.  When a hydatidiform mole invades the myometrium and broad ligament, or it is found in distant sites as vagina, vulva, and lung, it is referred as invasive mole.</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>Common Biorepository Model</name>
               <publicID>3204728</publicID>
               <version>1</version>
               <preferredDefinition>A common model to contain summary-level details of biorepository / biobank holdings which can be advertised through the OBBR Specimen Resource Locator</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>A gestational disorder characterized by an abnormal placenta with marked enlargement of the chorionic villi and hyperplasia of the villous trophoblastic cells.  According to the amount of villous involvement, a hydatidiform mole is defined as complete or partial.  Most molar pregnancies are complete and are characterized by generalized hydropic villous changes.  Partial moles are characterized by a mixture of large hydropic villi and normal placenta tissue.  Complete moles are usually diploid and typically present between the eleventh and twenty-fifth week of pregnancy, whereas partial moles are usually triploid and usually present around the nineteenth week of pregnancy.  The incidence of choriocarcinoma is higher in patients with complete hydatidiform mole.  When a hydatidiform mole invades the myometrium and broad ligament, or it is found in distant sites as vagina, vulva, and lung, it is referred as invasive mole.</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-03-25T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Paget&apos;s Disease</value>
          <valueMeaning>
           <publicID>3251708</publicID>
           <version>1</version>
           <longName>Paget&apos;s Disease</longName>
                                 <preferredDefinition>A malignant neoplasm composed of large cells with large nuclei, prominent nucleoli, and abundant pale cytoplasm (Paget cells).  Paget&apos;s cell neoplasms include Paget&apos;s disease of the nipple and extramammary Paget&apos;s disease which may affect the vulva, penis, anus, skin and scrotum. -- 2004</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-07-06T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Sertoli Cell Tumor</value>
          <valueMeaning>
           <publicID>3252068</publicID>
           <version>1</version>
           <longName>Sertoli Cell Tumor</longName>
                                 <preferredDefinition>A sex cord-stromal tumor of the testis or the ovary. It is characterized by the presence of Sertoli cells forming tubules. Leydig cells are rare or absent. It may be associated with Peutz-Jeghers syndrome. In males, the presenting symptom is a slow growing testicular mass. Most cases follow a benign clinical course. In females it may present with estrogenic or androgenic manifestations. The vast majority of cases have a benign clinical course.</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-07-07T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Leiomyosarcoma</value>
          <valueMeaning>
           <publicID>2562491</publicID>
           <version>1</version>
           <longName>Leiomyosarcoma</longName>
                       <designation>
             <createdBy>HARTLEYG</createdBy>
             <dateCreated>2015-02-26T20:56:16</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Leiomyosarcoma (excluding uterine leiomyosarcoma)</name>
             <type>VM Alt Name</type>
             <context>Theradex</context>
                         </designation>
                                  <definition>
             <createdBy>REEVESD</createdBy>
             <dateCreated>2010-11-03T20:55:27</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>a malignant tumor composed of cells showing distinct smooth muscle features.
</text>
             <type>Manually-curated</type>
                           <classification>
               <name>Common Biorepository Model</name>
               <publicID>3204728</publicID>
               <version>1</version>
               <preferredDefinition>A common model to contain summary-level details of biorepository / biobank holdings which can be advertised through the OBBR Specimen Resource Locator</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women. It is characterized by a proliferation of neoplastic spindle cells. Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-09-27T18:13:30</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Normal Tissue</value>
          <valueMeaning>
           <publicID>2559584</publicID>
           <version>1</version>
           <longName>NORMAL TISSUE</longName>
                                 <preferredDefinition>Normal Tissue</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-10-01T11:26:22</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Villoglandular carcinoma</value>
          <valueMeaning>
           <publicID>2562494</publicID>
           <version>1</version>
           <longName>VILLOGLANDULAR CARCINOMA</longName>
                                 <preferredDefinition>Villoglandular carcinoma </preferredDefinition>
          </valueMeaning>
          <beginDate>2002-10-01T11:28:01</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Benign NOS</value>
          <valueMeaning>
           <publicID>2558281</publicID>
           <version>1</version>
           <longName>Benign</longName>
                                 <preferredDefinition>(beh-NINE) Not cancerous; does not invade nearby tissue or spread to other parts of the body.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-10-01T11:28:01</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Adenosquamous carcinoma</value>
          <valueMeaning>
           <publicID>2558185</publicID>
           <version>1</version>
           <longName>ADENOSQUAMOUS</longName>
                                 <preferredDefinition>ADENOSQUAMOUS</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Carcinosarcoma MMT</value>
          <valueMeaning>
           <publicID>2567187</publicID>
           <version>1</version>
           <longName>Carcinosarcoma/Mesodermal (Mullerian) mixed tumor</longName>
                                 <preferredDefinition>Carcinosarcoma/Mesodermal (Mullerian) mixed tumor</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Verrucous Carcinoma</value>
          <valueMeaning>
           <publicID>2567899</publicID>
           <version>1</version>
           <longName>Verrucous squamous cell carcinoma</longName>
                                 <preferredDefinition>Verrucous squamous cell carcinoma</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Squamous Cell Carcinoma, in situ</value>
          <valueMeaning>
           <publicID>3346877</publicID>
           <version>1</version>
           <longName>Squamous Cell Carcinoma, in situ</longName>
                                 <preferredDefinition>Squamous Cell Carcinoma, in situ</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Sarcoma, unspecified</value>
          <valueMeaning>
           <publicID>2574579</publicID>
           <version>1</version>
           <longName>Sarcoma</longName>
                                 <preferredDefinition>A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Sarcoma, other</value>
          <valueMeaning>
           <publicID>3155794</publicID>
           <version>1</version>
           <longName>Sarcoma NOS</longName>
                                 <preferredDefinition>A malignant mesenchymal tumor for which a distinct line of differentiation cannot be determined. This term may be used for small biopsy specimens for which adequate tissue is not present for definitive classification. (not WHO diagnosis)</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Rhabdomyosarcoma, Embryonal</value>
          <valueMeaning>
           <publicID>2574678</publicID>
           <version>1</version>
           <longName>Stratum 4: Rhabdomyosarcoma</longName>
                                 <preferredDefinition>A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults.  Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomical sites.</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Neuroendocrine Tumor</value>
          <valueMeaning>
           <publicID>2559503</publicID>
           <version>1</version>
           <longName>Neuroendocrine Carcinoma</longName>
                       <designation>
             <createdBy>HARTLEYG</createdBy>
             <dateCreated>2015-02-26T20:56:17</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Neuroendocrine cancer, NOS</name>
             <type>VM Alt Name</type>
             <context>Theradex</context>
                         </designation>
            <designation>
             <createdBy>TAYLORT</createdBy>
             <dateCreated>2016-01-07T22:28:04</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Neuroendocrine Cancer</name>
             <type>VM Alt Name</type>
             <context>Theradex</context>
                         </designation>
                                 <preferredDefinition>A malignant neuroendocrine tumor composed of cells containing secretory granules that stain positive for NSE and chromogranin.  Tumor cells are often round and form clusters or trabecular sheets.  Representative examples are carcinoid tumor, small cell carcinoma, and Merkel cell carcinoma.</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Mesonephric Carcinoma</value>
          <valueMeaning>
           <publicID>3346878</publicID>
           <version>1</version>
           <longName>Mesonephric Carcinoma</longName>
                                 <preferredDefinition>Mesonephric Carcinoma</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Lymphomas, Malignant</value>
          <valueMeaning>
           <publicID>2567355</publicID>
           <version>1</version>
           <longName>Lymphoma</longName>
                       <designation>
             <createdBy>ROUILLAS</createdBy>
             <dateCreated>2013-10-30T14:22:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Lymphoma, type not specified</name>
             <type>VM Alt Name</type>
             <context>ECOG-ACRIN</context>
                         </designation>
            <designation>
             <createdBy>HARTLEYG</createdBy>
             <dateCreated>2015-02-26T20:56:16</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Lymphoma, NOS</name>
             <type>VM Alt Name</type>
             <context>Theradex</context>
                         </designation>
            <designation>
             <createdBy>TAYLORT</createdBy>
             <dateCreated>2017-07-19T16:29:07</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>LY</name>
             <type>VM Alt Name</type>
             <context>NCI Standards</context>
                         </designation>
                                 <preferredDefinition>A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Large Cell Carcinoma</value>
          <valueMeaning>
           <publicID>2567205</publicID>
           <version>1</version>
           <longName>Large cell carcinoma</longName>
                                 <preferredDefinition>Large cell carcinoma</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Invasive Squamous Cell Carcinoma</value>
          <valueMeaning>
           <publicID>3243061</publicID>
           <version>1</version>
           <longName>Squamous cell carcinoma, invasive</longName>
                                 <preferredDefinition>Squamous cell carcinoma, invasive</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Glassy Cell Carcinoma</value>
          <valueMeaning>
           <publicID>2564131</publicID>
           <version>1</version>
           <longName>8015-3 Glassy cell carcinoma</longName>
                                 <preferredDefinition>Glassy cell carcinoma</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Endometrial Stromal Sarcoma, Low Grade</value>
          <valueMeaning>
           <publicID>2567186</publicID>
           <version>1</version>
           <longName>Endometrial Stromal Sarcoma</longName>
                                 <preferredDefinition>A malignant, infiltrating mesenchymal tumor arising from the uterine corpus, cervix, vagina, and the ovary. Based on its morphologic characteristics, it is classified as either a low grade or an undifferentiated (high grade) stromal sarcoma. The low grade endometrial stromal sarcoma is characterized by the presence of oval to spindle-shape cells that resemble the cells of the endometrial stroma, without evidence of significant atypia and pleomorphism. Numerous small vessels are also present. The undifferentiated stromal sarcoma is characterized by an aggressive clinical course, the presence of significant cellular atypia, pleomorphism, and high mitotic activity.</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Endometrial Stromal Sarcoma, High Grade</value>
          <valueMeaning>
           <publicID>2567186</publicID>
           <version>1</version>
           <longName>Endometrial Stromal Sarcoma</longName>
                                 <preferredDefinition>A malignant, infiltrating mesenchymal tumor arising from the uterine corpus, cervix, vagina, and the ovary. Based on its morphologic characteristics, it is classified as either a low grade or an undifferentiated (high grade) stromal sarcoma. The low grade endometrial stromal sarcoma is characterized by the presence of oval to spindle-shape cells that resemble the cells of the endometrial stroma, without evidence of significant atypia and pleomorphism. Numerous small vessels are also present. The undifferentiated stromal sarcoma is characterized by an aggressive clinical course, the presence of significant cellular atypia, pleomorphism, and high mitotic activity.</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Dysplasia, Severe</value>
          <valueMeaning>
           <publicID>2838899</publicID>
           <version>1</version>
           <longName>Dysplasia</longName>
                                 <preferredDefinition>A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns.  The cellular changes include nuclear and cytoplasmic abnormalities.  Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer. -- 2004</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Dysplasia, Moderate</value>
          <valueMeaning>
           <publicID>2838899</publicID>
           <version>1</version>
           <longName>Dysplasia</longName>
                                 <preferredDefinition>A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns.  The cellular changes include nuclear and cytoplasmic abnormalities.  Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer. -- 2004</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Dysplasia, Mild</value>
          <valueMeaning>
           <publicID>2838899</publicID>
           <version>1</version>
           <longName>Dysplasia</longName>
                                 <preferredDefinition>A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns.  The cellular changes include nuclear and cytoplasmic abnormalities.  Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer. -- 2004</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Carcinosarcoma-homologous</value>
          <valueMeaning>
           <publicID>3178991</publicID>
           <version>1</version>
           <longName>Carcinosarcoma - homologous</longName>
                                 <preferredDefinition>Carcinosarcoma - homologous</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Carcinosarcoma-heterologous</value>
          <valueMeaning>
           <publicID>3178990</publicID>
           <version>1</version>
           <longName>Carcinosarcoma - heterologous</longName>
                                 <preferredDefinition>Carcinosarcoma - heterologous</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Carcinosarcoma, unspecified</value>
          <valueMeaning>
           <publicID>3185164</publicID>
           <version>1</version>
           <longName>Carcinosarcoma, type unspecified</longName>
                                 <preferredDefinition>Carcinosarcoma, type unspecified</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Adenocarcinoma, in situ</value>
          <valueMeaning>
           <publicID>3346879</publicID>
           <version>1</version>
           <longName>Adenocarcinoma, in situ</longName>
                                 <preferredDefinition>Adenocarcinoma in situ of the uterine cervix is a premalignant glandular condition. In situ is the only known precursor to cervical adenocarcinoma, and appropriate management can prevent the occurrence of invasive disease in many cases</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Villoglandular Adenocarcinoma</value>
          <valueMeaning>
           <publicID>3361420</publicID>
           <version>1</version>
           <longName>Villoglandular Adenocarcinoma</longName>
                                 <preferredDefinition>Villoglandular Adenocarcinoma</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-23T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Clear cell adenocarcinoma</value>
          <valueMeaning>
           <publicID>3081856</publicID>
           <version>1</version>
           <longName>Clear Cell Adenocarcinoma</longName>
                                 <preferredDefinition>(kar-sin-O-ma) A rare type of tumor of the female genital tract in which the inside of the cells looks clear when viewed under a microscope.</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-04-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Basal Cell Carcinoma</value>
          <valueMeaning>
           <publicID>2567411</publicID>
           <version>1</version>
           <longName>Basal Cell Carcinoma</longName>
                       <designation>
             <createdBy>TAYLORT</createdBy>
             <dateCreated>2016-01-11T17:20:58</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Basal Cell Carcinoma </name>
             <type>VM Alt Name</type>
             <context>Theradex</context>
                         </designation>
                                 <preferredDefinition>(BAY-sal sel kar-sin-O-ma) A type of skin cancer that arises from the basal cells, small round cells found in the lower part (or base) of the epidermis, the outer layer of the skin.</preferredDefinition>
          </valueMeaning>
          <beginDate>2003-12-10T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Melanoma</value>
          <valueMeaning>
           <publicID>2567413</publicID>
           <version>1</version>
           <longName>Melanoma</longName>
                                 <preferredDefinition>A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)</preferredDefinition>
          </valueMeaning>
          <beginDate>2003-12-10T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Sex cord tumor with annular tubules</value>
          <valueMeaning>
           <publicID>3645969</publicID>
           <version>1</version>
           <longName>Ovarian Sex Cord Tumor with Annular Tubules</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-08-25T17:26:52</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Sex cord tumor - annular tubules</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>An ovarian sex cord-stromal tumor characterized by the presence of Sertoli cells forming annular tubules. It may be associated with Peutz-Jeghers syndrome. Cases associated with Peutz-Jeghers syndrome have followed a benign clinical course. Cases which are not associated with Peutz-Jeghers syndrome have been reported having a clinically malignant course.</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-12-18T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Granulosa cell-theca cell tumor</value>
          <valueMeaning>
           <publicID>3645971</publicID>
           <version>1</version>
           <longName>Granulosa Cell-Theca Cell Tumor</longName>
                                 <preferredDefinition>A general term used to describe sex cord-stromal tumors characterized by the presence of granulosa cells in a thecomatous/fibrothecomatous background.</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-12-18T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Uterine leiomyosarcoma</value>
          <valueMeaning>
           <publicID>2568851</publicID>
           <version>1</version>
           <longName>Uterine leiomyosarcoma</longName>
                                 <preferredDefinition>Uterine leiomyosarcoma</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-03-29T15:53:22</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Other specify</value>
          <valueMeaning>
           <publicID>2570538</publicID>
           <version>1</version>
           <longName>Other specify</longName>
                       <designation>
             <createdBy>TAYLORT</createdBy>
             <dateCreated>2011-06-27T16:28:58</dateCreated>
             <dateModified>2011-06-28T10:31:28</dateModified>
             <modifiedBy>CHILLIJ</modifiedBy>
             <languageName>ENGLISH</languageName>
             <name>Other imaging time point, specify</name>
             <type>ACRIN Alt Name</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other, PLEASE SPECIFY</name>
             <type>LOINC_NAME</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>LA20318-4</name>
             <type>LOINC_CODE</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>KNABLEJ</createdBy>
             <dateCreated>2016-05-23T21:07:38</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other</name>
             <type>VM Alt Name</type>
             <context>DCP</context>
                         </designation>
                                  <definition>
             <createdBy>CHILLIJ</createdBy>
             <dateCreated>2008-05-06T14:58:03</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>anatomic location other than enumerated</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:46</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Leiomyoma</value>
          <valueMeaning>
           <publicID>2572962</publicID>
           <version>1</version>
           <longName>Leiomyoma</longName>
                                 <preferredDefinition>Leiomyoma</preferredDefinition>
          </valueMeaning>
          <beginDate>2005-02-03T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Undifferentiated adenocarcinoma</value>
          <valueMeaning>
           <publicID>4264976</publicID>
           <version>1</version>
           <longName>Undifferentiated Adenocarcinoma</longName>
                                 <preferredDefinition>A term used to describe cells or tissues that do not have specialized (&quot;mature&quot;) structures or functions. Undifferentiated cancer cells often grow and spread quickly.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-04-08T00:00:00</beginDate>
         </permissibleValue>
                       </valueDomain>
                      <referenceDocument>
         <name>COMMENT_360</name>
         <type>COMMENT</type>
         <context>CTEP</context>
         <doctext>Instructions on template form (to use with field 3 times): Epithelial-Stromal, Sex-cord Stromal, Germ cell</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>What is the cell type</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Histologic Type</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Histologic Type</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF Text 1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Type of Tumor</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=62334&amp;version=4</cdeBrowserLink>
      </dataElement>
             <validValue>
        <displayOrder>0</displayOrder>
        <value>Adenosquamous carcinoma</value>
        <meaningText>ADENOSQUAMOUS</meaningText>
        <description>ADENOSQUAMOUS</description>
                <valueMeaning>
         <publicID>2558185</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>1</displayOrder>
        <value>Adenocarcinoma, unspecified</value>
        <meaningText>ADENOCARCINOMA, UNSPECIFIED</meaningText>
        <description>ADENOCARCINOMA, UNSPECIFIED</description>
                <valueMeaning>
         <publicID>2567183</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>2</displayOrder>
        <value>Squamous cell carcinoma</value>
        <meaningText>SQUAMOUS CELL CARCINOMA</meaningText>
        <description>SQUAMOUS CELL CARCINOMA</description>
                <valueMeaning>
         <publicID>2574081</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>3</displayOrder>
        <value>Other specify</value>
        <meaningText>OTHER, SPECIFY</meaningText>
        <description>OTHER, SPECIFY</description>
                <valueMeaning>
         <publicID>2570538</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
           </question>
     <question>
      <publicID>2488583</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>5</displayOrder>
      <dateCreated>2006-06-22T13:36:01</dateCreated>
      <dateModified>2006-06-22T13:45:40</dateModified>
      <questionText>Other specify</questionText>
            <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Tumor Histologic Category Specify</longName>
       <shortName>TUMOR_HIST_CAT_SPEC</shortName>
       <publicID>3017</publicID>
       <version>5</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the pathologic classification of the tumor not otherwise identified.</preferredDefinition>
              <valueDomain>
        <longName>Diagnosis Specify</longName>
        <shortName>DX_SPEC</shortName>
        <publicID>2018432</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>100</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Specify Other Histologic Type</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Other specify</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Other specify</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Histology type</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Histology type</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF1 Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Specify</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text2</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Specify histologic type</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Specify other histology:</name>
         <type>Alternate Question Text</type>
         <context>NHLBI</context>
         <doctext>Specify other histology:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Specify histology</name>
         <type>Alternate Question Text</type>
         <context>NHLBI</context>
         <doctext>Specify histology</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Histologic Type</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF Text 1</name>
         <type>Alternate Question Text</type>
         <context>COG</context>
         <doctext>If Other, specify:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>DCP Text-1</name>
         <type>Alternate Question Text</type>
         <context>DCP</context>
         <doctext>Tumor Histology - Other Specify</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=3017&amp;version=5</cdeBrowserLink>
      </dataElement>
           </question>
     <question>
      <publicID>2488600</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>6</displayOrder>
      <dateCreated>2006-06-22T15:03:57</dateCreated>
      <dateModified>2006-06-22T15:04:51</dateModified>
      <questionText>Site of Involvement</questionText>
      <instruction>
       <text>(s)
(for Advanced Disease Studies)</text>
      </instruction>
      <isEditable>Yes</isEditable>
      <isMandatory>No</isMandatory>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Disease Involvement Site</longName>
       <shortName>DZ_INVLT_SITE</shortName>
       <publicID>65154</publicID>
       <version>3</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the anatomic site of disease involvement.</preferredDefinition>
              <valueDomain>
        <longName>Disease Involvement Site</longName>
        <shortName>DZ_INVLT_SITE</shortName>
        <publicID>2019238</publicID>
        <version>1</version>
        <type>Enumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>180</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                        <permissibleValue>
          <value>Peripheral nervous system</value>
          <valueMeaning>
           <publicID>2571853</publicID>
           <version>1</version>
           <longName>Peripheral Nervous System</longName>
                                 <preferredDefinition>The peripheral nervous system or PNS, is part of the nervous system, and consists of the nerves and neurons that reside or extend outside the central nervous system. (from Wikipedia)</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Gingival hypertrophy</value>
          <valueMeaning>
           <publicID>2576416</publicID>
           <version>1</version>
           <longName>Gingival hypertrophy</longName>
                                 <preferredDefinition>Gingival hypertrophy</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Mediastinal mass</value>
          <valueMeaning>
           <publicID>2576415</publicID>
           <version>1</version>
           <longName>Mediastinal mass</longName>
                                 <preferredDefinition>Mediastinal mass</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Peripheral lung</value>
          <valueMeaning>
           <publicID>3139459</publicID>
           <version>1</version>
           <longName>Peripheral Lung</longName>
                                 <preferredDefinition>On or near an edge or constituting an outer boundary; the outer area.: One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-10-22T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Central lung</value>
          <valueMeaning>
           <publicID>4550851</publicID>
           <version>1</version>
           <longName>Central lung</longName>
                                 <preferredDefinition>Central lung</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-10-22T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Mediastinal/Cervical Lymph Node</value>
          <valueMeaning>
           <publicID>4550852</publicID>
           <version>1</version>
           <longName>Mediastinal Cervical Lymph Node</longName>
                                 <preferredDefinition>Related to the mediastinum.: Any of the lymph nodes located in the neck.</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-10-22T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Spine</value>
          <valueMeaning>
           <publicID>4550853</publicID>
           <version>1</version>
           <longName>Vertebral Column</longName>
                                 <preferredDefinition>A series of bones, muscles, tendons, and other tissues reaching from the base of the skull to the tailbone. The vertebral column forms the axis of the skeleton and encloses as well as protects the spinal cord and the fluid surrounding the spinal cord.</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-10-22T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Abdomen/Pelvis</value>
          <valueMeaning>
           <publicID>4550854</publicID>
           <version>1</version>
           <longName>Abdomen Pelvis</longName>
                                 <preferredDefinition>The portion of the body that lies between the thorax and the pelvis.: The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-10-22T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Esophagus</value>
          <valueMeaning>
           <publicID>2567240</publicID>
           <version>1</version>
           <longName>Esophagus</longName>
                                 <preferredDefinition>The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Distal Bile Duct</value>
          <valueMeaning>
           <publicID>4039072</publicID>
           <version>1</version>
           <longName>Distal Bile Duct Carcinoma</longName>
                                 <preferredDefinition>A carcinoma that arises from the distal part of the extrahepatic bile duct.</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-12-30T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Perihilar Bile Ducts</value>
          <valueMeaning>
           <publicID>4647611</publicID>
           <version>1</version>
           <longName>Perihilar Bile Ducts</longName>
                                 <preferredDefinition>Perihilar Bile Ducts</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-12-30T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Intrahepatic Bile Ducts</value>
          <valueMeaning>
           <publicID>3691244</publicID>
           <version>1</version>
           <longName>Intrahepatic Bile Duct</longName>
                                 <preferredDefinition>The bile ducts that pass through and drain bile from the liver.</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-12-30T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Ovaries</value>
          <valueMeaning>
           <publicID>4363633</publicID>
           <version>1</version>
           <longName>Ovary</longName>
                                 <preferredDefinition>One of the paired female reproductive glands containing the ova or germ cells; the ovary&apos;s stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova.</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-12-30T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Other abdominal</value>
          <valueMeaning>
           <publicID>2570519</publicID>
           <version>1</version>
           <longName>Other Abdominal</longName>
                                 <preferredDefinition>Other Abdominal</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Other (non-CNS)</value>
          <valueMeaning>
           <publicID>4766045</publicID>
           <version>1</version>
           <longName>Other (non-CNS)</longName>
                                 <preferredDefinition>Other sites that are non-CNS</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-03-30T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Orbit(s)</value>
          <valueMeaning>
           <publicID>4766046</publicID>
           <version>1</version>
           <longName>Orbit(s)</longName>
                                 <preferredDefinition>the bony cavity perforated for the passage of nerves and blood vessels that occupies the lateral front of the skull immediately beneath the frontal bone on each side and encloses and protects the eye and its appendages</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-03-30T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Head and neck other than orbits</value>
          <valueMeaning>
           <publicID>4766047</publicID>
           <version>1</version>
           <longName>Head and neck other than orbits</longName>
                                 <preferredDefinition>Head and neck excluding orbit(s)</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-03-30T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Lymph Node(s) Mesenteric</value>
          <valueMeaning>
           <publicID>3778534</publicID>
           <version>1</version>
           <longName>Mesenteric Lymph Node</longName>
                                 <preferredDefinition>A lymph node located in the mesentery.</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-06-26T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Other non-CNS site, specify</value>
          <valueMeaning>
           <publicID>4892511</publicID>
           <version>1</version>
           <longName>Other non-CNS site, specify</longName>
                                 <preferredDefinition>Other non-CNS site, specify</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-07-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Pituitary gland</value>
          <valueMeaning>
           <publicID>4265275</publicID>
           <version>1</version>
           <longName>Pituitary Gland</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-08-05T17:42:03</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Pituitary gland</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>Pea-sized endocrine gland located at the base of the brain in the pituitary fossa. It produces and secretes hormones such as oxytocin and vasopressin, to regulate the activities of the hypothalamus.</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-07-15T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Kidney (right)</value>
          <valueMeaning>
           <publicID>4903231</publicID>
           <version>1</version>
           <longName>Kidney (right)</longName>
                                 <preferredDefinition>Kidney (right)</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-07-16T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Kidney (left)</value>
          <valueMeaning>
           <publicID>4903232</publicID>
           <version>1</version>
           <longName>Kidney (left)</longName>
                                 <preferredDefinition>Kidney (left)</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-07-16T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Chloroma</value>
          <valueMeaning>
           <publicID>2572957</publicID>
           <version>1</version>
           <longName>Myeloid Sarcoma</longName>
                                 <preferredDefinition>A tumor mass composed of myeloblasts or immature myeloid cells.  It occurs in extramedullary sites or the bone.  (WHO, 2001)</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Skin (leukemia cutis)</value>
          <valueMeaning>
           <publicID>2580523</publicID>
           <version>1</version>
           <longName>Leukaemia cutis</longName>
                       <designation>
             <createdBy>TSANE</createdBy>
             <dateCreated>2015-04-02T16:48:17</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Skin (leukemia cutis)</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>No Value Exists</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Testes/Ovary</value>
          <valueMeaning>
           <publicID>2630006</publicID>
           <version>1</version>
           <longName>Testes/Ovary</longName>
                                 <preferredDefinition>Testes (male sex glands)/Ovary (the female gonad)</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Lymph Node(s) Diaphragmatic</value>
          <valueMeaning>
           <publicID>5656058</publicID>
           <version>1</version>
           <longName>Diaphragm Lymph Node</longName>
                                 <preferredDefinition>Fibromuscular tissue that separates the thoracic from the abdominal cavity. It increases the volume of the thoracic cavity through contractions, thus facilitating respiration.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</preferredDefinition>
          </valueMeaning>
          <beginDate>2017-02-08T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Lymph Node(s) Axillary</value>
          <valueMeaning>
           <publicID>3282269</publicID>
           <version>1</version>
           <longName>Axillary Lymph Node</longName>
                                 <preferredDefinition>One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle. </preferredDefinition>
          </valueMeaning>
          <beginDate>2017-02-08T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Lymph Node(s) Hilar</value>
          <valueMeaning>
           <publicID>5656059</publicID>
           <version>1</version>
           <longName>Lymph Node Hilum</longName>
                                 <preferredDefinition>The concave side of the lymph node.</preferredDefinition>
          </valueMeaning>
          <beginDate>2017-02-08T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Lymph Node(s) Pelvic</value>
          <valueMeaning>
           <publicID>5216171</publicID>
           <version>1</version>
           <longName>Pelvic Lymph Node</longName>
                                 <preferredDefinition>Any lymph node within the abdominal pelvic region.</preferredDefinition>
          </valueMeaning>
          <beginDate>2017-02-08T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Lung parenchyma</value>
          <valueMeaning>
           <publicID>5656060</publicID>
           <version>1</version>
           <longName>Lung Parenchyma</longName>
                                 <preferredDefinition>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.: The tissue that constitutes the essential part of an organ as contrasted with e.g., connective tissue and blood vessels.</preferredDefinition>
          </valueMeaning>
          <beginDate>2017-02-08T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Other</value>
          <valueMeaning>
           <publicID>2570886</publicID>
           <version>1</version>
           <longName>Other, specify</longName>
                       <designation>
             <createdBy>MORENOC</createdBy>
             <dateCreated>2017-10-24T06:37:26</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                         </designation>
                                  <definition>
             <createdBy>REEVESD</createdBy>
             <dateCreated>2013-06-06T10:36:28</dateCreated>
             <dateModified>2016-10-20T13:13:48</dateModified>
             <modifiedBy>UMLLDR</modifiedBy>
             <languageName>ENGLISH</languageName>
             <text>other</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>Different than the one(s) previously specified or mentioned.</preferredDefinition>
          </valueMeaning>
          <beginDate>2009-02-04T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Soft Tissue</value>
          <valueMeaning>
           <publicID>2990372</publicID>
           <version>1</version>
           <longName>Soft Tissue</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-08-20T16:49:09</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Soft tissue</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-02-03T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Clitoris</value>
          <valueMeaning>
           <publicID>3123670</publicID>
           <version>1</version>
           <longName>Clitoris</longName>
                                 <preferredDefinition>The erectile tissue in the vulva. It is composed of the corpora cavernosa and the glans clitoris.</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-07-19T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Ascites</value>
          <valueMeaning>
           <publicID>3123209</publicID>
           <version>1</version>
           <longName>Ascites</longName>
                                 <preferredDefinition>A disorder characterized by accumulation of serous or hemorrhagic fluid in the peritoneal cavity.</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-07-30T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Adjacent viscera</value>
          <valueMeaning>
           <publicID>2558189</publicID>
           <version>1</version>
           <longName>ADJACENT VISCERA</longName>
                                 <preferredDefinition>ADJACENT VISCERA</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Adjacent viscera/vessels</value>
          <valueMeaning>
           <publicID>2558190</publicID>
           <version>1</version>
           <longName>ADJACENT VISCERA/VESSELS</longName>
                                 <preferredDefinition>ADJACENT VISCERA/VESSELS</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Appendix</value>
          <valueMeaning>
           <publicID>2558237</publicID>
           <version>1</version>
           <longName>Appendix</longName>
                       <designation>
             <createdBy>DAVISJ</createdBy>
             <dateCreated>2015-08-20T15:04:52</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Appendiceal</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>Small tissue projection existing as a cecal diverticulum with a questionable history of vestigial versus specialized organ.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Bone</value>
          <valueMeaning>
           <publicID>2567236</publicID>
           <version>1</version>
           <longName>Bone</longName>
                                 <preferredDefinition>Connective tissue that forms the skeletal components of the body.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Bone marrow</value>
          <valueMeaning>
           <publicID>2581613</publicID>
           <version>1</version>
           <longName>Bone Marrow</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2014-07-28T15:38:57</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Bone marrow</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes. </preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Brain</value>
          <valueMeaning>
           <publicID>2558329</publicID>
           <version>1</version>
           <longName>Brain</longName>
                       <designation>
             <createdBy>COLBERTM</createdBy>
             <dateCreated>2014-08-22T00:00:00</dateCreated>
             <dateModified>2014-08-22T00:00:00</dateModified>
             <modifiedBy>COLBERTM</modifiedBy>
             <languageName>ENGLISH</languageName>
             <name>Test2AltnNameOnlyOne</name>
             <type>Biomarker Synonym</type>
             <context>NCIP</context>
                         </designation>
                                 <preferredDefinition>An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>CNS/Brain</value>
          <valueMeaning>
           <publicID>2558522</publicID>
           <version>1</version>
           <longName>CNS/BRAIN</longName>
                                  <definition>
             <createdBy>LUY</createdBy>
             <dateCreated>2015-01-30T13:18:26</dateCreated>
             <text>CNS/BRAIN</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>The part of the nervous system that consists of the brain, spinal cord, and meninges.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Distant lymph nodes</value>
          <valueMeaning>
           <publicID>2558669</publicID>
           <version>1</version>
           <longName>DISTANT LYMPH NODES</longName>
                       <designation>
             <createdBy>MIRANDAA</createdBy>
             <dateCreated>2016-03-21T11:56:04</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Distant lymph nodes</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                         </designation>
                                 <preferredDefinition>DISTANT LYMPH NODES</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Distant nodes</value>
          <valueMeaning>
           <publicID>2570254</publicID>
           <version>1</version>
           <longName>Distant nodes</longName>
                                  <definition>
             <createdBy>LUY</createdBy>
             <dateCreated>2015-01-30T13:22:19</dateCreated>
             <text>Distant nodes</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>A lymph node located distant to the anatomic site of interest.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Ipsilateral supraclavicular nodes</value>
          <valueMeaning>
           <publicID>2570379</publicID>
           <version>1</version>
           <longName>Ipsilateral supraclavicular nodes</longName>
                                 <preferredDefinition>Ipsilateral supraclavicular nodes</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Lung/Pleura</value>
          <valueMeaning>
           <publicID>2570419</publicID>
           <version>1</version>
           <longName>Lung/Pleura</longName>
                       <designation>
             <createdBy>MORENOC</createdBy>
             <dateCreated>2017-02-08T15:07:51</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Lung pleura</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                         </designation>
                                  <definition>
             <createdBy>LUY</createdBy>
             <dateCreated>2015-01-30T13:16:20</dateCreated>
             <text>Lung/Pleura</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The tissue that lines the wall of the thoracic cavity and the surface of the lungs.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:45</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Lymph nodes</value>
          <valueMeaning>
           <publicID>2570420</publicID>
           <version>1</version>
           <longName>Lymph Nodes</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-08-05T17:42:03</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Lymph nodes</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                  <definition>
             <createdBy>LUY</createdBy>
             <dateCreated>2015-01-30T13:23:37</dateCreated>
             <dateModified>2016-10-20T13:13:39</dateModified>
             <modifiedBy>UMLLDR</modifiedBy>
             <languageName>ENGLISH</languageName>
             <text>Lymph Nodes</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:45</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Other CNS</value>
          <valueMeaning>
           <publicID>2570521</publicID>
           <version>1</version>
           <longName>Other CNS</longName>
                                  <definition>
             <createdBy>LUY</createdBy>
             <dateCreated>2015-02-05T14:25:35</dateCreated>
             <text>Other CNS</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>Different than the one(s) previously specified or mentioned.: The part of the nervous system that consists of the brain, spinal cord, and meninges.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:46</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Pelvis</value>
          <valueMeaning>
           <publicID>2570571</publicID>
           <version>1</version>
           <longName>Pelvis</longName>
                                  <definition>
             <createdBy>LUY</createdBy>
             <dateCreated>2015-01-29T12:33:39</dateCreated>
             <text>Pelvis</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:47</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Peritoneal disease</value>
          <valueMeaning>
           <publicID>2559792</publicID>
           <version>1</version>
           <longName>PERITONEAL DISEASE</longName>
                                 <preferredDefinition>PERITONEAL DISEASE</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:47</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Peritoneum</value>
          <valueMeaning>
           <publicID>2559796</publicID>
           <version>1</version>
           <longName>Peritoneum</longName>
                                  <definition>
             <createdBy>REEVESD</createdBy>
             <dateCreated>2009-05-14T13:46:55</dateCreated>
             <dateModified>2011-03-25T13:44:59</dateModified>
             <modifiedBy>UMLLDR</modifiedBy>
             <languageName>ENGLISH</languageName>
             <text>Peritoneum</text>
             <type>Manually-curated</type>
                           <classification>
               <name>Common Biorepository Model</name>
               <publicID>3204728</publicID>
               <version>1</version>
               <preferredDefinition>A common model to contain summary-level details of biorepository / biobank holdings which can be advertised through the OBBR Specimen Resource Locator</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>(PAIR-ih-toe-NEE-um) The tissue that lines the abdominal wall and covers most of the organs in the abdomen.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:47</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Pleura</value>
          <valueMeaning>
           <publicID>2559813</publicID>
           <version>1</version>
           <longName>Pleura</longName>
                       <designation>
             <createdBy>GOODINM</createdBy>
             <dateCreated>2017-03-29T10:28:06</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Pleura/Pleural effusion</name>
             <type>VM Alt Name</type>
             <context>NCIP</context>
                         </designation>
                                  <definition>
             <createdBy>REEVESD</createdBy>
             <dateCreated>2009-05-14T13:47:46</dateCreated>
             <text>Pleura</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>(PLOOR-a) A thin layer of tissue covering the lungs and the wall of the chest cavity to protect and cushion the lungs. A small amount of fluid that acts as a lubricant allows the lungs to move smoothly in the chest cavity during breathing.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:47</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Primary site/direct extension</value>
          <valueMeaning>
           <publicID>2570610</publicID>
           <version>1</version>
           <longName>Primary site/direct extension</longName>
                                  <definition>
             <createdBy>LUY</createdBy>
             <dateCreated>2015-02-19T11:20:14</dateCreated>
             <text>Primary site/direct extension</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>Occurring first in time or sequence; original; of greatest rank or importance or value.: Named locations of or within the body.: The spread or migration of cancer cells through the wall of an organ into surrounding organs and/or adjacent tissues.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:47</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Primary tumor/esophagus</value>
          <valueMeaning>
           <publicID>2559895</publicID>
           <version>1</version>
           <longName>PRIMARY TUMOR/ESOPHAGUS</longName>
                                 <preferredDefinition>PRIMARY TUMOR/ESOPHAGUS</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Primary tumor/pancreas</value>
          <valueMeaning>
           <publicID>2559896</publicID>
           <version>1</version>
           <longName>PRIMARY TUMOR/PANCREAS</longName>
                                 <preferredDefinition>PRIMARY TUMOR/PANCREAS</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Primary tumor/stomach</value>
          <valueMeaning>
           <publicID>2559897</publicID>
           <version>1</version>
           <longName>PRIMARY TUMOR/STOMACH</longName>
                                 <preferredDefinition>PRIMARY TUMOR/STOMACH</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Rectum</value>
          <valueMeaning>
           <publicID>2567247</publicID>
           <version>1</version>
           <longName>Rectum</longName>
                                 <preferredDefinition>The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Regional lymph nodes</value>
          <valueMeaning>
           <publicID>2559961</publicID>
           <version>1</version>
           <longName>REGIONAL LYMPH NODES</longName>
                       <designation>
             <createdBy>MIRANDAA</createdBy>
             <dateCreated>2016-03-21T13:44:57</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Regional lymph nodes</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                         </designation>
                                 <preferredDefinition>REGIONAL LYMPH NODES</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Regional nodes</value>
          <valueMeaning>
           <publicID>2570656</publicID>
           <version>1</version>
           <longName>Regional nodes</longName>
                                  <definition>
             <createdBy>LUY</createdBy>
             <dateCreated>2015-01-30T13:40:14</dateCreated>
             <text>Regional nodes</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>A lymph node that drains lymph from a region of interest.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Kidney</value>
          <valueMeaning>
           <publicID>2561100</publicID>
           <version>1</version>
           <longName>Kidney</longName>
                                 <preferredDefinition>One of the two organs that excrete the urine. The kidneys are bean-shaped organs (about 11 cm long, 5 cm wide, and 3 cm thick) lying on either side of the vertebral column, posterior to the peritoneum, about opposite the twelfth thoracic and first three lumbar vertebrae. SYN ren, nephros.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-04-17T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Effusion</value>
          <valueMeaning>
           <publicID>3211546</publicID>
           <version>1</version>
           <longName>Effusion</longName>
                                 <preferredDefinition>Effusion</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-03-25T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Epidural involvement</value>
          <valueMeaning>
           <publicID>3227938</publicID>
           <version>1</version>
           <longName>Epidural involvement</longName>
                                 <preferredDefinition>Epidural involvement</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-04-15T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Two or more extranodal sites</value>
          <valueMeaning>
           <publicID>3227939</publicID>
           <version>1</version>
           <longName>Two or more extranodal sites</longName>
                                 <preferredDefinition>Two or more extranodal sites</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-04-15T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Paranasal sinuses</value>
          <valueMeaning>
           <publicID>2573422</publicID>
           <version>1</version>
           <longName>Paranasal Sinus</longName>
                                 <preferredDefinition>Air-filled extensions of the respiratory part of the nasal cavity into the frontal, ethmoid, sphenoid, and maxillary cranial bones. They vary in size and form in different individuals and are lined by the ciliated mucous membranes of the nasal cavity.</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-04-15T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Testes</value>
          <valueMeaning>
           <publicID>2567251</publicID>
           <version>1</version>
           <longName>Testis</longName>
                       <designation>
             <createdBy>MAESKEB</createdBy>
             <dateCreated>2014-06-24T09:29:03</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Testicle</name>
             <type>VM Alt Name</type>
             <context>Theradex</context>
                         </designation>
                                  <definition>
             <createdBy>KUMMEROA</createdBy>
             <dateCreated>2010-03-30T10:34:20</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Either of the paired male reproductive glands that produce the male germ cells and the male hormones.
</text>
             <type>NCI</type>
                           <classification>
               <name>Common Biorepository Model</name>
               <publicID>3204728</publicID>
               <version>1</version>
               <preferredDefinition>A common model to contain summary-level details of biorepository / biobank holdings which can be advertised through the OBBR Specimen Resource Locator</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NHLBI</context>
            </definition>
                      <preferredDefinition>Either of the paired male reproductive glands that produce the male germ cells and the male hormones.</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-04-15T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Abdomen</value>
          <valueMeaning>
           <publicID>2562159</publicID>
           <version>1</version>
           <longName>Abdomen</longName>
                                 <preferredDefinition>That portion of the body that lies between the thorax and the pelvis.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-08-06T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Vulva</value>
          <valueMeaning>
           <publicID>2562490</publicID>
           <version>1</version>
           <longName>Vulva</longName>
                                 <preferredDefinition>The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-09-27T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Stomach</value>
          <valueMeaning>
           <publicID>3284854</publicID>
           <version>1</version>
           <longName>Stomach</longName>
                                 <preferredDefinition>An organ located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. The stomach is the primary organ of food digestion.</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-09-20T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Lymph Node(s) Retroperitoneal</value>
          <valueMeaning>
           <publicID>3284852</publicID>
           <version>1</version>
           <longName>Retroperitoneal Lymph Node</longName>
                       <designation>
             <createdBy>LEEW</createdBy>
             <dateCreated>2017-03-29T11:55:08</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Lymph Node(s) Retroperitoneal </name>
             <type>VM Alt Name</type>
             <context>NCIP</context>
                         </designation>
                                 <preferredDefinition>A lymph node located in the retroperitoneal space.</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-18T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Distal canal</value>
          <valueMeaning>
           <publicID>3355077</publicID>
           <version>1</version>
           <longName>Distal canal</longName>
                                 <preferredDefinition>Distal canal</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-18T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Mid canal</value>
          <valueMeaning>
           <publicID>3355078</publicID>
           <version>1</version>
           <longName>Mid canal</longName>
                                 <preferredDefinition>Mid canal</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-18T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Squamocolumnar Junction</value>
          <valueMeaning>
           <publicID>2580527</publicID>
           <version>1</version>
           <longName>Squamocolumnar junction</longName>
                                 <preferredDefinition>Squamocolumnar junction</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-01-18T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Lymph Node(s) Cervical</value>
          <valueMeaning>
           <publicID>3137531</publicID>
           <version>1</version>
           <longName>Cervical Lymph Node</longName>
                                 <preferredDefinition>Any of the lymph nodes located in the neck.</preferredDefinition>
          </valueMeaning>
          <beginDate>2005-07-14T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Lymph Node(s) Mediastinal</value>
          <valueMeaning>
           <publicID>2582005</publicID>
           <version>1</version>
           <longName>Mediastinal Lymph Node</longName>
                       <designation>
             <createdBy>ROUILLAS</createdBy>
             <dateCreated>2014-06-26T11:14:20</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Mediastinal nodes</name>
             <type>VM Alt Name</type>
             <context>ECOG-ACRIN</context>
                         </designation>
                                 <preferredDefinition>A lymph node located in the mediastinum. Mediastinal lymph nodes are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent.</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-03-01T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Skin (cutaneous)</value>
          <valueMeaning>
           <publicID>2567252</publicID>
           <version>1</version>
           <longName>Skin</longName>
                                 <preferredDefinition>An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:49</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Other</value>
          <valueMeaning>
           <publicID>2559668</publicID>
           <version>1</version>
           <longName>OTHER SPECIFY</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2014-10-27T13:13:10</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other (Specify)</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
            <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-07-20T18:12:05</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other, specify</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
            <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-07-16T14:05:37</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
            <designation>
             <createdBy>ZHANGWE</createdBy>
             <dateCreated>2017-09-22T15:34:23</dateCreated>
             <dateModified>2017-10-17T15:46:53</dateModified>
             <modifiedBy>COOPERM</modifiedBy>
             <languageName>ENGLISH</languageName>
             <name>Other (incl. trunk, retroperitoneum), specify</name>
             <type>VM Alt Name</type>
             <context>OCG</context>
                         </designation>
            <designation>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2017-10-01T08:47:06</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other (specify)</name>
             <type>VM Alt Name</type>
             <context>OCG</context>
                         </designation>
                                 <preferredDefinition>Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:46</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Central nervous system</value>
          <valueMeaning>
           <publicID>2558476</publicID>
           <version>1</version>
           <longName>Central Nervous System</longName>
                       <designation>
             <createdBy>ROUILLAS</createdBy>
             <dateCreated>2014-07-30T13:40:24</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>CNS</name>
             <type>VM Alt Name</type>
             <context>ECOG-ACRIN</context>
                         </designation>
                                  <definition>
             <createdBy>REEVESD</createdBy>
             <dateCreated>2009-05-14T13:48:53</dateCreated>
             <text>Central Nervous System</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Skin/subcutaneous</value>
          <valueMeaning>
           <publicID>3563241</publicID>
           <version>1</version>
           <longName>Skin/subcutaneous</longName>
                                 <preferredDefinition>Skin/subcutaneous</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-08-17T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Beyond Gerota&apos;s fascia</value>
          <valueMeaning>
           <publicID>3563242</publicID>
           <version>1</version>
           <longName>Beyond Gerota&apos;s fascia</longName>
                                 <preferredDefinition>Beyond Gerota&apos;s fascia</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-08-17T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Inferior vena cava invasion</value>
          <valueMeaning>
           <publicID>3563243</publicID>
           <version>1</version>
           <longName>Inferior vena cava invasion</longName>
                                 <preferredDefinition>Inferior vena cava invasion</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-08-17T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Renal artery/vein invasion</value>
          <valueMeaning>
           <publicID>3563244</publicID>
           <version>1</version>
           <longName>Renal artery/vein invasion</longName>
                                 <preferredDefinition>Renal artery/vein invasion</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-08-17T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Perineal tissues</value>
          <valueMeaning>
           <publicID>3563245</publicID>
           <version>1</version>
           <longName>Perineal tissues</longName>
                                 <preferredDefinition>Perineal tissues</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-08-17T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Urethra</value>
          <valueMeaning>
           <publicID>3625364</publicID>
           <version>1</version>
           <longName>Urethra</longName>
                                 <preferredDefinition>The tube carrying urine from the bladder to outside of the body. </preferredDefinition>
          </valueMeaning>
          <beginDate>2011-01-06T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Spleen</value>
          <valueMeaning>
           <publicID>2567549</publicID>
           <version>1</version>
           <longName>Spleen</longName>
                                 <preferredDefinition>An organ that produces lymphocytes, filters the blood, stores blood cells, and destroys those that are aging. It is located on the left side of the abdomen near the stomach. (OCC)</preferredDefinition>
          </valueMeaning>
          <beginDate>2003-12-19T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Abdomen (other than above)</value>
          <valueMeaning>
           <publicID>2558141</publicID>
           <version>1</version>
           <longName>ABDOMEN (OTHER THAN ABOVE)</longName>
                                 <preferredDefinition>ABDOMEN (OTHER THAN ABOVE)</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-01-12T15:45:54</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>GI tract</value>
          <valueMeaning>
           <publicID>2568045</publicID>
           <version>1</version>
           <longName>Gastrointestinal Tract</longName>
                                 <preferredDefinition>The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-01-12T15:57:46</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Pelvic (other than above)</value>
          <valueMeaning>
           <publicID>2559767</publicID>
           <version>1</version>
           <longName>PELVIC (OTHER THAN ABOVE)</longName>
                                 <preferredDefinition>PELVIC (OTHER THAN ABOVE)</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-01-12T15:47:36</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Adjacent structures specify</value>
          <valueMeaning>
           <publicID>2558188</publicID>
           <version>1</version>
           <longName>ADJACENT STRUCTURES, SPECIFY</longName>
                                 <preferredDefinition>ADJACENT STRUCTURES, SPECIFY</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-01-12T15:47:36</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Lower pelvic lymph node</value>
          <valueMeaning>
           <publicID>3648937</publicID>
           <version>1</version>
           <longName>Lower Pelvic Lymph Node</longName>
                                 <preferredDefinition>Lower; the bottom one of two.: Any lymph node within the pelvic region.</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-01-04T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Inguinal femoral lymph node</value>
          <valueMeaning>
           <publicID>3648938</publicID>
           <version>1</version>
           <longName>Inguinal Region Femoral Lymph Node</longName>
                                 <preferredDefinition>The external junctural region between the lower part of the abdomen and the thigh.: A lymph node located in the upper inner portion of the thigh.</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-01-04T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Labium minora</value>
          <valueMeaning>
           <publicID>3648939</publicID>
           <version>1</version>
           <longName>Labium minora</longName>
                                 <preferredDefinition>Labium minora</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-01-04T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Labium majora</value>
          <valueMeaning>
           <publicID>3648940</publicID>
           <version>1</version>
           <longName>Labium majora</longName>
                                 <preferredDefinition>Labium majora</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-01-04T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Ampulla</value>
          <valueMeaning>
           <publicID>3685443</publicID>
           <version>1</version>
           <longName>Ampulla</longName>
                       <designation>
             <createdBy>ROUILLAS</createdBy>
             <dateCreated>2014-12-30T10:36:46</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Ampulla of Vater</name>
             <type>VM Alt Name</type>
             <context>ECOG-ACRIN</context>
                         </designation>
                                 <preferredDefinition>A sac-like enlargement of a canal or duct.</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-02-12T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Eye</value>
          <valueMeaning>
           <publicID>3689467</publicID>
           <version>1</version>
           <longName>Eye</longName>
                                 <preferredDefinition>The organ of sight or vision.</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-02-20T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Lung</value>
          <valueMeaning>
           <publicID>2567244</publicID>
           <version>1</version>
           <longName>Lung</longName>
                                 <preferredDefinition>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-03-31T11:05:18</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Liver</value>
          <valueMeaning>
           <publicID>2567243</publicID>
           <version>1</version>
           <longName>Liver</longName>
                                 <preferredDefinition>A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-03-31T11:06:36</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Skin</value>
          <valueMeaning>
           <publicID>2567252</publicID>
           <version>1</version>
           <longName>Skin</longName>
                                 <preferredDefinition>An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-03-31T11:07:55</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Second other site</value>
          <valueMeaning>
           <publicID>3722691</publicID>
           <version>1</version>
           <longName>Second other site</longName>
                                 <preferredDefinition>Second other site</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-04-12T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>First other site</value>
          <valueMeaning>
           <publicID>3722692</publicID>
           <version>1</version>
           <longName>First other site</longName>
                                 <preferredDefinition>First other site</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-04-12T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Distant skin/subcutaneous tissue/subcutaneous tissue</value>
          <valueMeaning>
           <publicID>3722693</publicID>
           <version>1</version>
           <longName>Distant skin/subcutaneous tissue/subcutaneous tissue</longName>
                                 <preferredDefinition>Distant skin/subcutaneous tissue/subcutaneous tissue</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-04-12T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Ipsilateral breast</value>
          <valueMeaning>
           <publicID>3722694</publicID>
           <version>1</version>
           <longName>Ipsilateral Breast</longName>
                       <designation>
             <createdBy>TAYLORT</createdBy>
             <dateCreated>2015-03-11T14:56:10</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Ipsilateral</name>
             <type>ACRIN Alt Name</type>
             <context>ECOG-ACRIN</context>
                         </designation>
                                 <preferredDefinition>Having to do with the same side of the body.: One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-04-12T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Local regional (including chest wall; axillary, internal mammary, and infraclavicular nodes; local-regional skin and subcutaneous tissue)</value>
          <valueMeaning>
           <publicID>3722695</publicID>
           <version>1</version>
           <longName>Local regional (including chest wall; axillary, internal mammary, and infraclavicular nodes; local-regional skin and subcutaneous tissue)</longName>
                                 <preferredDefinition>Local regional (including chest wall; axillary, internal mammary, and infraclavicular nodes; local-regional skin and subcutaneous tissue)</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-04-12T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Anus</value>
          <valueMeaning>
           <publicID>2569544</publicID>
           <version>1</version>
           <longName>Anus</longName>
                                 <preferredDefinition>(AY-nus) The opening of the rectum to the outside of the body.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-12T11:26:45</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Pancreas</value>
          <valueMeaning>
           <publicID>2567245</publicID>
           <version>1</version>
           <longName>Pancreas</longName>
                       <designation>
             <createdBy>ROUILLAS</createdBy>
             <dateCreated>2013-10-30T14:22:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Pancreas adenocarcinoma/other</name>
             <type>VM Alt Name</type>
             <context>ECOG-ACRIN</context>
                         </designation>
                                 <preferredDefinition>A non-encapsulated elongated and lobulated organ, extending from the concavity of the duodenum to the spleen; it consists of a head, an elongated body, and a tail. It contains two functional components: an exocrine component that secretes juices into the intestine and an endocrine component that secretes hormones (insulin and glucagon).</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-12T11:45:09</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Colon</value>
          <valueMeaning>
           <publicID>2567239</publicID>
           <version>1</version>
           <longName>Colon</longName>
                                 <preferredDefinition>The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-13T13:17:09</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Adrenal gland</value>
          <valueMeaning>
           <publicID>2569663</publicID>
           <version>1</version>
           <longName>Adrenal Gland</longName>
                       <designation>
             <createdBy>ROUILLAS</createdBy>
             <dateCreated>2014-06-26T11:14:20</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Adrenal(s)</name>
             <type>VM Alt Name</type>
             <context>ECOG-ACRIN</context>
                         </designation>
            <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-08-06T16:58:36</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Adrenal gland</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
            <designation>
             <createdBy>GOODINM</createdBy>
             <dateCreated>2017-03-29T10:28:06</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Adrenal</name>
             <type>VM Alt Name</type>
             <context>NCIP</context>
                         </designation>
                                 <preferredDefinition>Paired glands situated in the retroperitoneal tissues at the superior pole of each kidney.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-25T16:33:55</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Gallbladder</value>
          <valueMeaning>
           <publicID>2569859</publicID>
           <version>1</version>
           <longName>Gallbladder</longName>
                                 <preferredDefinition>A pear-shaped organ just below the liver that stores the bile secreted by the liver, delivering the bile through the bile ducts into the intestines to help with digestion.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-06-04T15:53:01</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Perineum</value>
          <valueMeaning>
           <publicID>2565650</publicID>
           <version>1</version>
           <longName>PERINEUM</longName>
                                 <preferredDefinition>PERINEUM</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-06-04T17:11:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Opposite breast</value>
          <valueMeaning>
           <publicID>2570511</publicID>
           <version>1</version>
           <longName>Opposite Breast</longName>
                                 <preferredDefinition>Opposite Breast</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-06-30T09:54:15</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Bile duct</value>
          <valueMeaning>
           <publicID>2571102</publicID>
           <version>1</version>
           <longName>Bile Duct</longName>
                                 <preferredDefinition>A tube through which bile passes in and out of the liver.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-07-20T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Bladder</value>
          <valueMeaning>
           <publicID>2567211</publicID>
           <version>1</version>
           <longName>Bladder</longName>
                                 <preferredDefinition>The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-12-17T16:23:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Omentum</value>
          <valueMeaning>
           <publicID>2574087</publicID>
           <version>1</version>
           <longName>Omentum</longName>
                                 <preferredDefinition>A fold of peritoneum originating at the stomach and supporting the viscera. </preferredDefinition>
          </valueMeaning>
          <beginDate>2005-03-03T07:17:37</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Para-aortic nodes</value>
          <valueMeaning>
           <publicID>2573347</publicID>
           <version>1</version>
           <longName>Para-aortic nodes</longName>
                                 <preferredDefinition>Para-aortic nodes</preferredDefinition>
          </valueMeaning>
          <beginDate>2005-03-03T07:17:37</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Pelvic nodes</value>
          <valueMeaning>
           <publicID>2559771</publicID>
           <version>1</version>
           <longName>PELVIC NODES</longName>
                                 <preferredDefinition>PELVIC NODES</preferredDefinition>
          </valueMeaning>
          <beginDate>2005-03-03T07:17:37</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Small intestine</value>
          <valueMeaning>
           <publicID>3284853</publicID>
           <version>1</version>
           <longName>Small Intestine</longName>
                                 <preferredDefinition>The section of the intestines between the pylorus and cecum. The small intestine is approximately 20 feet long and consists of the duodenum, the jejunum, and the ileum. Its main function is to absorb nutrients from food as the food is transported to the large intestine.</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-04-08T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Perianus</value>
          <valueMeaning>
           <publicID>2575637</publicID>
           <version>1</version>
           <longName>Perianus</longName>
                                 <preferredDefinition>Perianus</preferredDefinition>
          </valueMeaning>
          <beginDate>2005-07-14T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Wrist</value>
          <valueMeaning>
           <publicID>4417272</publicID>
           <version>1</version>
           <longName>Wrist (distal radius, distal ulna, intrinsic wrist bones)</longName>
                                 <preferredDefinition>Wrist (distal radius, distal ulna, intrinsic wrist bones)</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-07-29T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Shoulder</value>
          <valueMeaning>
           <publicID>4417273</publicID>
           <version>1</version>
           <longName>Shoulder (proximal Humerus)</longName>
                                 <preferredDefinition>Shoulder (proximal Humerus)</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-07-29T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Knee</value>
          <valueMeaning>
           <publicID>4417274</publicID>
           <version>1</version>
           <longName>Knee (distal femur, proximal tibia)</longName>
                                 <preferredDefinition>Knee (distal femur, proximal tibia)</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-07-29T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Hip</value>
          <valueMeaning>
           <publicID>2575747</publicID>
           <version>1</version>
           <longName>Hip (Proximal Femur)</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2014-07-29T18:13:38</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Hip (proximal femur)</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>Hip (Proximal Femur)</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-07-29T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Heel</value>
          <valueMeaning>
           <publicID>4417275</publicID>
           <version>1</version>
           <longName>Heel (calcaneus)</longName>
                                 <preferredDefinition>Heel (calcaneus)</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-07-29T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Radius</value>
          <valueMeaning>
           <publicID>4417276</publicID>
           <version>1</version>
           <longName>Radius (proximal ulna)</longName>
                                 <preferredDefinition>Radius (proximal ulna)</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-07-29T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Elbow</value>
          <valueMeaning>
           <publicID>4417277</publicID>
           <version>1</version>
           <longName>Elbow (distal humerus, proximal)</longName>
                                 <preferredDefinition>Elbow (distal humerus, proximal)</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-07-29T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Ankle</value>
          <valueMeaning>
           <publicID>4417278</publicID>
           <version>1</version>
           <longName>Ankle (distal tibia, intrinsic ankle bones)</longName>
                                 <preferredDefinition>Ankle (distal tibia, intrinsic ankle bones)</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-07-29T00:00:00</beginDate>
         </permissibleValue>
                       </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Disease Involvement Site</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Site of Involvement</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Site of Involvement</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text2</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Disease site</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>BRIDG mapping path for CDE:65154 /</name>
         <type>BRIDG Mapping Path</type>
         <context>NHLBI</context>
         <doctext>PerformedDiagnosis [primary] &gt; AssessedResultRelationship &gt; PerformedObservation [assessment] &gt; AssessedResultRelationship &gt; PerformedDiagnosis [secondary] &gt; TargetAnatomicSite.code WHERE PerformedDiagnosis.value [primary] = &quot;Breast Cancer&quot; AND PerformedObservation [assessment] &gt; PerformedClinicalInterpretation.value = &quot;involvement&quot;</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text3</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Cell of origin</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Sites of Involvement</name>
         <type>Alternate Question Text</type>
         <context>SWOG</context>
         <doctext>Sites of Involvement</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Distant metastatic involvement</name>
         <type>Alternate Question Text</type>
         <context>SWOG</context>
         <doctext>Distant metastatic involvement at registration</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>ECOG CRF 1</name>
         <type>Alternate Question Text</type>
         <context>ECOG-ACRIN</context>
         <doctext>Site of Disease</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Site(s) of disease</name>
         <type>Alternate Question Text</type>
         <context>SWOG</context>
         <doctext>Site(s) of disease (at time of study entryl select all involved sites)</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF Text 1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Site(s) of joint involvement</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF TEXT 3</name>
         <type>Alternate Question Text</type>
         <context>COG</context>
         <doctext>Select all sites of disease identified either clinically, pathologically or by imaging:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF TEXT 2</name>
         <type>Alternate Question Text</type>
         <context>COG</context>
         <doctext>Site(s) of Relapse:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF TEXT 5</name>
         <type>Alternate Question Text</type>
         <context>COG</context>
         <doctext>Site(s) of disease:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF Text 4</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Sites of disease at initial recurrence:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF Text 6</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>If metastatic site, organ of origin:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text5</name>
         <type>Alternate Question Text</type>
         <context>Alliance</context>
         <doctext>New lesion site(s)</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text4</name>
         <type>Alternate Question Text</type>
         <context>Alliance</context>
         <doctext>Baseline indeterminate Lesion site(s)</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=65154&amp;version=3</cdeBrowserLink>
      </dataElement>
             <validValue>
        <displayOrder>0</displayOrder>
        <value>Bladder</value>
        <meaningText>BLADDER</meaningText>
        <description>BLADDER</description>
                <valueMeaning>
         <publicID>2567211</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>1</displayOrder>
        <value>Bone</value>
        <meaningText>BONE</meaningText>
        <description>BONE</description>
                <valueMeaning>
         <publicID>2567236</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>2</displayOrder>
        <value>Colon</value>
        <meaningText>COLON</meaningText>
        <description>COLON</description>
                <valueMeaning>
         <publicID>2567239</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>3</displayOrder>
        <value>Liver</value>
        <meaningText>LIVER</meaningText>
        <description>LIVER</description>
                <valueMeaning>
         <publicID>2567243</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>4</displayOrder>
        <value>Lung</value>
        <meaningText>LUNG</meaningText>
        <description>LUNG</description>
                <valueMeaning>
         <publicID>2567244</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>5</displayOrder>
        <value>Pelvic (other than above)</value>
        <meaningText>PELVIC (OTHER THAN ABOVE)</meaningText>
        <description>PELVIC (OTHER THAN ABOVE)</description>
                <valueMeaning>
         <publicID>2559767</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>6</displayOrder>
        <value>Abdomen (other than above)</value>
        <meaningText>ABDOMEN (OTHER THAN ABOVE)</meaningText>
        <description>ABDOMEN (OTHER THAN ABOVE)</description>
                <valueMeaning>
         <publicID>2558141</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>7</displayOrder>
        <value>Other</value>
        <meaningText>OTHER SPECIFY</meaningText>
        <description>OTHER SPECIFY</description>
                <valueMeaning>
         <publicID>2559668</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
           </question>
     <question>
      <publicID>2488591</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>7</displayOrder>
      <dateCreated>2006-06-22T14:23:02</dateCreated>
      <dateModified>2006-06-22T15:03:57</dateModified>
      <questionText>Other specify</questionText>
            <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Disease Involved Site Specify</longName>
       <shortName>DZ_INVL_SITE_SPEC</shortName>
       <publicID>61291</publicID>
       <version>3</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the text field to specify the other anatomic site of disease involvement.</preferredDefinition>
              <valueDomain>
        <longName>Involvement Extent Disease Specify</longName>
        <shortName>INV_EXT_DZ_SPEC</shortName>
        <publicID>2182211</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>100</maximumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>Other specify</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Other specify</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Disease Involvement Site, Other</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Specify sites</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>ECOG CRF 1</name>
         <type>Alternate Question Text</type>
         <context>ECOG-ACRIN</context>
         <doctext>Specify site of disease</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>ECOG CRF Text 2</name>
         <type>Alternate Question Text</type>
         <context>ECOG-ACRIN</context>
         <doctext>Specify site of involvement</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=61291&amp;version=3</cdeBrowserLink>
      </dataElement>
           </question>
     <question>
      <publicID>2488592</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>8</displayOrder>
      <dateCreated>2006-06-22T14:23:02</dateCreated>
      <dateModified>2006-06-22T15:03:57</dateModified>
      <questionText>Lymph Nodes Type</questionText>
      <instruction>
       <text>Lymph Node Involvement (Indicate the most sensitive method of evaluation with a positive finding)</text>
      </instruction>
      <isEditable>Yes</isEditable>
      <isMandatory>No</isMandatory>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Gynecologic Lymph Node Anatomic Site</longName>
       <shortName>GYN_LN_ANAT_SITE</shortName>
       <publicID>62335</publicID>
       <version>3</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>a description of the position within the body of a rounded mass of lymphatic tissue  in proximity to the female reproductive organs.</preferredDefinition>
              <valueDomain>
        <longName>Gynecologic Lymph Node Anatomic Site</longName>
        <shortName>GYN_LN_ANAT_SITE</shortName>
        <publicID>2015350</publicID>
        <version>3</version>
        <type>Enumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>25</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                        <permissibleValue>
          <value>Mediastinal</value>
          <valueMeaning>
           <publicID>2582005</publicID>
           <version>1</version>
           <longName>Mediastinal Lymph Node</longName>
                       <designation>
             <createdBy>ROUILLAS</createdBy>
             <dateCreated>2014-06-26T11:14:20</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Mediastinal nodes</name>
             <type>VM Alt Name</type>
             <context>ECOG-ACRIN</context>
                         </designation>
                                 <preferredDefinition>A lymph node located in the mediastinum. Mediastinal lymph nodes are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>other</value>
          <valueMeaning>
           <publicID>2559668</publicID>
           <version>1</version>
           <longName>OTHER SPECIFY</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2014-10-27T13:13:10</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other (Specify)</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
            <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-07-20T18:12:05</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other, specify</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
            <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-07-16T14:05:37</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
            <designation>
             <createdBy>ZHANGWE</createdBy>
             <dateCreated>2017-09-22T15:34:23</dateCreated>
             <dateModified>2017-10-17T15:46:53</dateModified>
             <modifiedBy>COOPERM</modifiedBy>
             <languageName>ENGLISH</languageName>
             <name>Other (incl. trunk, retroperitoneum), specify</name>
             <type>VM Alt Name</type>
             <context>OCG</context>
                         </designation>
            <designation>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2017-10-01T08:47:06</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other (specify)</name>
             <type>VM Alt Name</type>
             <context>OCG</context>
                         </designation>
                                 <preferredDefinition>Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:53</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Obturator</value>
          <valueMeaning>
           <publicID>2581132</publicID>
           <version>1</version>
           <longName>Obturator lymph node</longName>
                                 <preferredDefinition>No Value Exists</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-06-07T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>External Iliac</value>
          <valueMeaning>
           <publicID>3280096</publicID>
           <version>1</version>
           <longName>External Iliac Lymph Node</longName>
                       <designation>
             <createdBy>LEEW</createdBy>
             <dateCreated>2017-03-29T11:55:08</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Lymph Node(s) Iliac-external</name>
             <type>VM Alt Name</type>
             <context>NCIP</context>
                         </designation>
                                 <preferredDefinition>A lymph node located along the external iliac artery.</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-06-07T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Internal Iliac</value>
          <valueMeaning>
           <publicID>3280095</publicID>
           <version>1</version>
           <longName>Internal Iliac Lymph Node</longName>
                       <designation>
             <createdBy>LEEW</createdBy>
             <dateCreated>2017-03-29T11:55:08</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Lymph Node(s) Iliac-common</name>
             <type>VM Alt Name</type>
             <context>NCIP</context>
                         </designation>
                                 <preferredDefinition>A lymph node located along the internal iliac artery.</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-06-07T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Common Iliac</value>
          <valueMeaning>
           <publicID>3354957</publicID>
           <version>1</version>
           <longName>Common Iliac Lymph Node</longName>
                                 <preferredDefinition>Widely known or encountered.: One of the three lymph nodes of the pelvis: the superior gluteal, interior gluteal or sacral.</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-06-07T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>inguinal</value>
          <valueMeaning>
           <publicID>2558972</publicID>
           <version>1</version>
           <longName>INGUINAL</longName>
                                 <preferredDefinition>INGUINAL</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>para-aortic</value>
          <valueMeaning>
           <publicID>2559699</publicID>
           <version>1</version>
           <longName>PARA-AORTIC</longName>
                                  <definition>
             <createdBy>LUY</createdBy>
             <dateCreated>2015-02-26T15:16:05</dateCreated>
             <text>PARA-AORTIC</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>A lymph node located adjacent to the lumbar region of the spine.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:53</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>pelvic</value>
          <valueMeaning>
           <publicID>2559766</publicID>
           <version>1</version>
           <longName>PELVIC</longName>
                                 <preferredDefinition>PELVIC</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:53</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>scalene</value>
          <valueMeaning>
           <publicID>2560015</publicID>
           <version>1</version>
           <longName>SCALENE</longName>
                                 <preferredDefinition>SCALENE</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:54</beginDate>
         </permissibleValue>
                       </valueDomain>
                      <referenceDocument>
         <name>Lymph Nodes Type</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Lymph Nodes Type</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Lymph Node Type</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=62335&amp;version=3</cdeBrowserLink>
      </dataElement>
             <validValue>
        <displayOrder>0</displayOrder>
        <value>para-aortic</value>
        <meaningText>PARA-AORTIC</meaningText>
        <description>PARA-AORTIC</description>
                <valueMeaning>
         <publicID>2559699</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>1</displayOrder>
        <value>pelvic</value>
        <meaningText>PELVIC</meaningText>
        <description>PELVIC</description>
                <valueMeaning>
         <publicID>2559766</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>2</displayOrder>
        <value>other</value>
        <meaningText>OTHER SPECIFY</meaningText>
        <description>OTHER SPECIFY</description>
                <valueMeaning>
         <publicID>2559668</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
           </question>
     <question>
      <publicID>2488639</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>9</displayOrder>
      <dateCreated>2006-06-22T15:21:38</dateCreated>
      <dateModified>2006-06-22T15:22:27</dateModified>
      <questionText>Other specify</questionText>
            <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Lymph Node Anatomic Site Specify</longName>
       <shortName>LN_ANAT_SITE_SPEC</shortName>
       <publicID>61335</publicID>
       <version>3.1</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>a text field to describe a position within the body of a rounded mass of lymphatic tissue.</preferredDefinition>
              <valueDomain>
        <longName>Anatomic Site Specify</longName>
        <shortName>ANATSITE_SPEC</shortName>
        <publicID>2226669</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>100</maximumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>Other specify</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Other specify</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Lymph Nodes Other Type</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=61335&amp;version=3.1</cdeBrowserLink>
      </dataElement>
           </question>
     <question>
      <publicID>2488610</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>10</displayOrder>
      <dateCreated>2006-06-22T15:11:34</dateCreated>
      <dateModified>2006-06-22T15:20:16</dateModified>
      <questionText>Lymph Node Involvement</questionText>
            <isEditable>Yes</isEditable>
      <isMandatory>No</isMandatory>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Lymph Node Involvement Type</longName>
       <shortName>LN_INVLT_TP</shortName>
       <publicID>61334</publicID>
       <version>3</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the description of the presence or absence of disease in the lymph nodes upon evaluation.</preferredDefinition>
              <valueDomain>
        <longName>Lymph Node Involvement Type</longName>
        <shortName>LN_INVLT_TP</shortName>
        <publicID>2015384</publicID>
        <version>3</version>
        <type>Enumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>80</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                        <permissibleValue>
          <value>&lt;4</value>
          <valueMeaning>
           <publicID>4488271</publicID>
           <version>1</version>
           <longName>&lt;4</longName>
                                 <preferredDefinition>&lt;4</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-09-22T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Not sampled</value>
          <valueMeaning>
           <publicID>2576975</publicID>
           <version>1</version>
           <longName>Not sampled</longName>
                                 <preferredDefinition>Not sampled</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Node negative, no neoadjuvant chemotherapy</value>
          <valueMeaning>
           <publicID>2667379</publicID>
           <version>1</version>
           <longName>Node negative, no neoadjuvant chemotherapy</longName>
                                 <preferredDefinition>Node negative, no neoadjuvant chemotherapy</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>1-3 positive nodes, no neoadjuvant chemotherapy</value>
          <valueMeaning>
           <publicID>2667380</publicID>
           <version>1</version>
           <longName>1-3 positive nodes, no neoadjuvant chemotherapy</longName>
                                 <preferredDefinition>1-3 positive nodes, no neoadjuvant chemotherapy</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>&gt;= 4 positive nodes, no neoadjuvant chemotherapy</value>
          <valueMeaning>
           <publicID>2667381</publicID>
           <version>1</version>
           <longName>&gt;= 4 positive nodes, no neoadjuvant chemotherapy</longName>
                                 <preferredDefinition>&gt;= 4 positive nodes, no neoadjuvant chemotherapy</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Known</value>
          <valueMeaning>
           <publicID>2626108</publicID>
           <version>1</version>
           <longName>known</longName>
                                 <preferredDefinition>Recognized, familiar, or within the scope of knowledge.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>equivocal</value>
          <valueMeaning>
           <publicID>2558729</publicID>
           <version>1</version>
           <longName>Equivocal</longName>
                                  <definition>
             <createdBy>CAMPBELB</createdBy>
             <dateCreated>2010-09-10T11:25:19</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance</text>
             <type>NCI</type>
                          <context>CTEP</context>
            </definition>
                      <preferredDefinition>Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>negative</value>
          <valueMeaning>
           <publicID>2559499</publicID>
           <version>1</version>
           <longName>Negative</longName>
                                 <preferredDefinition>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:53</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>positive</value>
          <valueMeaning>
           <publicID>2559831</publicID>
           <version>1</version>
           <longName>Positive</longName>
                                 <preferredDefinition>Involving advantage or good.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:53</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>unknown</value>
          <valueMeaning>
           <publicID>2575365</publicID>
           <version>1</version>
           <longName>Unknown</longName>
                       <designation>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-05-29T13:13:48</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Grade/differentiation unknown, not stated, or not applicable</name>
             <type>NAACCR Alt Name</type>
             <context>NCIP</context>
                           <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>CancerID11.1</name>
                <publicID>3103520</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
                <preferredDefinition>Cancer Identification11.1</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
                <preferredDefinition>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>UMLLOADER_C3PRPRD</createdBy>
             <dateCreated>2010-07-08T14:47:33</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Unknown</name>
             <type>UML Value Name</type>
             <context>NCIP</context>
                           <classification>
               <name>C3PR</name>
               <publicID>2551427</publicID>
               <version>2.8</version>
               <preferredDefinition>Version 2.8 The Cancer Central Clinical Participent Registry (C3PR) is a web-based application used to manage participants in cancer clinical trials. Research staff will use C3PR as a participant-centric entry point to clinical trial management systems. C3PR provides a central registry for study participants, and it enables the end-user to access participant-centric information that is stored in multiple clinical trial systems. Participants that can be tracked include patients or potential patients, their guardians, family members, and referring physicians. The system also allows tracking other types of participants such as principal investigators, caregivers, referring physicians, and the users of the system.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
                <preferredDefinition>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Grid Enabled Measures</name>
               <publicID>2983752</publicID>
               <version>1</version>
               <preferredDefinition>A resource to allow researchers to access metadata about measures used in cancer research and the population sciences.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Common Biorepository Model</name>
               <publicID>3204728</publicID>
               <version>1</version>
               <preferredDefinition>A common model to contain summary-level details of biorepository / biobank holdings which can be advertised through the OBBR Specimen Resource Locator</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2010-12-22T12:10:38</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>unknown</name>
             <type>NAACCR VM Name</type>
             <context>PS-CC</context>
                           <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>NAACCR 12.1</name>
                <publicID>3134707</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
                <preferredDefinition>North American Association of Central Cancer Registries</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
                <preferredDefinition>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2010-12-22T12:42:41</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>UNK</name>
             <type>HL7 Code</type>
             <context>PS-CC</context>
                           <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>NAACCR 12.1</name>
                <publicID>3134707</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
                <preferredDefinition>North American Association of Central Cancer Registries</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
                <preferredDefinition>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2015-10-16T14:09:25</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>LA4489-6</name>
             <type>LOINC_CODE</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:30</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>LA4489-6</name>
             <type>LOINC_CODE</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Unknown</name>
             <type>LOINC_NAME</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-04-04T13:18:57</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Unknown</name>
             <type>LOINC_NAME</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2017-03-29T08:57:16</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Unknown cause of death</name>
             <type>VM Alt Name</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>MORENOC</createdBy>
             <dateCreated>2017-04-21T06:18:54</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>I don&apos;t know</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                         </designation>
                                  <definition>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-04-30T14:19:12</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Unknown whether Spanish or not
</text>
             <type>NAACCR</type>
                           <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>Demographic11.1</name>
                <publicID>3242099</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>PS-CC</context>
            </definition>
            <definition>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-07-18T16:11:28</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Patient&apos;s address is unknown</text>
             <type>NAACCR</type>
                           <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>Demographic11.1</name>
                <publicID>3242099</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>PS-CC</context>
            </definition>
            <definition>
             <createdBy>UMLLOADER_GEM</createdBy>
             <dateCreated>2011-01-27T16:26:05</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>A response indicating that the respondent does not know what the correct answer is.</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Grid Enabled Measures</name>
               <publicID>2983752</publicID>
               <version>1</version>
               <preferredDefinition>A resource to allow researchers to access metadata about measures used in cancer research and the population sciences.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
            <definition>
             <createdBy>UMLLOADER_C3PRPRD</createdBy>
             <dateCreated>2010-07-08T14:47:33</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Could not be determined or unsure.</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>C3PR</name>
               <publicID>2551427</publicID>
               <version>2.8</version>
               <preferredDefinition>Version 2.8 The Cancer Central Clinical Participent Registry (C3PR) is a web-based application used to manage participants in cancer clinical trials. Research staff will use C3PR as a participant-centric entry point to clinical trial management systems. C3PR provides a central registry for study participants, and it enables the end-user to access participant-centric information that is stored in multiple clinical trial systems. Participants that can be tracked include patients or potential patients, their guardians, family members, and referring physicians. The system also allows tracking other types of participants such as principal investigators, caregivers, referring physicians, and the users of the system.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
            <definition>
             <createdBy>UMLLOADER_C3PRPRD</createdBy>
             <dateCreated>2010-07-08T14:47:35</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Not known, not observed, not recorded, or refused.</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>C3PR</name>
               <publicID>2551427</publicID>
               <version>2.8</version>
               <preferredDefinition>Version 2.8 The Cancer Central Clinical Participent Registry (C3PR) is a web-based application used to manage participants in cancer clinical trials. Research staff will use C3PR as a participant-centric entry point to clinical trial management systems. C3PR provides a central registry for study participants, and it enables the end-user to access participant-centric information that is stored in multiple clinical trial systems. Participants that can be tracked include patients or potential patients, their guardians, family members, and referring physicians. The system also allows tracking other types of participants such as principal investigators, caregivers, referring physicians, and the users of the system.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
            <definition>
             <createdBy>CHILLIJ</createdBy>
             <dateCreated>2010-07-13T22:01:19</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Not known, not observed, or not recorded.</text>
             <type>Manually-curated</type>
                           <classification>
               <name>Data Standards</name>
               <publicID>2192345</publicID>
               <version>1</version>
               <preferredDefinition>Data standards developed for the NCI community.</preferredDefinition>
               <classificationSchemeItem>
                <name>Image Quality CRF</name>
                <publicID>3079057</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
            <definition>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2010-12-22T12:10:38</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>a proper value is applicable but not known.  this event occurred, but the date is unknown (e.g., birth date).</text>
             <type>NAACCR</type>
                           <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>NAACCR 12.1</name>
                <publicID>3134707</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>PS-CC</context>
            </definition>
                      <preferredDefinition>Not known, not observed, not recorded, or refused.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:54</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Not dissected</value>
          <valueMeaning>
           <publicID>3192093</publicID>
           <version>1</version>
           <longName>Not dissected</longName>
                                 <preferredDefinition>Not dissected</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-02-15T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>&gt; 4 sites</value>
          <valueMeaning>
           <publicID>3216252</publicID>
           <version>1</version>
           <longName>&gt; 4 sites</longName>
                                 <preferredDefinition>&gt; 4 sites</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-03-30T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>&lt;= 4 sites</value>
          <valueMeaning>
           <publicID>3216253</publicID>
           <version>1</version>
           <longName>&lt;= 4 sites</longName>
                                 <preferredDefinition>&lt;= 4 sites</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-03-30T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>N/A</value>
          <valueMeaning>
           <publicID>2561784</publicID>
           <version>1</version>
           <longName>N/A</longName>
                       <designation>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2014-04-10T10:28:40</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>not applicable</name>
             <type>VM Alt Name</type>
             <context>ABTC</context>
                           <classification>
               <name>Protocols</name>
               <publicID>3335728</publicID>
               <version>1</version>
               <preferredDefinition>Collection of CDEs by ABTC Protocols</preferredDefinition>
               <classificationSchemeItem>
                <name>ABTC 1302</name>
                <publicID>4264871</publicID>
                <version>1</version>
                <type>Case Report Form</type>
                <preferredDefinition>ABTC 1302</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
                                  <definition>
             <createdBy>CAMPBELB</createdBy>
             <dateCreated>2014-04-09T15:54:44</dateCreated>
             <text>N/A</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>Determination of a value is not relevant in the current context.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-07-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>7 or more</value>
          <valueMeaning>
           <publicID>3397606</publicID>
           <version>1</version>
           <longName>7 or more</longName>
                                 <preferredDefinition>7 or more measurable nodes at baseline</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-03-02T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Less than or equal to 6</value>
          <valueMeaning>
           <publicID>3397607</publicID>
           <version>1</version>
           <longName>Less than or equal to 6</longName>
                                 <preferredDefinition>Less than or equal to 6 measurable nodes at baseline</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-03-02T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Involved</value>
          <valueMeaning>
           <publicID>2566887</publicID>
           <version>1</version>
           <longName>INVOLVED</longName>
                                 <preferredDefinition>INVOLVED</preferredDefinition>
          </valueMeaning>
          <beginDate>2003-08-22T16:35:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Not involved</value>
          <valueMeaning>
           <publicID>2566888</publicID>
           <version>1</version>
           <longName>NOT INVOLVED</longName>
                                 <preferredDefinition>NOT INVOLVED</preferredDefinition>
          </valueMeaning>
          <beginDate>2003-08-22T16:35:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>clinically negative</value>
          <valueMeaning>
           <publicID>2566884</publicID>
           <version>1</version>
           <longName>NEGATIVE BASED ON CLINICAL EVALUATION</longName>
                                 <preferredDefinition>NEGATIVE BASED ON CLINICAL EVALUATION</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>clinically positive</value>
          <valueMeaning>
           <publicID>2566883</publicID>
           <version>1</version>
           <longName>POSITIVE BASED ON CLINICAL EVALUATION</longName>
                                 <preferredDefinition>POSITIVE BASED ON CLINICAL EVALUATION</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>pathologically negative</value>
          <valueMeaning>
           <publicID>2566886</publicID>
           <version>1</version>
           <longName>NEGATIVE BASED ON PATHOLOGIC EVALUATION</longName>
                                 <preferredDefinition>NEGATIVE BASED ON PATHOLOGIC EVALUATION</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:53</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>pathologically positive</value>
          <valueMeaning>
           <publicID>2566885</publicID>
           <version>1</version>
           <longName>POSITIVE BASED ON PATHOLOGIC EVALUATION</longName>
                                 <preferredDefinition>POSITIVE BASED ON PATHOLOGIC EVALUATION</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:53</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>not evaluated</value>
          <valueMeaning>
           <publicID>2570488</publicID>
           <version>1</version>
           <longName>Not Evaluated</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-02-26T13:06:37</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Not evaluated</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
            <designation>
             <createdBy>SARAHB</createdBy>
             <dateCreated>2017-10-03T13:13:47</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Not all evaluated</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                         </designation>
                                  <definition>
             <createdBy>CHILLIJ</createdBy>
             <dateCreated>2008-07-09T19:20:01</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Not evaluated for presence or absence of disease within lymph nodes as seen on imaging.</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>The non-affirmative response to a question.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-07-13T12:42:26</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>1-3</value>
          <valueMeaning>
           <publicID>2571167</publicID>
           <version>1</version>
           <longName>1-3</longName>
                                 <preferredDefinition>1-3 lymph nodes</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-07-23T13:34:22</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>&gt;=4</value>
          <valueMeaning>
           <publicID>2571168</publicID>
           <version>1</version>
           <longName>&gt;=4</longName>
                                 <preferredDefinition>&gt;=4 lymph nodes</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-07-23T13:34:30</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Not applicable</value>
          <valueMeaning>
           <publicID>2581003</publicID>
           <version>1</version>
           <longName>Not applicable</longName>
                       <designation>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2007-08-02T15:44:56</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Not applicable sequence feature</name>
             <type>UML Value Name</type>
             <context>NCIP</context>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caArray_1.1</name>
               <publicID>2534950</publicID>
               <version>1.1</version>
               <preferredDefinition>This model makes up a the portion of caArray that reflects MGED&apos;s MAGE model.</preferredDefinition>
               <classificationSchemeItem>
                <name>gov.nih.nci.mageom.domain.Measurement</name>
                <publicID>2812473</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>gov.nih.nci.mageom.domain.Measurement</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>edu.wustl.catissuecore.domain.ValueDomain</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-06-07T15:54:35</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>NA</name>
             <type>NAACCR Alt Name</type>
             <context>PS-CC</context>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>edu.wustl.catissuecore.domain.ValueDomain</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2014-12-18T01:56:53</dateCreated>
             <dateModified>2014-12-18T01:59:53</dateModified>
             <modifiedBy>DWARZEL</modifiedBy>
             <languageName>ENGLISH</languageName>
             <name>Doesn&apos;t Apply</name>
             <type>VM Alt Name</type>
             <context>NCIP</context>
                           <classification>
               <name>FDA MedWatch Form 3500</name>
               <publicID>4382692</publicID>
               <version>1</version>
               <preferredDefinition>CDEs in MedWatch Form FDA 3500</preferredDefinition>
               <classificationSchemeItem>
                <name>Suspect Product(s)</name>
                <publicID>4394093</publicID>
                <version>1</version>
                <type>Case Report Form</type>
                <preferredDefinition>Suspect Product(s) Case Report Form CDEs</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
                                  <definition>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2007-08-02T15:44:56</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>How a sequence feature was determined is not applicable.</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caArray_1.1</name>
               <publicID>2534950</publicID>
               <version>1.1</version>
               <preferredDefinition>This model makes up a the portion of caArray that reflects MGED&apos;s MAGE model.</preferredDefinition>
               <classificationSchemeItem>
                <name>gov.nih.nci.mageom.domain.BioSequence</name>
                <publicID>2812479</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
            <definition>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-04-30T12:22:44</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Not applicable 9e.g., census tracting not attempted); Census Tract Certainty information for 1970/80/90 not coded.</text>
             <type>NAACCR</type>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>Demographic11.1</name>
                <publicID>3242099</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>PS-CC</context>
            </definition>
            <definition>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-04-30T12:32:10</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Not applicable (e.g., census tracting not attempted); Census Tract Certainty information for 2000 not coded.</text>
             <type>NAACCR</type>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>Demographic11.1</name>
                <publicID>3242099</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>PS-CC</context>
            </definition>
                      <preferredDefinition>Determination of a value is not relevant in the current context.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-08-17T12:51:19</beginDate>
         </permissibleValue>
                       </valueDomain>
                      <referenceDocument>
         <name>COMMENT_329</name>
         <type>COMMENT</type>
         <context>CTEP</context>
         <doctext>Instruction on GYN template form: *Indicate Node Involvement: 0=not evaluated, 1=positive, 2=negative, 3=equivocal, 4=unknown</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Involvement</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>2-COMMENT</name>
         <type>COMMENT</type>
         <context>CTEP</context>
         <doctext>Instruction on template form: *Indicate Lymph Node Involvement:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Lymph Node Involvement</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Lymph Node Involvement</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text1</name>
         <type>Alternate Question Text</type>
         <context>Alliance</context>
         <doctext>Nodes</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=61334&amp;version=3</cdeBrowserLink>
      </dataElement>
             <validValue>
        <displayOrder>0</displayOrder>
        <value>not evaluated</value>
        <meaningText>NOT EVALUATED</meaningText>
        <description>NOT EVALUATED</description>
        <instruction>
         <text>0</text>
        </instruction>
        <valueMeaning>
         <publicID>2570488</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>1</displayOrder>
        <value>positive</value>
        <meaningText>POSITIVE</meaningText>
        <description>POSITIVE</description>
        <instruction>
         <text>1</text>
        </instruction>
        <valueMeaning>
         <publicID>2559831</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>2</displayOrder>
        <value>negative</value>
        <meaningText>NEGATIVE</meaningText>
        <description>NEGATIVE</description>
        <instruction>
         <text>2</text>
        </instruction>
        <valueMeaning>
         <publicID>2559499</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>3</displayOrder>
        <value>equivocal</value>
        <meaningText>EQUIVOCAL</meaningText>
        <description>No Value Exists</description>
        <instruction>
         <text>3</text>
        </instruction>
        <valueMeaning>
         <publicID>2558729</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>4</displayOrder>
        <value>unknown</value>
        <meaningText>UNKNOWN</meaningText>
        <description>Not known, not observed, not recorded, or refused.
</description>
        <instruction>
         <text>4</text>
        </instruction>
        <valueMeaning>
         <publicID>2575365</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
           </question>
     <question>
      <publicID>2488614</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>11</displayOrder>
      <dateCreated>2006-06-22T15:11:34</dateCreated>
      <dateModified>2006-06-22T15:20:16</dateModified>
      <questionText>Method of Evaluation</questionText>
            <isEditable>Yes</isEditable>
      <isMandatory>No</isMandatory>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Assessment Method Type</longName>
       <shortName>ASSESS_METH_TP</shortName>
       <publicID>2309</publicID>
       <version>5</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>the type or description of a method of assessment.</preferredDefinition>
               <designation>
         <createdBy>TSANE</createdBy>
         <dateCreated>2014-04-02T14:03:07</dateCreated>
         <languageName>ENGLISH</languageName>
         <name>FDG-PET</name>
         <type>VM Alt Name</type>
         <context>COG</context>
                 </designation>
        <designation>
         <createdBy>TSANE</createdBy>
         <dateCreated>2014-04-02T14:03:07</dateCreated>
         <languageName>ENGLISH</languageName>
         <name>MRI + DWI</name>
         <type>VM Alt Name</type>
         <context>COG</context>
                 </designation>
              <valueDomain>
        <longName>Assessment Method Type</longName>
        <shortName>ASSESS_METH_TP</shortName>
        <publicID>2015230</publicID>
        <version>3</version>
        <type>Enumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>100</maximumLengthNumber>
                        <permissibleValue>
          <value>Core biopsy</value>
          <valueMeaning>
           <publicID>2576317</publicID>
           <version>1</version>
           <longName>Core Needle Biopsy</longName>
                                 <preferredDefinition>The removal of a tissue sample using a needle with a relatively large diameter, for microscopic examination.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>CT of Neck</value>
          <valueMeaning>
           <publicID>4512871</publicID>
           <version>1</version>
           <longName>CT of Neck</longName>
                                 <preferredDefinition>CT of Neck</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-10-06T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>None of the above</value>
          <valueMeaning>
           <publicID>2577583</publicID>
           <version>1</version>
           <longName>None of the above</longName>
                                 <preferredDefinition>None of the above</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Combination of these methods</value>
          <valueMeaning>
           <publicID>4669452</publicID>
           <version>1</version>
           <longName>Combination of these methods</longName>
                                 <preferredDefinition>Combination of these methods</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-01-20T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Direct inspection / endoscopy under anesthesia</value>
          <valueMeaning>
           <publicID>4669453</publicID>
           <version>1</version>
           <longName>Direct inspection / endoscopy under anesthesia</longName>
                                 <preferredDefinition>Direct inspection / endoscopy under anesthesia</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-01-20T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Direct inspection / in office endoscopy</value>
          <valueMeaning>
           <publicID>4669454</publicID>
           <version>1</version>
           <longName>Direct inspection / in office endoscopy</longName>
                                 <preferredDefinition>Direct inspection / in office endoscopy</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-01-20T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Urinary cytology with mass visualized during upper tract endoscopy</value>
          <valueMeaning>
           <publicID>4719232</publicID>
           <version>1</version>
           <longName>Urinary cytology with mass visualized during upper tract endoscopy</longName>
                                 <preferredDefinition>Urinary cytology with mass visualized during upper tract endoscopy</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-02-18T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Urinary cytology with 3-D upper urinary tract mass on Cross-Sectional Imaging</value>
          <valueMeaning>
           <publicID>4719233</publicID>
           <version>1</version>
           <longName>Urinary cytology with 3-D upper urinary tract mass on Cross-Sectional Imaging</longName>
                                 <preferredDefinition>Urinary cytology with 3-D upper urinary tract mass on Cross-Sectional Imaging</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-02-18T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Image-guided Biopsy</value>
          <valueMeaning>
           <publicID>4719251</publicID>
           <version>1</version>
           <longName>Image-guided Biopsy</longName>
                                 <preferredDefinition>Image-guided Biopsy</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-02-18T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>MSK Nomogram</value>
          <valueMeaning>
           <publicID>2578375</publicID>
           <version>1</version>
           <longName>Nomograms</longName>
                                 <preferredDefinition>Graphical representation of a statistical model containing scales for calculating the prognostic weight of a value for each individual variable. Nomograms are instruments that can be used to predict outcomes using specific clinical parameters. They use ALGORITHMS that incorporate several variables to calculate the predicted probability that a patient will achieve a particular clinical endpoint.</preferredDefinition>
          </valueMeaning>
          <beginDate>2006-03-20T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>MRV</value>
          <valueMeaning>
           <publicID>4723853</publicID>
           <version>1</version>
           <longName>MRV</longName>
                                 <preferredDefinition>Magnetic resonance venography</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-02-24T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>MRA</value>
          <valueMeaning>
           <publicID>4723855</publicID>
           <version>1</version>
           <longName>MRI-Based Angiogram</longName>
                       <designation>
             <createdBy>TSANE</createdBy>
             <dateCreated>2015-02-24T16:14:49</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>MRA</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                         </designation>
                                 <preferredDefinition>An image of blood vessels constructed using magnetic resonance imaging.</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-02-24T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Fiberoptic nasopharyngolaryngoscopy</value>
          <valueMeaning>
           <publicID>4726691</publicID>
           <version>1</version>
           <longName>Fiberoptic nasopharyngolaryngoscopy</longName>
                                 <preferredDefinition>Fiberoptic nasopharyngolaryngoscopy</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-02-27T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Myelin-Associated Glycoprotein</value>
          <valueMeaning>
           <publicID>4811579</publicID>
           <version>1</version>
           <longName>Myelin-Associated Glycoprotein</longName>
                                 <preferredDefinition>An autoantibody directed against myelin-associated glycoprotein (MAG). It is associated with active demyelination in peripheral neuropathy and is detected in about 50% of patients with IgM&amp;#8200;paraproteinemia and may occur in some patients with multiple sclerosis, Guillain-Barre syndrome, chronic polyneuropathy, or myasthenia gravis.</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-05-06T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Electromyography</value>
          <valueMeaning>
           <publicID>4821875</publicID>
           <version>1</version>
           <longName>Electromyography</longName>
                                 <preferredDefinition>An assessment of skeletal muscle function and nerve control, obtained by recording and studying the intrinsic electrical properties of the muscles.</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-05-07T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>WBC differential</value>
          <valueMeaning>
           <publicID>4845352</publicID>
           <version>1</version>
           <longName>WBC differential</longName>
                                 <preferredDefinition>WBC differential</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-06-03T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Peripheral smear</value>
          <valueMeaning>
           <publicID>4845353</publicID>
           <version>1</version>
           <longName>Peripheral smear</longName>
                                 <preferredDefinition>Peripheral smear</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-06-03T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>PET/CT scan</value>
          <valueMeaning>
           <publicID>2580798</publicID>
           <version>1</version>
           <longName>PET/CT scan</longName>
                                 <preferredDefinition>PET/CT scan</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>PSA Assessment</value>
          <valueMeaning>
           <publicID>2580427</publicID>
           <version>1</version>
           <longName>Prostate-Specific Antigen</longName>
                       <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2014-11-12T09:50:54</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>PSA</name>
             <type>Biomarker Synonym</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2014-11-12T09:50:54</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>kallikrein 3</name>
             <type>Biomarker Synonym</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2014-11-12T09:51:17</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>APS</name>
             <type>Biomarker Synonym</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2014-11-12T09:51:17</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Prostate-specific antigen</name>
             <type>Biomarker Synonym</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2014-11-12T09:51:17</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>kallikrein-related peptidase 3</name>
             <type>Biomarker Synonym</type>
             <context>NCIP</context>
                         </designation>
                                 <preferredDefinition>Alternate isoforms of the single-chain 261-aa 30-kD Kallikrein 3 (Prostate Specific Antigen) glycoprotein precursor are encoded by human KLK3 Gene (Kallikrein Family). Frameshifted isoform 2 has a shorter distinct C-terminus. A serine protease in seminal plasma, PSA may function in liquefaction of seminal coagulum by (preferential Tyr-X) cleavage of seminal vesicle protein. Kallikrein proteases have diverse functions. Mounting evidence implicates kallikreins in carcinogenesis; some have potential as cancer biomarkers. The serum level of PSA is useful in diagnosis and monitoring of prostatic carcinoma. (from LocusLink, Swiss-Prot, OMIM, and NCI)</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Biopsy other</value>
          <valueMeaning>
           <publicID>2574093</publicID>
           <version>1</version>
           <longName>Biopsy</longName>
                                 <preferredDefinition>Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Digital rectal exam</value>
          <valueMeaning>
           <publicID>2581179</publicID>
           <version>1</version>
           <longName>Digital Rectal Examination</longName>
                                 <preferredDefinition>Digital rectal examination.  An examination in which a doctor inserts a lubricated, gloved finger into the rectum to feel for abnormalities.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>MUGA scan</value>
          <valueMeaning>
           <publicID>2571740</publicID>
           <version>1</version>
           <longName>MUGA Scan</longName>
                                  <definition>
             <createdBy>ZHANGWE</createdBy>
             <dateCreated>2015-02-23T13:33:07</dateCreated>
             <text>MUGA Scan</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>A multi-gated acquisition (MUGA) scan and a form of radionuclide imaging that provides a comprehensive look at blood flow and the function of the lower chambers of the heart ventricles.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Ipsilateral Axilla Ultrasound</value>
          <valueMeaning>
           <publicID>2581522</publicID>
           <version>1</version>
           <longName>Ipsilateral Axilla Ultrasound</longName>
                                 <preferredDefinition>Ipsilateral Axilla Ultrasound</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>SQUID</value>
          <valueMeaning>
           <publicID>5039992</publicID>
           <version>1</version>
           <longName>Superconducting Quantum Interference Device</longName>
                                 <preferredDefinition>A device designed to measure extremely weak magnetic fields. It is comprised of a Josephson junction with two superconducting loops separated by an insulating layer thin enough to allow electrons to pass through.</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-10-29T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>MRI</value>
          <valueMeaning>
           <publicID>5039993</publicID>
           <version>1</version>
           <longName>Magnetic Resonance Imaging</longName>
                                 <preferredDefinition>Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-10-29T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Chimerism testing</value>
          <valueMeaning>
           <publicID>5043868</publicID>
           <version>1</version>
           <longName>Chimerism testing</longName>
                                 <preferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.: The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with mosaicism in which the different cell populations are derived from a single individual.</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-11-10T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Culture</value>
          <valueMeaning>
           <publicID>2577346</publicID>
           <version>1</version>
           <longName>Culture Procedure</longName>
                                 <preferredDefinition>Any laboratory procedure for growing microorganisms.</preferredDefinition>
          </valueMeaning>
          <beginDate>2005-03-29T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Disease specific molecular marker</value>
          <valueMeaning>
           <publicID>5084231</publicID>
           <version>1</version>
           <longName>Disease specific molecular marker</longName>
                                  <definition>
             <createdBy>CAMPBELB</createdBy>
             <dateCreated>2015-12-14T09:54:08</dateCreated>
             <text>Disease specific molecular marker</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.::2: Clearly and explicitly stated.::2: A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.</preferredDefinition>
          </valueMeaning>
          <beginDate>2015-12-14T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>CT/MRI scan</value>
          <valueMeaning>
           <publicID>2604641</publicID>
           <version>1</version>
           <longName>CT/MRI scan</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2013-12-17T10:53:24</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>CT/ MRI</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>Computed tomographic and magnetic image resonance scan</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Endoscopy with biopsy</value>
          <valueMeaning>
           <publicID>2604642</publicID>
           <version>1</version>
           <longName>Endoscopy with biopsy</longName>
                                 <preferredDefinition>Endoscopy with biopsy</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>FDG-PET + MRI</value>
          <valueMeaning>
           <publicID>5170915</publicID>
           <version>1</version>
           <longName>FDG-PET + MRI</longName>
                                 <preferredDefinition>FDG-PET + MRI</preferredDefinition>
          </valueMeaning>
          <beginDate>2016-03-18T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>FDG-PET + CT</value>
          <valueMeaning>
           <publicID>5170916</publicID>
           <version>1</version>
           <longName>FDG-PET + CT</longName>
                                 <preferredDefinition>FDG-PET + CT</preferredDefinition>
          </valueMeaning>
          <beginDate>2016-03-18T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>CEA</value>
          <valueMeaning>
           <publicID>2633456</publicID>
           <version>1</version>
           <longName>Carcinoembryonic Antigen</longName>
                       <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2014-11-12T09:50:54</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>CD66e</name>
             <type>Biomarker Synonym</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2014-11-12T09:50:54</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>CEA</name>
             <type>Biomarker Synonym</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2014-11-12T09:50:54</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>carcinoembryonic antigen-related cell adhesion molecule 5</name>
             <type>Biomarker Synonym</type>
             <context>NCIP</context>
                         </designation>
                                 <preferredDefinition>Carcinoembryonic antigen. A substance that is sometimes found in an increased amount in the blood of people with certain cancers.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Radiological</value>
          <valueMeaning>
           <publicID>2640362</publicID>
           <version>1</version>
           <longName>Radiologic</longName>
                                 <preferredDefinition>Any imaging procedure that uses radiation to create an image for the purpose of assisting with the execution of an intervention.: The use of radiation (such as x-rays) or other imaging technologies (such as ultrasound and magnetic resonance imaging) to diagnose or treat disease.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Upper endoscopy</value>
          <valueMeaning>
           <publicID>2574269</publicID>
           <version>1</version>
           <longName>Upper Endoscopy Esophagogastroduodenoscopy</longName>
                                 <preferredDefinition>Upper Endoscopy Esophagogastroduodenoscopy</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Lymphangiogram</value>
          <valueMeaning>
           <publicID>2573980</publicID>
           <version>1</version>
           <longName>Lymphangiogram</longName>
                                 <preferredDefinition>No Value Exists</preferredDefinition>
          </valueMeaning>
          <beginDate>2007-05-29T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Not evaluated</value>
          <valueMeaning>
           <publicID>2570488</publicID>
           <version>1</version>
           <longName>Not Evaluated</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-02-26T13:06:37</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Not evaluated</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
            <designation>
             <createdBy>SARAHB</createdBy>
             <dateCreated>2017-10-03T13:13:47</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Not all evaluated</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                         </designation>
                                  <definition>
             <createdBy>CHILLIJ</createdBy>
             <dateCreated>2008-07-09T19:20:01</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Not evaluated for presence or absence of disease within lymph nodes as seen on imaging.</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>The non-affirmative response to a question.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Clinical Palpation</value>
          <valueMeaning>
           <publicID>5283971</publicID>
           <version>1</version>
           <longName>Clinical Palpation</longName>
                                 <preferredDefinition>Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.: A method of feeling with the hands during a physical examination. The health care provider touches and feels the patient&apos;s body to examine the size, consistency, texture, location and tenderness of an organ or body part.</preferredDefinition>
          </valueMeaning>
          <beginDate>2016-05-31T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Imaging</value>
          <valueMeaning>
           <publicID>5283972</publicID>
           <version>1</version>
           <longName>Imaging</longName>
                                 <preferredDefinition>Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.</preferredDefinition>
          </valueMeaning>
          <beginDate>2016-05-31T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Chest CT</value>
          <valueMeaning>
           <publicID>2580421</publicID>
           <version>1</version>
           <longName>Chest Radiography</longName>
                                 <preferredDefinition>An x-ray examination of the chest.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Abdominal CT</value>
          <valueMeaning>
           <publicID>2667062</publicID>
           <version>1</version>
           <longName>Abdominal CT-scan</longName>
                                 <preferredDefinition>Abdominal CT-scan</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Pelvic CT</value>
          <valueMeaning>
           <publicID>2671035</publicID>
           <version>1</version>
           <longName>Pelvic CT</longName>
                                 <preferredDefinition>Pelvic computed tomography</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Proctoscopy/sigmoidoscopy</value>
          <valueMeaning>
           <publicID>2672935</publicID>
           <version>1</version>
           <longName>Proctoscopy/sigmoidoscopy</longName>
                                 <preferredDefinition>Examination of the anus or sigmoid colon using a flexible tube enclosing a light and camera.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Abdominal MRI</value>
          <valueMeaning>
           <publicID>2673036</publicID>
           <version>1</version>
           <longName>Abdominal MRI</longName>
                                 <preferredDefinition>Magnetic Resonance Imaging of the abdomen.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Transrectal ultrasound</value>
          <valueMeaning>
           <publicID>2581622</publicID>
           <version>1</version>
           <longName>Transrectal Ultrasound</longName>
                                 <preferredDefinition>A procedure that uses sound waves to create a video image of the prostate gland. A small, lubricated probe placed into the rectum releases sound waves, which create echoes as they enter the prostate. Prostate tumors sometimes create echoes that are different from normal prostate tissue. The echoes that bounce back are sent to a computer that translates the pattern of echoes into a picture of the prostate.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Sokal</value>
          <valueMeaning>
           <publicID>5485916</publicID>
           <version>1</version>
           <longName>Sokal Score</longName>
                                 <preferredDefinition>A method for assessing prognosis for patients with chronic myeloid leukemia. The numerical value is calculated at diagnosis from the percentage of blast cells in peripheral blood, the platelet count, the spleen size, and the age of the patient.</preferredDefinition>
          </valueMeaning>
          <beginDate>2016-09-27T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Hasford</value>
          <valueMeaning>
           <publicID>5485917</publicID>
           <version>1</version>
           <longName>Hasford Score</longName>
                                 <preferredDefinition>A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high, medium, or low risk on the basis of age, spleen size, and eosinophil, basophil, and platelet counts.</preferredDefinition>
          </valueMeaning>
          <beginDate>2016-09-27T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>EUTOS</value>
          <valueMeaning>
           <publicID>5485918</publicID>
           <version>1</version>
           <longName>European Treatment Outcome Study Score</longName>
                                 <preferredDefinition>A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high or low risk on the basis of the percentage of basophils in the peripheral blood and spleen size at diagnosis.</preferredDefinition>
          </valueMeaning>
          <beginDate>2016-09-27T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Contralateral mammogram</value>
          <valueMeaning>
           <publicID>2697040</publicID>
           <version>1</version>
           <longName>Contralateral mammogram</longName>
                                 <preferredDefinition>An x-ray picture of the breast not involved with the primary tumor.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Ipsilateral mammogram</value>
          <valueMeaning>
           <publicID>2697041</publicID>
           <version>1</version>
           <longName>Ipsilateral mammogram</longName>
                                 <preferredDefinition>An x-ray picture of the breast with the primary tumor.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Pelvic MRI</value>
          <valueMeaning>
           <publicID>2717946</publicID>
           <version>1</version>
           <longName>Pelvic Magnetic Resonance imaging</longName>
                                 <preferredDefinition>A procedure in which a magnet linked to a computer is used to create detailed pictures of areas inside the pelivs. Also called nuclear magnetic resonance </preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Colonscopy/proctoscopy</value>
          <valueMeaning>
           <publicID>2717947</publicID>
           <version>1</version>
           <longName>Colonscopy/proctoscopy</longName>
                                 <preferredDefinition>An examination of the rectum using a thin, lighted tube called a proctoscope or An examination of the inside of the colon using a thin, lighted tube (called a colonoscope).</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Excisional biopsy with frozen section</value>
          <valueMeaning>
           <publicID>2722512</publicID>
           <version>1</version>
           <longName>Excisional biopsy with frozen section</longName>
                                 <preferredDefinition>Excisional biopsy with frozen section</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Skin biopsy</value>
          <valueMeaning>
           <publicID>2722511</publicID>
           <version>1</version>
           <longName>Skin biopsy</longName>
                                 <preferredDefinition>the removal of a piece of skin to diagnose or rule out an illness.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Morphology</value>
          <valueMeaning>
           <publicID>4661331</publicID>
           <version>1</version>
           <longName>Morphology</longName>
                                 <preferredDefinition>The science of the form and structure of organisms (plants, animals, and other forms of life), or of their parts, and the study or science of the same.  In pathology, the specific appearance of cells and tissues (normal and abnormal) under the light or electron microscope.</preferredDefinition>
          </valueMeaning>
          <beginDate>2017-01-27T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IgH/TCR PCR</value>
          <valueMeaning>
           <publicID>5664683</publicID>
           <version>1</version>
           <longName>Immunoglobulin Heavy Locus T-Cell Receptor Polymerase Chain Reaction</longName>
                                 <preferredDefinition>This region represents the germline organization of the immunoglobulin heavy chain locus. The locus includes V (variable), J (joining), diversity (D), and C (constant) segments. During B cell development, a recombination event at the DNA level joins a D segment with a J segment; a V segment is then joined to the D-J gene. The C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several D and J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase, and by somatic hypermutation, which occurs during B cell maturation in the spleen and lymph nodes. (from LocusLink): Heterodimeric antigen receptors present on the surface of T-cells.  Two T-cell antigen receptors have been identified, consisting of heterodimeric 40-55 kD Ig-like alpha/beta or gamma/delta integral membrane glycoproteins.  Genes for TCR alpha, beta, gamma, and delta subunits are assembled during T-cell development by somatic rearrangement of germline gene segments, resembling B-cell Ig genes in their mechanisms of diversity generation and activation of expression.  Alpha/beta heterodimers are found on helper and cytotoxic T-cells and are specific for antigenic peptides presented by MHC gene products.  T-cells expressing gamma/delta heterodimers directly recognize proteins and non-proteinacious phospho-ligands.  T-cell receptors are non-covalently associated with CD3, forming the TCR-CD3 complex.  TCRs activate MAPKs and JNK1 through the CD3 antigens, the adaptor protein LAT, and tyrosine kinases LCK and ZAP70.  (from OMIM and NCI): A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly s</preferredDefinition>
          </valueMeaning>
          <beginDate>2017-02-14T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>BCR-ABL1/FISH</value>
          <valueMeaning>
           <publicID>5664705</publicID>
           <version>1</version>
           <longName>BCR Protein Fluorescence in Situ Hybridization</longName>
                                 <preferredDefinition>The 160 kD BCR phosphoprotein exhibits a unique serine/threonine kinase activity, at least two SH2 binding sites, and a C-terminal GTPase activating domain for p21(rac).  The Philadelphia translocation produces a BCR-ABL1 chimeric product required for induction and maintenance of leukemia.  (from OMIM 151410 and NCI): A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.</preferredDefinition>
          </valueMeaning>
          <beginDate>2017-02-14T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Evaluated but no disease found</value>
          <valueMeaning>
           <publicID>2738850</publicID>
           <version>1</version>
           <longName>Evaluated but no disease found</longName>
                                 <preferredDefinition>Evaluated but no disease found</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Immunohistochemistry</value>
          <valueMeaning>
           <publicID>3031358</publicID>
           <version>1</version>
           <longName>Immunohistochemistry Staining Method</longName>
                       <designation>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2015-07-20T13:46:59</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>IHC</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.</preferredDefinition>
          </valueMeaning>
          <beginDate>2017-05-05T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>CT of Abdomen/Pelvis</value>
          <valueMeaning>
           <publicID>2765399</publicID>
           <version>1</version>
           <longName>CT of Abdomen/Pelvis</longName>
                                 <preferredDefinition>CT of Abdomen/Pelvis</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>MRI of Abdomen/Pelvis</value>
          <valueMeaning>
           <publicID>2765400</publicID>
           <version>1</version>
           <longName>MRI of Abdomen/Pelvis</longName>
                                 <preferredDefinition>MRI of Abdomen/Pelvis</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Radiologic</value>
          <valueMeaning>
           <publicID>2640362</publicID>
           <version>1</version>
           <longName>Radiologic</longName>
                                 <preferredDefinition>Any imaging procedure that uses radiation to create an image for the purpose of assisting with the execution of an intervention.: The use of radiation (such as x-rays) or other imaging technologies (such as ultrasound and magnetic resonance imaging) to diagnose or treat disease.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Radiographic confirmation only</value>
          <valueMeaning>
           <publicID>5977653</publicID>
           <version>1</version>
           <longName>Radiographic Examination Confirmation Only</longName>
                                 <preferredDefinition>A radiographic procedure using the emission of penetrating energy waves to form an image of the structure penetrated by the radiation.: Having been established or verified.: No Value Exists</preferredDefinition>
          </valueMeaning>
          <beginDate>2017-09-12T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Pathologic confirmation</value>
          <valueMeaning>
           <publicID>5633738</publicID>
           <version>1</version>
           <longName>Pathologic Confirmation</longName>
                                 <preferredDefinition>Caused by or altered by or manifesting disease or pathology.: Having been established or verified.</preferredDefinition>
          </valueMeaning>
          <beginDate>2017-09-12T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Flow cytometry, cerebrospinal fluid</value>
          <valueMeaning>
           <publicID>2824966</publicID>
           <version>1</version>
           <longName>Flow cytometry, cerebrospinal fluid</longName>
                                 <preferredDefinition>Flow cytometry, cerebrospinal fluid</preferredDefinition>
          </valueMeaning>
          <beginDate>2009-01-13T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Laryngoscopy</value>
          <valueMeaning>
           <publicID>2832055</publicID>
           <version>1</version>
           <longName>Laryngoscopy</longName>
                                 <preferredDefinition>Endoscopic examination of the larynx.</preferredDefinition>
          </valueMeaning>
          <beginDate>2009-02-03T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Serological</value>
          <valueMeaning>
           <publicID>2562238</publicID>
           <version>1</version>
           <longName>Serology</longName>
                                  <definition>
             <createdBy>CAMPBELB</createdBy>
             <dateCreated>2014-05-05T10:20:45</dateCreated>
             <text>SEROLOGY</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>Pertaining to the in vitro reactions and properties of immune sera, particularly, the concept refers to the use of such reactions to measure serum titers of antibody against infectious and non-infectious agents (serologic tests), to the clinical correlations of the antibody titer, and to the use of serologic reactions to detect antigens.</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>2-D Echocardiogram</value>
          <valueMeaning>
           <publicID>2847201</publicID>
           <version>1</version>
           <longName>2-D Echocardiogram</longName>
                                 <preferredDefinition>2-D Echocardiogram</preferredDefinition>
          </valueMeaning>
          <beginDate>2009-03-09T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>CT w/contrast</value>
          <valueMeaning>
           <publicID>2876591</publicID>
           <version>1</version>
           <longName>CT w/contrast</longName>
                                 <preferredDefinition>CT with contrast</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>FDG-PET</value>
          <valueMeaning>
           <publicID>2919109</publicID>
           <version>1</version>
           <longName>Positron Emission Tomography</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2014-04-02T14:19:08</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>FDG PET</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.</preferredDefinition>
          </valueMeaning>
          <beginDate>2009-07-14T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Bone Marrow Biopsy</value>
          <valueMeaning>
           <publicID>2562182</publicID>
           <version>1</version>
           <longName>BONE MARROW BIOPSY</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-08-13T18:27:12</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Bone marrow biopsy </name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>BONE MARROW BIOPSY</preferredDefinition>
          </valueMeaning>
          <beginDate>2009-08-20T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Bone Marrow Aspirate</value>
          <valueMeaning>
           <publicID>2573943</publicID>
           <version>1</version>
           <longName>Aspirate, Bone Marrow</longName>
                       <designation>
             <createdBy>TSANE</createdBy>
             <dateCreated>2013-05-21T20:06:52</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Bone Marrow Aspirate</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                         </designation>
                                  <definition>
             <createdBy>REEVESD</createdBy>
             <dateCreated>2007-10-13T17:44:00</dateCreated>
             <text>Aspirate, Bone Marrow</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>(as-per-AY-shun) The removal of a small sample of bone marrow (usually from the hip) through a needle for examination under a microscope.</preferredDefinition>
          </valueMeaning>
          <beginDate>2009-08-20T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>ECHO</value>
          <valueMeaning>
           <publicID>2951058</publicID>
           <version>1</version>
           <longName>ECHO</longName>
                                 <preferredDefinition>Echocardiogram</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Spiral CT</value>
          <valueMeaning>
           <publicID>2970362</publicID>
           <version>1</version>
           <longName>Spiral CT</longName>
                                 <preferredDefinition>A method of computed tomography (CT) that uses continuous rotation of the X-ray tube and continuous transport of the patient through the scanning aperture that allows the rapid acquisition of a volume of CT data.  Advantages over conventional CT include: rapid acquisition of a large volume of data within a single breath-hold, thus minimizing respiration artifact and misregistration between slices; the ability to reconstruct images retrospectively at any level within the scanned volume; optimization of intravenous contrast enhancement due to the short scan times; improved multi-planar and 3-D reconstruction; and the potential for radiation dose reduction.  Same as helical computed tomography. (British Journal of Radiology 1994 May;67(797):436-44)</preferredDefinition>
          </valueMeaning>
          <beginDate>2009-12-17T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Plain X-Ray</value>
          <valueMeaning>
           <publicID>2970340</publicID>
           <version>1</version>
           <longName>X-Ray</longName>
                                 <preferredDefinition>A type of high-energy radiation.  In low doses, x-rays are used to diagnose diseases by making pictures of the inside of the body.  In high doses, x-rays are used to treat cancer.</preferredDefinition>
          </valueMeaning>
          <beginDate>2009-12-17T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Peripheral Blood Counts</value>
          <valueMeaning>
           <publicID>2978652</publicID>
           <version>1</version>
           <longName>Peripheral Blood Counts</longName>
                                 <preferredDefinition>Peripheral Blood Counts</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-01-05T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Heavy chain gene rearrangement</value>
          <valueMeaning>
           <publicID>3027713</publicID>
           <version>1</version>
           <longName>Immunoglobulin Heavy Chain Gene Rearrangement</longName>
                                 <preferredDefinition>A protein complex that consists of two heavy chains (gamma, alpha, delta, epsilon or mu). The larger of the two immunoglobulin chain types determines the immunoglobulin class (G, A, D, E or M, respectively). The heavy chain molecules exhibit the same structure and composition, which consists of constant, variable, and hypervariable regions.: No value exists.</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-03-16T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Cytogenetic analysis by FISH</value>
          <valueMeaning>
           <publicID>3028332</publicID>
           <version>1</version>
           <longName>Cytogenetic Analysis Fluorescence in situ Hybridization</longName>
                                 <preferredDefinition>Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.: A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-03-18T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Immunophenotyping (4 Color flow cytometry)</value>
          <valueMeaning>
           <publicID>3027791</publicID>
           <version>1</version>
           <longName>Four Color Flow Cytometry Immunophenotype</longName>
                                 <preferredDefinition>A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.: The appearance of objects (or light sources) described in terms of a person&apos;s perception of their hue and lightness (or brightness) and saturation.: A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.: Immunophenotype is the characterization of a set of cells according to the antigens expressed.</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-04-19T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Clinical and/or hematologic analysis</value>
          <valueMeaning>
           <publicID>3028333</publicID>
           <version>1</version>
           <longName>Clinical And/Or Hematologic Analysis</longName>
                                 <preferredDefinition>Having to do with the examination and treatment of patients.: Used to indicate that either or both of two items or options: Pertaining to or related to the blood and blood-forming organs.: Analysis; examination and interpretation.</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-04-19T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Cytogenetic Analysis</value>
          <valueMeaning>
           <publicID>2861225</publicID>
           <version>1</version>
           <longName>Cytogenetic Analysis</longName>
                                 <preferredDefinition>Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-04-19T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Molecular Analysis</value>
          <valueMeaning>
           <publicID>2861224</publicID>
           <version>1</version>
           <longName>Molecular Analysis</longName>
                                 <preferredDefinition>Techniques for studying or analyzing the genetic composition and mechanisms of living organisms at the molecular level. May refer to the understanding and manipulation of genes (DNA).</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-04-19T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>DEXA scan</value>
          <valueMeaning>
           <publicID>2574279</publicID>
           <version>1</version>
           <longName>Scan, Dual-Energy X-ray Absorpitometry</longName>
                                 <preferredDefinition>Scan, Dual-Energy X-ray Absorpitometry</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-06-16T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Flow Cytometry</value>
          <valueMeaning>
           <publicID>2974014</publicID>
           <version>1</version>
           <longName>Flow Cytometry</longName>
                                 <preferredDefinition>A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-08-23T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Caliper measurement by clinical exam</value>
          <valueMeaning>
           <publicID>3131893</publicID>
           <version>1</version>
           <longName>Vernier Caliper Measurement Physical Examination</longName>
                                 <preferredDefinition>A medical device that is a combination of ruler and caliper that can measure the distance between two points. The configuration of this device permits the measurement of internal dimensions.: Measurement; the size or magnitude of something.: A physical examination is a systemic evaluation of the body and its functions using visual inspection, palpation, percussion, and auscultation, aimed to determine the presence or absence of physical signs of disease or abnormality for individual&apos;s health assessment.</preferredDefinition>
          </valueMeaning>
          <beginDate>2010-08-24T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Aspergillus galactomannan assay</value>
          <valueMeaning>
           <publicID>3173905</publicID>
           <version>1</version>
           <longName>ELISA</longName>
                                 <preferredDefinition>A highly sensitive technique for detecting and measuring antigens or antibodies in a solution; the solution is run over a surface to which immobilized antibodies specific to the substance have been attatched, and if the substance is present, it will bind to the antibody layer, and its presence is verified and visualized with an application of antibodies that have been tagged in some way. (BioTech Life Science Dictionary)</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-01-06T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>KOH / calcofluor stain</value>
          <valueMeaning>
           <publicID>3181377</publicID>
           <version>1</version>
           <longName>Calcofluor White Stain</longName>
                                 <preferredDefinition>A fluorescent stain that binds to the cell wall.  It is used for the detection of fungi, parasites, and yeasts, using fluorescent microscopy.</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-01-06T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Autopsy</value>
          <valueMeaning>
           <publicID>2567287</publicID>
           <version>1</version>
           <longName>Autopsy</longName>
                                 <preferredDefinition>Autopsy; an examination and dissection of a dead body to determine cause of death or the changes produced by disease.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Bimanual examination</value>
          <valueMeaning>
           <publicID>2558295</publicID>
           <version>1</version>
           <longName>BIMANUAL EXAMINATION</longName>
                                 <preferredDefinition>BIMANUAL EXAMINATION</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Bone scan</value>
          <valueMeaning>
           <publicID>2558319</publicID>
           <version>1</version>
           <longName>Bone Scan</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2014-07-29T15:48:50</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Bone scan</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>A nuclear imaging method used to evaluate pathological bone metabolism. </preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Clinical examination</value>
          <valueMeaning>
           <publicID>2558517</publicID>
           <version>1</version>
           <longName>CLINICAL EXAMINATION (PE)</longName>
                                 <preferredDefinition>CLINICAL EXAMINATION (PE)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Cytology</value>
          <valueMeaning>
           <publicID>2558589</publicID>
           <version>1</version>
           <longName>Cytology</longName>
                                 <preferredDefinition>Cytology; the branch of biology that studies the structure and function of cells.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Direct inspection</value>
          <valueMeaning>
           <publicID>2558627</publicID>
           <version>1</version>
           <longName>DIRECT INSPECTION</longName>
                                 <preferredDefinition>DIRECT INSPECTION</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Endoscopy</value>
          <valueMeaning>
           <publicID>2558723</publicID>
           <version>1</version>
           <longName>Endoscopy</longName>
                                 <preferredDefinition>(en-DAHS-ko-pee) The use of a thin, lighted tube (called an endoscope) to examine the inside of the body.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:43</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Histology</value>
          <valueMeaning>
           <publicID>2558883</publicID>
           <version>1</version>
           <longName>HISTOLOGY</longName>
                                 <preferredDefinition>HISTOLOGY</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Incisional biopsy</value>
          <valueMeaning>
           <publicID>2558933</publicID>
           <version>1</version>
           <longName>INCISIONAL BIOPSY</longName>
                                 <preferredDefinition>INCISIONAL BIOPSY</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Intraoperative ultrasound</value>
          <valueMeaning>
           <publicID>2558991</publicID>
           <version>1</version>
           <longName>INTRAOPERATIVE ULTRASOUND</longName>
                                 <preferredDefinition>INTRAOPERATIVE ULTRASOUND</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Laparoscopy</value>
          <valueMeaning>
           <publicID>2559024</publicID>
           <version>1</version>
           <longName>Laparoscopy</longName>
                                 <preferredDefinition>(lap-a-RAHS-ko-pee) The insertion of a thin, lighted tube (called a laparoscope) through the abdominal wall to inspect the inside of the abdomen and remove tissue samples.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Laparotomy</value>
          <valueMeaning>
           <publicID>2559025</publicID>
           <version>1</version>
           <longName>LAPAROTOMY</longName>
                                 <preferredDefinition>LAPAROTOMY</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>MRI (NMR)</value>
          <valueMeaning>
           <publicID>2559279</publicID>
           <version>1</version>
           <longName>MRI</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2014-07-29T15:48:50</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>MRI (NMR)</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>Magnetic Resonance Imaging</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:45</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Mastectomy</value>
          <valueMeaning>
           <publicID>2559154</publicID>
           <version>1</version>
           <longName>Mastectomy</longName>
                       <designation>
             <createdBy>JONSDOTTIRT</createdBy>
             <dateCreated>2008-03-01T13:18:57</dateCreated>
             <languageName>Icelandic</languageName>
             <name>Brottn¿m brj¿sts</name>
             <type>NAACCR Alt Name</type>
             <context>NCIP</context>
                         </designation>
                                 <preferredDefinition>Surgical removal of the breast.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:45</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Needle biopsy (tru-cut or core)</value>
          <valueMeaning>
           <publicID>2559497</publicID>
           <version>1</version>
           <longName>NEEDLE BIOPSY (TRU-CUT OR CORE)</longName>
                                 <preferredDefinition>NEEDLE BIOPSY (TRU-CUT OR CORE)</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:46</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Not done</value>
          <valueMeaning>
           <publicID>2559596</publicID>
           <version>1</version>
           <longName>NOT DONE</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2015-08-10T14:25:16</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Not done</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                  <definition>
             <createdBy>ZHANGW</createdBy>
             <dateCreated>2011-01-06T16:01:15</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Indicates a task, process or examination that has either not been initiated or not been completed.</text>
             <type>NCI</type>
                          <context>NHLBI</context>
            </definition>
                      <preferredDefinition>NOT DONE</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:46</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Other</value>
          <valueMeaning>
           <publicID>2559653</publicID>
           <version>1</version>
           <longName>Other</longName>
                       <designation>
             <createdBy>UMLLOADER_AIM</createdBy>
             <dateCreated>2008-12-02T09:45:51</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other</name>
             <type>UML Value Name</type>
             <context>NCIP</context>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>AIM</name>
               <publicID>2614824</publicID>
               <version>1</version>
               <preferredDefinition>Annotations and Imaging Markup (AIM) is an information model used to capture information about how images are perceived by human or machine observers that is directly tied to medical images.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomain</name>
                <publicID>2812708</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomain</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>ZIEGLERK</createdBy>
             <dateCreated>2013-11-04T11:59:13</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other specify</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                         </designation>
            <designation>
             <createdBy>ZIEGLERK</createdBy>
             <dateCreated>2014-06-25T13:42:07</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other (specify)</name>
             <type>VM Alt Name</type>
             <context>Alliance</context>
                         </designation>
            <designation>
             <createdBy>GARRIDOJ</createdBy>
             <dateCreated>2016-12-19T15:59:58</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other (specify)</name>
             <type>VM Alt Name</type>
             <context>ECOG-ACRIN</context>
                         </designation>
            <designation>
             <createdBy>ZHANGWE</createdBy>
             <dateCreated>2017-10-31T12:00:43</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other, specify</name>
             <type>VM Alt Name</type>
             <context>DCP</context>
                         </designation>
            <designation>
             <createdBy>HARTLEYG</createdBy>
             <dateCreated>2017-10-17T16:42:37</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other (intersex, disorders of sexual development/DSD)</name>
             <type>VM Alt Name</type>
             <context>PS-CC</context>
                           <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>NAACCR 16</name>
                <publicID>5899833</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
                <preferredDefinition>North American Association of Central Cancer Registries</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2007-08-14T11:44:30</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other distance units</name>
             <type>UML Value Name</type>
             <context>NCIP</context>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caArray_1.1</name>
               <publicID>2534950</publicID>
               <version>1.1</version>
               <preferredDefinition>This model makes up a the portion of caArray that reflects MGED&apos;s MAGE model.</preferredDefinition>
               <classificationSchemeItem>
                <name>gov.nih.nci.mageom.domain.Measurement</name>
                <publicID>2812473</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>gov.nih.nci.mageom.domain.Measurement</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
                                  <definition>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2007-08-14T11:44:30</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Distance units not specified in MAGE.</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caArray_1.1</name>
               <publicID>2534950</publicID>
               <version>1.1</version>
               <preferredDefinition>This model makes up a the portion of caArray that reflects MGED&apos;s MAGE model.</preferredDefinition>
               <classificationSchemeItem>
                <name>gov.nih.nci.mageom.domain.Measurement</name>
                <publicID>2812473</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
            <definition>
             <createdBy>UMLLOADER_AIM</createdBy>
             <dateCreated>2008-12-02T09:45:51</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Other</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>AIM</name>
               <publicID>2614824</publicID>
               <version>1</version>
               <preferredDefinition>Annotations and Imaging Markup (AIM) is an information model used to capture information about how images are perceived by human or machine observers that is directly tied to medical images.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomain</name>
                <publicID>2812708</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
            <definition>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2010-11-23T00:00:00</dateCreated>
             <dateModified>2010-11-23T00:00:00</dateModified>
             <modifiedBy>COOPERM</modifiedBy>
             <languageName>ENGLISH</languageName>
             <text>Different than the one(s) previously specified or mentioned.</text>
             <type>NCI</type>
                           <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>Different than the one(s) previously specified or mentioned.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:46</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Other, specify</value>
          <valueMeaning>
           <publicID>2570538</publicID>
           <version>1</version>
           <longName>Other specify</longName>
                       <designation>
             <createdBy>TAYLORT</createdBy>
             <dateCreated>2011-06-27T16:28:58</dateCreated>
             <dateModified>2011-06-28T10:31:28</dateModified>
             <modifiedBy>CHILLIJ</modifiedBy>
             <languageName>ENGLISH</languageName>
             <name>Other imaging time point, specify</name>
             <type>ACRIN Alt Name</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other, PLEASE SPECIFY</name>
             <type>LOINC_NAME</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>LA20318-4</name>
             <type>LOINC_CODE</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>KNABLEJ</createdBy>
             <dateCreated>2016-05-23T21:07:38</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Other</name>
             <type>VM Alt Name</type>
             <context>DCP</context>
                         </designation>
                                  <definition>
             <createdBy>CHILLIJ</createdBy>
             <dateCreated>2008-05-06T14:58:03</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>anatomic location other than enumerated</text>
             <type>Manually-curated</type>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:46</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Pathologic</value>
          <valueMeaning>
           <publicID>2559724</publicID>
           <version>1</version>
           <longName>Pathologic</longName>
                                 <preferredDefinition>Caused by or altered by or manifesting disease or pathology.: Caused by or altered by or manifesting disease or pathology.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:47</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Physical exam</value>
          <valueMeaning>
           <publicID>2559805</publicID>
           <version>1</version>
           <longName>PHYSICAL EXAM</longName>
                                 <preferredDefinition>PHYSICAL EXAM</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:47</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Radiograph</value>
          <valueMeaning>
           <publicID>2559945</publicID>
           <version>1</version>
           <longName>RADIOGRAPH</longName>
                                 <preferredDefinition>RADIOGRAPH</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Resection/re-excision of lumpectomy margins</value>
          <valueMeaning>
           <publicID>2559972</publicID>
           <version>1</version>
           <longName>RESECTION/RE-EXCISION OF LUMPECTOMY MARGINS</longName>
                                 <preferredDefinition>RESECTION/RE-EXCISION OF LUMPECTOMY MARGINS</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:48</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Spiral CT scan</value>
          <valueMeaning>
           <publicID>2560090</publicID>
           <version>1</version>
           <longName>SPIRAL CT SCAN</longName>
                                 <preferredDefinition>SPIRAL CT SCAN</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:49</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Surgery</value>
          <valueMeaning>
           <publicID>2560125</publicID>
           <version>1</version>
           <longName>Surgery</longName>
                                 <preferredDefinition>A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:49</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Ultrasound</value>
          <valueMeaning>
           <publicID>2570770</publicID>
           <version>1</version>
           <longName>Ultrasound</longName>
                       <designation>
             <createdBy>UMLLOADER_CANANOLAB</createdBy>
             <dateCreated>2008-10-15T23:12:00</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>ultrasound</name>
             <type>UML Value Name</type>
             <context>NCIP</context>
                           <classification>
               <name>caNanoLab</name>
               <publicID>2612100</publicID>
               <version>1.4</version>
               <preferredDefinition>Version 1.4 caNanoLab is a data sharing portal designed to facilitate information sharing in the biomedical nanotechnology research community to expedite and validate the use of nanotechnology in biomedicine. caNanoLab allows researchers to share information on nanoparticles including the composition of the particle, the functions (e.g. therapeutic, targeting, diagnostic imaging) of the particle, the characterizations of the particle from physical (e.g. size, molecular weight) and in vitro (e.g. cytotoxicity, immunotoxicity) nanoparticle assays, and the protocols of these characterization.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caNanoLab</name>
               <publicID>2915522</publicID>
               <version>1.5</version>
               <preferredDefinition>Version 1.5 caNanoLab is designed to facilitate information sharing in the biomedical nanotechnology research community to expedite and validate the use of nanotechnology in biomedicine. caNanoLab allows researchers to share information on nanoparticles including the composition of the particle, the functions (e.g. therapeutic, targeting, diagnostic imaging) of the particle, the characterizations of the particle from physico-chemical (e.g. size, molecular weight, surface) and in vitro (e.g. cytotoxicity, blood contact) nanoparticle assays, and the protocols of these characterization.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
                                  <definition>
             <createdBy>UMLLOADER_CANANOLAB</createdBy>
             <dateCreated>2008-10-15T23:12:01</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Very high frequency sound.</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>caNanoLab</name>
               <publicID>2612100</publicID>
               <version>1.4</version>
               <preferredDefinition>Version 1.4 caNanoLab is a data sharing portal designed to facilitate information sharing in the biomedical nanotechnology research community to expedite and validate the use of nanotechnology in biomedicine. caNanoLab allows researchers to share information on nanoparticles including the composition of the particle, the functions (e.g. therapeutic, targeting, diagnostic imaging) of the particle, the characterizations of the particle from physical (e.g. size, molecular weight) and in vitro (e.g. cytotoxicity, immunotoxicity) nanoparticle assays, and the protocols of these characterization.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caNanoLab</name>
               <publicID>2915522</publicID>
               <version>1.5</version>
               <preferredDefinition>Version 1.5 caNanoLab is designed to facilitate information sharing in the biomedical nanotechnology research community to expedite and validate the use of nanotechnology in biomedicine. caNanoLab allows researchers to share information on nanoparticles including the composition of the particle, the functions (e.g. therapeutic, targeting, diagnostic imaging) of the particle, the characterizations of the particle from physico-chemical (e.g. size, molecular weight, surface) and in vitro (e.g. cytotoxicity, blood contact) nanoparticle assays, and the protocols of these characterization.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>Very high frequency sound. </preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:50</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Unknown</value>
          <valueMeaning>
           <publicID>2575365</publicID>
           <version>1</version>
           <longName>Unknown</longName>
                       <designation>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-05-29T13:13:48</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Grade/differentiation unknown, not stated, or not applicable</name>
             <type>NAACCR Alt Name</type>
             <context>NCIP</context>
                           <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>CancerID11.1</name>
                <publicID>3103520</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
                <preferredDefinition>Cancer Identification11.1</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
                <preferredDefinition>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>UMLLOADER_C3PRPRD</createdBy>
             <dateCreated>2010-07-08T14:47:33</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Unknown</name>
             <type>UML Value Name</type>
             <context>NCIP</context>
                           <classification>
               <name>C3PR</name>
               <publicID>2551427</publicID>
               <version>2.8</version>
               <preferredDefinition>Version 2.8 The Cancer Central Clinical Participent Registry (C3PR) is a web-based application used to manage participants in cancer clinical trials. Research staff will use C3PR as a participant-centric entry point to clinical trial management systems. C3PR provides a central registry for study participants, and it enables the end-user to access participant-centric information that is stored in multiple clinical trial systems. Participants that can be tracked include patients or potential patients, their guardians, family members, and referring physicians. The system also allows tracking other types of participants such as principal investigators, caregivers, referring physicians, and the users of the system.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
                <preferredDefinition>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Grid Enabled Measures</name>
               <publicID>2983752</publicID>
               <version>1</version>
               <preferredDefinition>A resource to allow researchers to access metadata about measures used in cancer research and the population sciences.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Common Biorepository Model</name>
               <publicID>3204728</publicID>
               <version>1</version>
               <preferredDefinition>A common model to contain summary-level details of biorepository / biobank holdings which can be advertised through the OBBR Specimen Resource Locator</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2010-12-22T12:10:38</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>unknown</name>
             <type>NAACCR VM Name</type>
             <context>PS-CC</context>
                           <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>NAACCR 12.1</name>
                <publicID>3134707</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
                <preferredDefinition>North American Association of Central Cancer Registries</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
                <preferredDefinition>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2010-12-22T12:42:41</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>UNK</name>
             <type>HL7 Code</type>
             <context>PS-CC</context>
                           <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>NAACCR 12.1</name>
                <publicID>3134707</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
                <preferredDefinition>North American Association of Central Cancer Registries</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
                <preferredDefinition>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2015-10-16T14:09:25</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>LA4489-6</name>
             <type>LOINC_CODE</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:30</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>LA4489-6</name>
             <type>LOINC_CODE</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-05-12T14:24:31</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Unknown</name>
             <type>LOINC_NAME</type>
             <context>ONC SDC Project</context>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2016-04-04T13:18:57</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Unknown</name>
             <type>LOINC_NAME</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2017-03-29T08:57:16</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Unknown cause of death</name>
             <type>VM Alt Name</type>
             <context>NCIP</context>
                         </designation>
            <designation>
             <createdBy>MORENOC</createdBy>
             <dateCreated>2017-04-21T06:18:54</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>I don&apos;t know</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                         </designation>
                                  <definition>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-04-30T14:19:12</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Unknown whether Spanish or not
</text>
             <type>NAACCR</type>
                           <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>Demographic11.1</name>
                <publicID>3242099</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>PS-CC</context>
            </definition>
            <definition>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-07-18T16:11:28</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Patient&apos;s address is unknown</text>
             <type>NAACCR</type>
                           <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>Demographic11.1</name>
                <publicID>3242099</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>PS-CC</context>
            </definition>
            <definition>
             <createdBy>UMLLOADER_GEM</createdBy>
             <dateCreated>2011-01-27T16:26:05</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>A response indicating that the respondent does not know what the correct answer is.</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Grid Enabled Measures</name>
               <publicID>2983752</publicID>
               <version>1</version>
               <preferredDefinition>A resource to allow researchers to access metadata about measures used in cancer research and the population sciences.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
            <definition>
             <createdBy>UMLLOADER_C3PRPRD</createdBy>
             <dateCreated>2010-07-08T14:47:33</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Could not be determined or unsure.</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>C3PR</name>
               <publicID>2551427</publicID>
               <version>2.8</version>
               <preferredDefinition>Version 2.8 The Cancer Central Clinical Participent Registry (C3PR) is a web-based application used to manage participants in cancer clinical trials. Research staff will use C3PR as a participant-centric entry point to clinical trial management systems. C3PR provides a central registry for study participants, and it enables the end-user to access participant-centric information that is stored in multiple clinical trial systems. Participants that can be tracked include patients or potential patients, their guardians, family members, and referring physicians. The system also allows tracking other types of participants such as principal investigators, caregivers, referring physicians, and the users of the system.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
            <definition>
             <createdBy>UMLLOADER_C3PRPRD</createdBy>
             <dateCreated>2010-07-08T14:47:35</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Not known, not observed, not recorded, or refused.</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>C3PR</name>
               <publicID>2551427</publicID>
               <version>2.8</version>
               <preferredDefinition>Version 2.8 The Cancer Central Clinical Participent Registry (C3PR) is a web-based application used to manage participants in cancer clinical trials. Research staff will use C3PR as a participant-centric entry point to clinical trial management systems. C3PR provides a central registry for study participants, and it enables the end-user to access participant-centric information that is stored in multiple clinical trial systems. Participants that can be tracked include patients or potential patients, their guardians, family members, and referring physicians. The system also allows tracking other types of participants such as principal investigators, caregivers, referring physicians, and the users of the system.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
            <definition>
             <createdBy>CHILLIJ</createdBy>
             <dateCreated>2010-07-13T22:01:19</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Not known, not observed, or not recorded.</text>
             <type>Manually-curated</type>
                           <classification>
               <name>Data Standards</name>
               <publicID>2192345</publicID>
               <version>1</version>
               <preferredDefinition>Data standards developed for the NCI community.</preferredDefinition>
               <classificationSchemeItem>
                <name>Image Quality CRF</name>
                <publicID>3079057</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
            <definition>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2010-12-22T12:10:38</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>a proper value is applicable but not known.  this event occurred, but the date is unknown (e.g., birth date).</text>
             <type>NAACCR</type>
                           <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>NAACCR 12.1</name>
                <publicID>3134707</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>NMDP: CDEs to review</name>
               <publicID>2695319</publicID>
               <version>1</version>
               <preferredDefinition>NMDP CDEs to be reviewed</preferredDefinition>
               <classificationSchemeItem>
                <name>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</name>
                <publicID>2964895</publicID>
                <version>1</version>
                <type>Case Report Form</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>PICUcoreClinicalData</name>
               <publicID>3588382</publicID>
               <version>1</version>
               <preferredDefinition>Descriptive information about pediatric intensive care unit (PICU) discharges from NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers, based primarily on hospital billing databases. The Core Clinical Data Project (CCDP) provides pilot and descriptive data for hypothesis generation, study design, preliminary power analyses, and recruitment projections for CPCCRN studies under development.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>PS-CC</context>
            </definition>
                      <preferredDefinition>Not known, not observed, not recorded, or refused.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:54</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Axillary dissection</value>
          <valueMeaning>
           <publicID>2558265</publicID>
           <version>1</version>
           <longName>AXILLARY DISSECTION</longName>
                                 <preferredDefinition>AXILLARY DISSECTION</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:51</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Mammogram</value>
          <valueMeaning>
           <publicID>2561001</publicID>
           <version>1</version>
           <longName>Mammogram</longName>
                                 <preferredDefinition>A low voltage X-ray photograph of the breast generally done to detect breast cancer. This method is also valuable in diagnosis of benign abnormal conditions of the breast such as fibroadenoma, mastitis, abscess, and cysts.</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-04-11T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>PET/Conventional CT</value>
          <valueMeaning>
           <publicID>3237468</publicID>
           <version>1</version>
           <longName>Computed Tomography Positron Emission Tomography</longName>
                                 <preferredDefinition>A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. : A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-05-23T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>PET/Spiral CT</value>
          <valueMeaning>
           <publicID>3237469</publicID>
           <version>1</version>
           <longName>Spiral CT Positron Emission Tomography</longName>
                                 <preferredDefinition>A method of computed tomography (CT) that uses continuous rotation of the X-ray tube and continuous transport of the patient through the scanning aperture that allows the rapid acquisition of a volume of CT data.  Advantages over conventional CT include: rapid acquisition of a large volume of data within a single breath-hold, thus minimizing respiration artifact and misregistration between slices; the ability to reconstruct images retrospectively at any level within the scanned volume; optimization of intravenous contrast enhancement due to the short scan times; improved multi-planar and 3-D reconstruction; and the potential for radiation dose reduction.  Same as helical computed tomography. (British Journal of Radiology 1994 May;67(797):436-44): A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.</preferredDefinition>
          </valueMeaning>
          <beginDate>2011-05-23T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>EKG</value>
          <valueMeaning>
           <publicID>2562326</publicID>
           <version>1</version>
           <longName>EKG</longName>
                                 <preferredDefinition>A procedure to assess heart function using an electrocardiogram (EKG) device</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-08-12T11:41:31</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Primary surgery</value>
          <valueMeaning>
           <publicID>2562495</publicID>
           <version>1</version>
           <longName>PRIMARY SURGERY</longName>
                                 <preferredDefinition>Surgery of curative intent to remove tumor or malignant tissue</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-10-01T11:49:57</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Bilateral mammogram</value>
          <valueMeaning>
           <publicID>2563569</publicID>
           <version>1</version>
           <longName>Bilateral mammogram</longName>
                                 <preferredDefinition>Bilateral mammogram</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-11-06T13:17:07</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Preoperative CT scan</value>
          <valueMeaning>
           <publicID>2570151</publicID>
           <version>1</version>
           <longName>CT Scan</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2014-07-29T15:53:25</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>CT scan</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>CT Scan</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-12-19T18:01:27</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>X-ray</value>
          <valueMeaning>
           <publicID>2562460</publicID>
           <version>1</version>
           <longName>X-RAY </longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2014-07-29T15:48:50</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>X-ray</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>X-RAY </preferredDefinition>
          </valueMeaning>
          <beginDate>2002-12-19T18:11:56</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>CT scan</value>
          <valueMeaning>
           <publicID>2570151</publicID>
           <version>1</version>
           <longName>CT Scan</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2014-07-29T15:53:25</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>CT scan</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>CT Scan</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Chest x-ray</value>
          <valueMeaning>
           <publicID>2570173</publicID>
           <version>1</version>
           <longName>Chest X-Ray</longName>
                                 <preferredDefinition>Chest X-Ray</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:42</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Incisional biopsy, with wire localization</value>
          <valueMeaning>
           <publicID>2558934</publicID>
           <version>1</version>
           <longName>INCISIONAL BIOPSY, WITH WIRE LOCALIZATION</longName>
                                 <preferredDefinition>INCISIONAL BIOPSY, WITH WIRE LOCALIZATION</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:44</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Needle biopsy (tru-cut or core), with wire localization)</value>
          <valueMeaning>
           <publicID>2559498</publicID>
           <version>1</version>
           <longName>NEEDLE BIOPSY (TRU-CUT OR CORE), WITH WIRE LOCALIZATION</longName>
                                 <preferredDefinition>NEEDLE BIOPSY (TRU-CUT OR CORE), WITH WIRE LOCALIZATION</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:46</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Ductal lavage</value>
          <valueMeaning>
           <publicID>2558693</publicID>
           <version>1</version>
           <longName>DUCTAL LAVAGE</longName>
                                 <preferredDefinition>DUCTAL LAVAGE</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Ductoscopic biopsy</value>
          <valueMeaning>
           <publicID>2558694</publicID>
           <version>1</version>
           <longName>DUCTOSCOPIC BIOPSY</longName>
                                 <preferredDefinition>DUCTOSCOPIC BIOPSY</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Excisional biopsy or lumpectomy</value>
          <valueMeaning>
           <publicID>2558745</publicID>
           <version>1</version>
           <longName>EXCISIONAL BIOPSY OR LUMPECTOMY</longName>
                       <designation>
             <createdBy>JONSDOTTIRT</createdBy>
             <dateCreated>2008-03-01T13:18:56</dateCreated>
             <languageName>Icelandic</languageName>
             <name>¿nnur a¿fer¿</name>
             <type>NAACCR Alt Name</type>
             <context>NCIP</context>
                         </designation>
                                 <preferredDefinition>EXCISIONAL BIOPSY OR LUMPECTOMY</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Excisional biopsy or lumpectomy, with wire localization</value>
          <valueMeaning>
           <publicID>2559103</publicID>
           <version>1</version>
           <longName>LUMPECTOMY, WITH WIRE LOCALIZATION</longName>
                                 <preferredDefinition>LUMPECTOMY, WITH WIRE LOCALIZATION</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Fluid cytology, ascites</value>
          <valueMeaning>
           <publicID>2558792</publicID>
           <version>1</version>
           <longName>FLUID CYTOLOGY, ASCITES</longName>
                                 <preferredDefinition>FLUID CYTOLOGY, ASCITES</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Fluid cytology, cerebrospinal fluid</value>
          <valueMeaning>
           <publicID>2558793</publicID>
           <version>1</version>
           <longName>FLUID CYTOLOGY, CEREBROSPINAL FLUID</longName>
                                 <preferredDefinition>FLUID CYTOLOGY, CEREBROSPINAL FLUID</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Fluid cytology, pleural</value>
          <valueMeaning>
           <publicID>2558794</publicID>
           <version>1</version>
           <longName>FLUID CYTOLOGY, PLEURAL</longName>
                                 <preferredDefinition>FLUID CYTOLOGY, PLEURAL</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Nipple fluid</value>
          <valueMeaning>
           <publicID>2559514</publicID>
           <version>1</version>
           <longName>NIPPLE FLUID</longName>
                                 <preferredDefinition>NIPPLE FLUID</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:53</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Prophalactic mastectomy</value>
          <valueMeaning>
           <publicID>2559913</publicID>
           <version>1</version>
           <longName>PROPHALACTIC MASTECTOMY</longName>
                                 <preferredDefinition>PROPHALACTIC MASTECTOMY</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:53</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Sentinel node biopsy</value>
          <valueMeaning>
           <publicID>2560027</publicID>
           <version>1</version>
           <longName>SENTINEL NODE BIOPSY</longName>
                                 <preferredDefinition>SENTINEL NODE BIOPSY</preferredDefinition>
          </valueMeaning>
          <beginDate>2002-02-11T15:18:54</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>MIBG</value>
          <valueMeaning>
           <publicID>2565821</publicID>
           <version>1</version>
           <longName>MIBG</longName>
                                 <preferredDefinition>MIBG</preferredDefinition>
          </valueMeaning>
          <beginDate>2003-03-20T15:23:19</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Bone marrow morphology</value>
          <valueMeaning>
           <publicID>2565826</publicID>
           <version>1</version>
           <longName>Bone marrow morphology</longName>
                                 <preferredDefinition>Bone marrow morphology</preferredDefinition>
          </valueMeaning>
          <beginDate>2003-03-25T16:08:41</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>MRI of Spine</value>
          <valueMeaning>
           <publicID>3392215</publicID>
           <version>1</version>
           <longName>MRI of Spine</longName>
                                 <preferredDefinition>MRI of Spine</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-02-28T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>MRI of Brain</value>
          <valueMeaning>
           <publicID>3392216</publicID>
           <version>1</version>
           <longName>MRI of Brain</longName>
                                 <preferredDefinition>MRI of Brain</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-02-28T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>PET scan</value>
          <valueMeaning>
           <publicID>2565860</publicID>
           <version>1</version>
           <longName>PET Scan</longName>
                                 <preferredDefinition>Positron Emission Tomography</preferredDefinition>
          </valueMeaning>
          <beginDate>2003-05-02T12:08:53</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Gallium scan</value>
          <valueMeaning>
           <publicID>2565861</publicID>
           <version>1</version>
           <longName>Gallium Scan</longName>
                                 <preferredDefinition>Gallium Scan</preferredDefinition>
          </valueMeaning>
          <beginDate>2003-05-02T12:08:53</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>MIBG scintiscan</value>
          <valueMeaning>
           <publicID>3458598</publicID>
           <version>1</version>
           <longName>MIBG scintiscan</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2013-12-17T10:53:24</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>MIBG</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>An imaging test that uses a radioisotope (MIBG, iodine-131-meta-iodobenzylguanidine) tracer and a special scanner to find or confirm the presence of pheochromocytoma and neuroblastoma, which are tumors of specific types of nervous tissue.</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-05-10T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>CA-125 assay</value>
          <valueMeaning>
           <publicID>3485237</publicID>
           <version>1</version>
           <longName>CA-125 assay</longName>
                                 <preferredDefinition>CA-125 assay</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-06-20T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Bronchoscopy</value>
          <valueMeaning>
           <publicID>2566854</publicID>
           <version>1</version>
           <longName>Bronchoscopy</longName>
                                 <preferredDefinition>A procedure in which a thin, lighted tube is inserted through the nose or mouth. NCI Concept Code C16366</preferredDefinition>
          </valueMeaning>
          <beginDate>2003-08-18T14:53:24</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Urine catecholamines</value>
          <valueMeaning>
           <publicID>3566835</publicID>
           <version>1</version>
           <longName>Urine catecholamines</longName>
                                 <preferredDefinition>Urine catecholamines</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-08-27T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Polymerase Chain Reaction</value>
          <valueMeaning>
           <publicID>3234683</publicID>
           <version>1</version>
           <longName>Polymerase Chain Reaction</longName>
                       <designation>
             <createdBy>ROUILLAS</createdBy>
             <dateCreated>2014-02-20T10:31:23</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>PCR</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                         </designation>
                                 <preferredDefinition>method for reproducing specific DNA sequences based on elongation of complementary primers by DNA polymerase; primarily used to increase quantities for analytical detection of, e.g., virus genome.</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-10-19T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>in situ hybridization</value>
          <valueMeaning>
           <publicID>2939763</publicID>
           <version>1</version>
           <longName>in situ Hybridization</longName>
                                 <preferredDefinition>Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-10-19T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Radiographic Imaging</value>
          <valueMeaning>
           <publicID>3626193</publicID>
           <version>1</version>
           <longName>Radiograph Imaging Technique</longName>
                                 <preferredDefinition>An image produced on a radiosensitive surface by x-ray radiation that has penetrated and passed through a structure.: Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.</preferredDefinition>
          </valueMeaning>
          <beginDate>2012-11-13T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Clinical</value>
          <valueMeaning>
           <publicID>2568063</publicID>
           <version>1</version>
           <longName>Clinical</longName>
                       <designation>
             <createdBy>UMLLOADER_DMR</createdBy>
             <dateCreated>2008-10-01T11:52:59</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Clinical</name>
             <type>UML Value Name</type>
             <context>NCIP</context>
                           <classification>
               <name>DigitalModelRepository(DMR)</name>
               <publicID>2786997</publicID>
               <version>1</version>
               <preferredDefinition>Digital Model Repository (DMR) to facilitate the collection and sharing of in silico models for the NCI ICBP program. This includes submission and retrieval of digital models, simulation-related workflow designs, visualization, parallelization, and multi-resolution modeling.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>ValueDomains</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
                                  <definition>
             <createdBy>UMLLOADER_DMR</createdBy>
             <dateCreated>2008-10-01T11:53:00</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Relating to the examination and treatment of patients dependent on direct observation.</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>DigitalModelRepository(DMR)</name>
               <publicID>2786997</publicID>
               <version>1</version>
               <preferredDefinition>Digital Model Repository (DMR) to facilitate the collection and sharing of in silico models for the NCI ICBP program. This includes submission and retrieval of digital models, simulation-related workflow designs, visualization, parallelization, and multi-resolution modeling.</preferredDefinition>
               <classificationSchemeItem>
                <name>ValueDomains</name>
                <publicID>2812842</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
                      <preferredDefinition>Having to do with the examination and treatment of patients.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-01-14T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Radiographic</value>
          <valueMeaning>
           <publicID>2568067</publicID>
           <version>1</version>
           <longName>Radiographic</longName>
                                 <preferredDefinition>The use of Radiographic methodology</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-01-14T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Differential</value>
          <valueMeaning>
           <publicID>2568031</publicID>
           <version>1</version>
           <longName>DIFFERENTIAL</longName>
                                 <preferredDefinition>evaluation by differential</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-01-12T11:59:14</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Visual assessment</value>
          <valueMeaning>
           <publicID>2568030</publicID>
           <version>1</version>
           <longName>VISUAL ASSESSMENT</longName>
                                 <preferredDefinition>evaluation by visual assessment</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-01-12T11:59:14</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Biopsy</value>
          <valueMeaning>
           <publicID>2574093</publicID>
           <version>1</version>
           <longName>Biopsy</longName>
                                 <preferredDefinition>Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-04-01T12:51:58</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Colonoscopy</value>
          <valueMeaning>
           <publicID>2569094</publicID>
           <version>1</version>
           <longName>Colonoscopy</longName>
                                 <preferredDefinition>Endoscopic examination of the luminal surface of the colon.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-04-08T12:40:52</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Palpation</value>
          <valueMeaning>
           <publicID>2569463</publicID>
           <version>1</version>
           <longName>Palpation</longName>
                       <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2012-09-20T16:00:58</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>cdec859e-54f2-4d6c-aefe-838188747ebc</name>
             <type>CEM Key</type>
             <context>TEST</context>
                         </designation>
                                 <preferredDefinition>Palpation</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-03T09:08:33</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Visualization</value>
          <valueMeaning>
           <publicID>2569464</publicID>
           <version>1</version>
           <longName>Visualization</longName>
                                 <preferredDefinition>Visualization</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-03T09:08:33</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Colposcopy</value>
          <valueMeaning>
           <publicID>2569465</publicID>
           <version>1</version>
           <longName>Colposcopy</longName>
                                 <preferredDefinition>Colposcopy</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-03T09:08:33</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>MRI scan</value>
          <valueMeaning>
           <publicID>2569466</publicID>
           <version>1</version>
           <longName>MRI scan</longName>
                                 <preferredDefinition>MRI scan</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-03T09:08:33</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Plain film/X-ray without contrast</value>
          <valueMeaning>
           <publicID>2569469</publicID>
           <version>1</version>
           <longName>Plain film/X-ray without contrast</longName>
                                 <preferredDefinition>Plain film/X-ray without contrast</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-03T09:11:28</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Plain film/X-ray with contrast</value>
          <valueMeaning>
           <publicID>2569468</publicID>
           <version>1</version>
           <longName>Plain film/X-ray with contrast</longName>
                                 <preferredDefinition>Plain film/X-ray with contrast</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-03T09:11:28</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Radioisotope scan</value>
          <valueMeaning>
           <publicID>2569467</publicID>
           <version>1</version>
           <longName>Radioisotope scan</longName>
                                 <preferredDefinition>Radioisotope scan</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-03T09:11:28</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Cystoscopy</value>
          <valueMeaning>
           <publicID>2569349</publicID>
           <version>1</version>
           <longName>Cystoscopy</longName>
                                 <preferredDefinition>(sist-OSS-ko-pee) Examination of the bladder and urethra using a thin, lighted instrument (called a cystoscope) inserted into the urethra. Tissue samples can be removed and examined under a microscope to determine whether disease is present.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-03T09:11:28</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Histologic confirmation</value>
          <valueMeaning>
           <publicID>2569471</publicID>
           <version>1</version>
           <longName>Histologic confirmation</longName>
                                 <preferredDefinition>Histologic confirmation</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-03T09:13:07</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Cytologic confirmation</value>
          <valueMeaning>
           <publicID>2569470</publicID>
           <version>1</version>
           <longName>Cytologic confirmation</longName>
                                 <preferredDefinition>Cytologic confirmation</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-05-03T09:13:07</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Not applicable</value>
          <valueMeaning>
           <publicID>2581003</publicID>
           <version>1</version>
           <longName>Not applicable</longName>
                       <designation>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2007-08-02T15:44:56</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Not applicable sequence feature</name>
             <type>UML Value Name</type>
             <context>NCIP</context>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caArray_1.1</name>
               <publicID>2534950</publicID>
               <version>1.1</version>
               <preferredDefinition>This model makes up a the portion of caArray that reflects MGED&apos;s MAGE model.</preferredDefinition>
               <classificationSchemeItem>
                <name>gov.nih.nci.mageom.domain.Measurement</name>
                <publicID>2812473</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>gov.nih.nci.mageom.domain.Measurement</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>edu.wustl.catissuecore.domain.ValueDomain</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-06-07T15:54:35</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>NA</name>
             <type>NAACCR Alt Name</type>
             <context>PS-CC</context>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>No Value Exists.</preferredDefinition>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
                <preferredDefinition>edu.wustl.catissuecore.domain.ValueDomain</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
            <designation>
             <createdBy>DWARZEL</createdBy>
             <dateCreated>2014-12-18T01:56:53</dateCreated>
             <dateModified>2014-12-18T01:59:53</dateModified>
             <modifiedBy>DWARZEL</modifiedBy>
             <languageName>ENGLISH</languageName>
             <name>Doesn&apos;t Apply</name>
             <type>VM Alt Name</type>
             <context>NCIP</context>
                           <classification>
               <name>FDA MedWatch Form 3500</name>
               <publicID>4382692</publicID>
               <version>1</version>
               <preferredDefinition>CDEs in MedWatch Form FDA 3500</preferredDefinition>
               <classificationSchemeItem>
                <name>Suspect Product(s)</name>
                <publicID>4394093</publicID>
                <version>1</version>
                <type>Case Report Form</type>
                <preferredDefinition>Suspect Product(s) Case Report Form CDEs</preferredDefinition>
               </classificationSchemeItem>
              </classification>
                         </designation>
                                  <definition>
             <createdBy>COOPERM</createdBy>
             <dateCreated>2007-08-02T15:44:56</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>How a sequence feature was determined is not applicable.</text>
             <type>UML Value Definition</type>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caArray_1.1</name>
               <publicID>2534950</publicID>
               <version>1.1</version>
               <preferredDefinition>This model makes up a the portion of caArray that reflects MGED&apos;s MAGE model.</preferredDefinition>
               <classificationSchemeItem>
                <name>gov.nih.nci.mageom.domain.BioSequence</name>
                <publicID>2812479</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>NCIP</context>
            </definition>
            <definition>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-04-30T12:22:44</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Not applicable 9e.g., census tracting not attempted); Census Tract Certainty information for 1970/80/90 not coded.</text>
             <type>NAACCR</type>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>Demographic11.1</name>
                <publicID>3242099</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>PS-CC</context>
            </definition>
            <definition>
             <createdBy>CURTIST</createdBy>
             <dateCreated>2007-04-30T12:32:10</dateCreated>
             <languageName>ENGLISH</languageName>
             <text>Not applicable (e.g., census tracting not attempted); Census Tract Certainty information for 2000 not coded.</text>
             <type>NAACCR</type>
                           <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>MMQL</name>
                <publicID>3111285</publicID>
                <version>1</version>
                <type>UML_PACKAGE_ALIAS</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Clinical Trial Mgmt Systems</name>
               <publicID>2183535</publicID>
               <version>1</version>
               <preferredDefinition>This Workspace will address the Cancer Center community need for consistent, open and comprehensive tools for clinical trials management.</preferredDefinition>
               <classificationSchemeItem>
                <name>LocalValueDomains</name>
                <publicID>3024955</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>Division of Cancer Control and Population Sciences</name>
               <publicID>2193114</publicID>
               <version>1</version>
               <preferredDefinition>Classification of the Division of Cancer Control and Population Sciences</preferredDefinition>
               <classificationSchemeItem>
                <name>Demographic11.1</name>
                <publicID>3242099</publicID>
                <version>1</version>
                <type>GROUP_TYPE</type>
               </classificationSchemeItem>
              </classification>
              <classification>
               <name>caTissue_Suite</name>
               <publicID>2782636</publicID>
               <version>1</version>
               <preferredDefinition>caTissue Suite version 1.0</preferredDefinition>
               <classificationSchemeItem>
                <name>edu.wustl.catissuecore.domain.ValueDomain</name>
                <publicID>2813063</publicID>
                <version>1</version>
                <type>UML_PACKAGE_NAME</type>
               </classificationSchemeItem>
              </classification>
                          <context>PS-CC</context>
            </definition>
                      <preferredDefinition>Determination of a value is not relevant in the current context.</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-08-17T12:51:19</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Physical examination with imaging</value>
          <valueMeaning>
           <publicID>3906854</publicID>
           <version>1</version>
           <longName>Imaging With Physical Examination</longName>
                                 <preferredDefinition>No value exists.: Used to indicate the presence of something or someone.: A physical examination is a systemic evaluation of the body and its functions using visual inspection, palpation, percussion, and auscultation, aimed to determine the presence or absence of physical signs of disease or abnormality for individual&apos;s health assessment.</preferredDefinition>
          </valueMeaning>
          <beginDate>2013-09-24T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Histologic</value>
          <valueMeaning>
           <publicID>2570861</publicID>
           <version>1</version>
           <longName>histologic</longName>
                                 <preferredDefinition>histologic</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-10-27T15:31:15</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Tumor markers</value>
          <valueMeaning>
           <publicID>2570768</publicID>
           <version>1</version>
           <longName>Tumor Markers</longName>
                                 <preferredDefinition>Tumor Markers</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-10-27T15:31:16</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Tumor Marker</value>
          <valueMeaning>
           <publicID>2572218</publicID>
           <version>1</version>
           <longName>Tumor Marker</longName>
                                 <preferredDefinition>Tumor Marker</preferredDefinition>
          </valueMeaning>
          <beginDate>2004-11-09T13:05:31</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Microscopic evaluation</value>
          <valueMeaning>
           <publicID>4120631</publicID>
           <version>1</version>
           <longName>Microscopic evaluation</longName>
                                 <preferredDefinition>Microscopic evaluation</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-01-30T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Macroscopic evaluation</value>
          <valueMeaning>
           <publicID>4120632</publicID>
           <version>1</version>
           <longName>Macroscopic evaluation</longName>
                                 <preferredDefinition>Macroscopic evaluation</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-01-30T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Diagnostic Imaging</value>
          <valueMeaning>
           <publicID>2573670</publicID>
           <version>1</version>
           <longName>Diagnostic Imaging</longName>
                                 <preferredDefinition>Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation..</preferredDefinition>
          </valueMeaning>
          <beginDate>2005-03-21T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Echocardiogram</value>
          <valueMeaning>
           <publicID>2566540</publicID>
           <version>1</version>
           <longName>Echocardiogram</longName>
                                 <preferredDefinition>An image of the heart produced by ultrasonography.</preferredDefinition>
          </valueMeaning>
          <beginDate>2005-03-29T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>IVP</value>
          <valueMeaning>
           <publicID>2573974</publicID>
           <version>1</version>
           <longName>Intravenous Pyelogram</longName>
                                 <preferredDefinition>Intravenous Pyelogram</preferredDefinition>
          </valueMeaning>
          <beginDate>2005-03-29T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Sigmoidoscopy</value>
          <valueMeaning>
           <publicID>2574288</publicID>
           <version>1</version>
           <longName>Sigmoidoscopy</longName>
                                 <preferredDefinition>Sigmoidoscopy</preferredDefinition>
          </valueMeaning>
          <beginDate>2005-04-01T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Liver Biopsy</value>
          <valueMeaning>
           <publicID>2831213</publicID>
           <version>1</version>
           <longName>Liver Biopsy</longName>
                       <designation>
             <createdBy>PATELV</createdBy>
             <dateCreated>2017-10-10T14:14:27</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>Biopsy</name>
             <type>VM Alt Name</type>
             <context>NRG</context>
                         </designation>
                                 <preferredDefinition>Removal of tissue from the liver for microscopic examination.</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-03-05T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Fine needle aspiration biopsy</value>
          <valueMeaning>
           <publicID>2574518</publicID>
           <version>1</version>
           <longName>FINE NEEDLE ASPIRATION BIOPSY</longName>
                                 <preferredDefinition>Biopsy by a fine needle aspiration technique</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Fine needle aspiration biopsy, with wire localization</value>
          <valueMeaning>
           <publicID>2574519</publicID>
           <version>1</version>
           <longName>FINE NEEDLE ASPIRATION BIOPSY WITH WIRE LOCALIZATION</longName>
                                 <preferredDefinition>Biopsy by a fine needle aspiration technique using wire localization</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>Cytoscopy</value>
          <valueMeaning>
           <publicID>2569472</publicID>
           <version>1</version>
           <longName>cytoscopy</longName>
                                 <preferredDefinition>cytoscopy</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>MRI T2</value>
          <valueMeaning>
           <publicID>4231311</publicID>
           <version>1</version>
           <longName>MRI T2</longName>
                       <designation>
             <createdBy>ZIEGLERK</createdBy>
             <dateCreated>2014-07-01T12:38:10</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>MRI T2 only</name>
             <type>VM Alt Name</type>
             <context>Alliance</context>
                         </designation>
                                 <preferredDefinition>Magnetic resonance imaging (MRI) of the extra-ocular muscle T2</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-03-17T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>MRI T1gad</value>
          <valueMeaning>
           <publicID>4231312</publicID>
           <version>1</version>
           <longName>MRI T1gad</longName>
                       <designation>
             <createdBy>ZIEGLERK</createdBy>
             <dateCreated>2014-07-01T12:38:09</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>MRI T1gad only</name>
             <type>VM Alt Name</type>
             <context>CTEP</context>
                         </designation>
                                 <preferredDefinition>Magnetic resonance imaging (MRI) of the T1gad signal intensity ratio (SIR)</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-03-17T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>MRI + DWI</value>
          <valueMeaning>
           <publicID>4253231</publicID>
           <version>1</version>
           <longName>MRI DWI</longName>
                       <designation>
             <createdBy>WONGW</createdBy>
             <dateCreated>2014-04-02T14:22:49</dateCreated>
             <languageName>ENGLISH</languageName>
             <name>MRI + DWI</name>
             <type>VM Alt Name</type>
             <context>COG</context>
                         </designation>
                                 <preferredDefinition>Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.: A diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence.</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-03-26T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Antigen</value>
          <valueMeaning>
           <publicID>3167779</publicID>
           <version>1</version>
           <longName>Antigen</longName>
                                 <preferredDefinition>Any substance that appears foreign or potentially adverse to the body and elicits immune response.</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-04-03T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Shell Vial Culture</value>
          <valueMeaning>
           <publicID>4262871</publicID>
           <version>1</version>
           <longName>Shell Vial Culture</longName>
                                 <preferredDefinition>A method for virus culture and detection in which a virus sample is mixed with a susceptible cell type and then centrifuged into a single layer of cells. Following a short incubation, viral growth is determined using immunological detection techniques.</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-04-04T00:00:00</beginDate>
         </permissibleValue>
         <permissibleValue>
          <value>Contrast enhanced CT scan/CT perfusion exam</value>
          <valueMeaning>
           <publicID>2575809</publicID>
           <version>1</version>
           <longName>CONTRAST ENHANCED CT SCAN</longName>
                                 <preferredDefinition>Contrast enhanced computed tomography scan</preferredDefinition>
          </valueMeaning>
         </permissibleValue>
         <permissibleValue>
          <value>MRI T1gad and MRI T2</value>
          <valueMeaning>
           <publicID>4377743</publicID>
           <version>1</version>
           <longName>MRI T1gad and MRI T2</longName>
                                 <preferredDefinition>MRI T1gad and MRI T2</preferredDefinition>
          </valueMeaning>
          <beginDate>2014-07-01T00:00:00</beginDate>
         </permissibleValue>
                       </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Assessment Type</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Method of Evaluation</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Method of Evaluation</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Outcome Measures CRF Question Text</name>
         <type>Alternate Question Text</type>
         <context>NCIP</context>
         <doctext>Method of Disease Status Evaluation</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Outcome Measures CRF Question</name>
         <type>Alternate Question Text</type>
         <context>NCIP</context>
         <doctext>Method of Evaluation for Current Response</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Outcome Measures CRF Text</name>
         <type>Alternate Question Text</type>
         <context>NCIP</context>
         <doctext>Method of Evaluation for Recurrence</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Outcome Measure CRF Question Text</name>
         <type>Alternate Question Text</type>
         <context>NCIP</context>
         <doctext>Method of Evaluation for Progressive Disease</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Evaluation Method</name>
         <type>Alternate Question Text</type>
         <context>NCIP</context>
         <doctext>Evaluation Method</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text2</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>What method of evaluation is used to obtain tumor measurements?</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG_CRF_TEXT_1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>How was the new disease detected during this reporting period</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Method of Evaluation</name>
         <type>Alternate Question Text</type>
         <context>NCIP</context>
         <doctext>Method of Evaluation</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text 3</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Method of evaluation</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>ECOG CRF 1</name>
         <type>Alternate Question Text</type>
         <context>ECOG-ACRIN</context>
         <doctext>Method of Assessment</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF TEXT 2</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Modality:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF TEXT 3</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Method of evaluation:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text 11</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Cardiac Evaluation</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF TEXT 4</name>
         <type>Alternate Question Text</type>
         <context>COG</context>
         <doctext>Method of imaging:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>ECOG CRF</name>
         <type>Alternate Question Text</type>
         <context>ECOG-ACRIN</context>
         <doctext>Procedure</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF Text 5</name>
         <type>Alternate Question Text</type>
         <context>COG</context>
         <doctext>How was this diagnosed?</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Specify method of assessment</name>
         <type>Application Standard Question Text</type>
         <context>NHLBI</context>
         <doctext>Specify method of assessment</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Specify method of assessment</name>
         <type>Alternate Question Text</type>
         <context>NHLBI</context>
         <doctext>Specify method of assessment</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=2309&amp;version=5</cdeBrowserLink>
      </dataElement>
             <validValue>
        <displayOrder>0</displayOrder>
        <value>Not applicable</value>
        <meaningText>NOT APPLICABLE</meaningText>
        <description>Determination of a value is not relevant in the current context.</description>
        <instruction>
         <text>0</text>
        </instruction>
        <valueMeaning>
         <publicID>2581003</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>1</displayOrder>
        <value>CT scan</value>
        <meaningText>CT SCAN</meaningText>
        <description>CT SCAN</description>
        <instruction>
         <text>1</text>
        </instruction>
        <valueMeaning>
         <publicID>2570151</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>2</displayOrder>
        <value>MRI (NMR)</value>
        <meaningText>MRI</meaningText>
        <description>Magnetic Resonance Imaging</description>
        <instruction>
         <text>2</text>
        </instruction>
        <valueMeaning>
         <publicID>2559279</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>3</displayOrder>
        <value>Pathologic</value>
        <meaningText>PATHOLOGIC</meaningText>
        <description>PATHOLOGIC</description>
        <instruction>
         <text>3</text>
        </instruction>
        <valueMeaning>
         <publicID>2559724</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>4</displayOrder>
        <value>Physical exam</value>
        <meaningText>PHYSICAL EXAM</meaningText>
        <description>PHYSICAL EXAM</description>
        <instruction>
         <text>4</text>
        </instruction>
        <valueMeaning>
         <publicID>2559805</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>5</displayOrder>
        <value>Ultrasound</value>
        <meaningText>Ultrasound</meaningText>
        <description>Ultrasound</description>
        <instruction>
         <text>7</text>
        </instruction>
        <valueMeaning>
         <publicID>2570770</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
       <validValue>
        <displayOrder>6</displayOrder>
        <value>Other, specify</value>
        <meaningText>OTHER, SPECIFY</meaningText>
        <description>OTHER, SPECIFY</description>
        <instruction>
         <text>9</text>
        </instruction>
        <valueMeaning>
         <publicID>2570538</publicID>
         <version>1</version>
        </valueMeaning>
       </validValue>
           </question>
     <question>
      <publicID>2488618</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>12</displayOrder>
      <dateCreated>2006-06-22T15:11:34</dateCreated>
      <dateModified>2006-06-22T15:20:16</dateModified>
      <questionText>Clinical Size of Tumor</questionText>
      <instruction>
       <text>at Diagnosis
(If microscopic, enter 0)
cm
(Note:  Record either the maximum diameter of the tumor or the diameter of the expanded cervix principally involved with cancer)</text>
      </instruction>
      <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Primary Tumor Size Measurement</longName>
       <shortName>PRM_TUMOR_SZ_MSRMT</shortName>
       <publicID>1140</publicID>
       <version>3</version>
       <context>CTEP</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>measurement of the primary tumor.</preferredDefinition>
              <valueDomain>
        <longName>Primary Tumor Size Measurement</longName>
        <shortName>PRM_TUMOR_SZ_MSRMT</shortName>
        <publicID>2018529</publicID>
        <version>1</version>
        <type>NonEnumerated</type>
        <context>CTEP</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>NUMBER</datatypeName>
        <maximumLengthNumber>6</maximumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Primary Tumor Size</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Clinical Size of Tumor</name>
         <type>Preferred Question Text</type>
         <context>CTEP</context>
         <doctext>Clinical Size of Tumor</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text2</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Clinical size of tumor (at diagnosis)</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF TEXT 1</name>
         <type>Alternate Question Text</type>
         <context>COG</context>
         <doctext>Primary Tumor Size Measurement</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text 3</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Tumor Size</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF TEXT 2</name>
         <type>Alternate Question Text</type>
         <context>COG</context>
         <doctext>Size of primary tumor at presentation</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text1</name>
         <type>Alternate Question Text</type>
         <context>Alliance</context>
         <doctext>Size of primary tumor</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text_4</name>
         <type>Alternate Question Text</type>
         <context>NRG</context>
         <doctext>Tumor Greatest Dimension (lesion 3-cm)</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text_7</name>
         <type>Alternate Question Text</type>
         <context>NRG</context>
         <doctext>Tumor Greatest Dimension (lesion #3;report in CM)</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>HCMI Question Text</name>
         <type>Alternate Question Text</type>
         <context>OCG</context>
         <doctext>Primary tumor size (cm; largest dimension)</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=1140&amp;version=3</cdeBrowserLink>
      </dataElement>
           </question>
       </module>
   <module>
    <displayOrder>3</displayOrder>
    <maximumModuleRepeat>0</maximumModuleRepeat>
    <longName>Comments</longName>
    <instruction>
     <text>(optional)</text>
    </instruction>
    <preferredDefinition>Allows documentation of any additional cooments </preferredDefinition>
    <publicID>2488508</publicID>
    <version>3</version>
    <usageCategory>
     <usageType>None</usageType>
     <rule>(optional)</rule>
    </usageCategory>
         <question>
      <publicID>2488641</publicID>
      <version>3</version>
      <isDerived>false</isDerived>
      <displayOrder>0</displayOrder>
      <dateCreated>2006-06-22T15:23:31</dateCreated>
      <dateModified>2006-06-22T15:23:38</dateModified>
      <questionText>Comments</questionText>
            <isEditable>Yes</isEditable>
      <multiValue>No</multiValue>
      <dataElement>
       <longName>Research Comments Text</longName>
       <shortName>RSCH_COMMENTS_TXT</shortName>
       <publicID>797</publicID>
       <version>5</version>
       <context>NCI Standards</context>
       <workflowStatusName>RELEASED</workflowStatusName>
       <preferredDefinition>The free text field for general notes.</preferredDefinition>
              <valueDomain>
        <longName>Comments Text</longName>
        <shortName>COM_TXT</shortName>
        <publicID>2015802</publicID>
        <version>3</version>
        <type>NonEnumerated</type>
        <context>NCI Standards</context>
        <workflowStatusName>RELEASED</workflowStatusName>
        <datatypeName>CHARACTER</datatypeName>
        <maximumLengthNumber>200</maximumLengthNumber>
        <minimumLengthNumber>1</minimumLengthNumber>
                              </valueDomain>
                      <referenceDocument>
         <name>CRF Text</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Comments</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Comments</name>
         <type>Preferred Question Text</type>
         <context>NCI Standards</context>
         <doctext>Comments</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>NINDS CDE Project</name>
         <type>REFERENCE</type>
         <context>NINDS</context>
         <doctext>NINDS CDE Project</doctext>
         <languageName>ENGLISH</languageName>
         <URL>http://www.commondataelements.ninds.nih.gov/</URL>
                 </referenceDocument>
        <referenceDocument>
         <name>Notes</name>
         <type>Alternate Question Text</type>
         <context>CCR</context>
         <doctext>Notes</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Optional NCI Standard CRF Question</name>
         <type>COMMENT</type>
         <context>NCIP</context>
         <doctext>No requirement for inclusion on CRF; use this data element if needed.</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>ISA-TAB-Nano</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Comment</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>CRF Text1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Other comments</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Comments related to inadequacy of specimen</name>
         <type>Alternate Question Text</type>
         <context>SWOG</context>
         <doctext>Comments related to inadequacy of specimen</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Session Comments:</name>
         <type>Alternate Question Text</type>
         <context>DCI</context>
         <doctext>Session Comments:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>COG CRF Text 1</name>
         <type>Alternate Question Text</type>
         <context>CTEP</context>
         <doctext>Comments:</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>BPV - Pathology review comments</name>
         <type>Alternate Question Text</type>
         <context>BBRB</context>
         <doctext>Pathology review comments</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>BPV - General Comments</name>
         <type>Alternate Question Text</type>
         <context>BBRB</context>
         <doctext>General Comments</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>BPV - Case Quality Review Comments</name>
         <type>Alternate Question Text</type>
         <context>BBRB</context>
         <doctext>Case Quality Review Comments</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>BPV - Comments to Consent Section</name>
         <type>Alternate Question Text</type>
         <context>BBRB</context>
         <doctext>Comments to Consent Section</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>BPV - Additional Notes</name>
         <type>Alternate Question Text</type>
         <context>BBRB</context>
         <doctext>Additional Notes</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>NRDS Question Text 2</name>
         <type>Alternate Question Text</type>
         <context>NRDS</context>
         <doctext>Comments</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>NRDS Question Text 1</name>
         <type>Alternate Question Text</type>
         <context>NRDS</context>
         <doctext>Comments (Site)</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
        <referenceDocument>
         <name>Pr Margaret - 1</name>
         <type>Alternate Question Text</type>
         <context>NCIP</context>
         <doctext>TPN Comments</doctext>
         <languageName>ENGLISH</languageName>
                 </referenceDocument>
              <cdeBrowserLink>https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&amp;FirstTimer=0&amp;PageId=ElementDetailsGroup&amp;publicId=797&amp;version=5</cdeBrowserLink>
      </dataElement>
           </question>
       </module>
         <referenceDocument>
    <name>PRIMARY_CERVICAL_CANCER-ON-ST*</name>
    <type>IMAGE_FILE</type>
    <context>CTEP</context>
    <doctext>CRF_619.docV2</doctext>
    <languageName>ENGLISH</languageName>
    <attachments>
     <name>F2129525631/crf_619.doc</name>
     <mimeType>application/msword</mimeType>
     <size>27136</size>
    </attachments>
   </referenceDocument>
   <referenceDocument>
    <name>Primary Cervical Cancer - On-S</name>
    <type>PDF</type>
    <context>CTEP</context>
    <doctext>Primary Cervical Cancer - On-Study Form </doctext>
    <attachments>
     <name>F110707260CervicalOnstud__2105880494.pdf</name>
     <mimeType>application/pdf</mimeType>
     <size>151780</size>
    </attachments>
   </referenceDocument>
       <classification>
    <name>Phase</name>
    <publicID>2008608</publicID>
    <version>1</version>
    <preferredDefinition>Phase</preferredDefinition>
    <classificationSchemeItem>
     <name>Phase III</name>
     <publicID>2811890</publicID>
     <version>1</version>
     <type>Phase Type</type>
     <preferredDefinition>Phase III</preferredDefinition>
    </classificationSchemeItem>
   </classification>
   <classification>
    <name>RESERVED FOR SENTINEL MONITOR</name>
    <publicID>2465726</publicID>
    <version>1</version>
    <preferredDefinition>RESERVED FOR SENTINEL MONITOR</preferredDefinition>
    <classificationSchemeItem>
     <name>Monitor for ALAIS</name>
     <publicID>2812288</publicID>
     <version>1</version>
     <type>CATEGORY_TYPE</type>
     <preferredDefinition>Created by system process</preferredDefinition>
    </classificationSchemeItem>
   </classification>
   <classification>
    <name>CRF Disease</name>
    <publicID>2857165</publicID>
    <version>2.31</version>
    <preferredDefinition>this scheme is used to classify by disease case report forms and their associated data elements.  Assignments to this scheme should not be made manually but occur through use of the CRF Loader and the CRT.</preferredDefinition>
    <classificationSchemeItem>
     <name>Gynecologic</name>
     <publicID>2811908</publicID>
     <version>1</version>
     <type>DISEASE_TYPE</type>
     <preferredDefinition>Gynecologic</preferredDefinition>
    </classificationSchemeItem>
   </classification>
   </form>
   </forms>
